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ABSTRACT 
The influence of prenatal exposure to aluminium sulphate (Al2 (SO4 )3)  on 
the behavioural development of mice (Mus musculus) from two inbred strains was 
examined. Pregnant CBAIF6 and C57BLJ'6J mice were exposed by intraperitoneal 
(i.p.) injection (200mg/kg) or orally (750, 1000 and 1250mg/L) to Al, (S94) On 
postnatal day one, pups were cross-fostered and tested in a variety of ethological 
measures, from birth to adulthood, to assess effects on the mother and the behavioural 
development of the pups. As a neurochemical marker for the cholinergic system, 
choline acetyltransferase (ChAT) activity was measured at different developmental 
stages. 
Breeding performance, the length of gestation and sex ratio were 
unaffected by Al exposure administered via the i.p. route. There was a transient 
reduction in maternal weight gain during gestation. CBA pups born to Al-treated 
mothers exhibited lower body weights at birth; this reduction persisted into adulthood 
only in treated pups reared by treated mothers and was more pronounced in the case of 
female mice. The body weight changes were accompanied by delays in the maturation 
of several of the tests of sensory-motor development. Al-treated CBA females were 
hypoactive at weaning compared to controls whilst the converse was true for males. 
77% control and 55% treated males reached criterion in a maze test and controls 
required fewer days to do so. The effect of Al exposure on the cholinergic system was 
dependent on the region of the brain studied, and still showed significant effects in the 
adult. 
In utero exposure to injected Al resulted in a reduction in the rate of 
ultrasonic calling by CBA pups and was accompanied by a delay in the timing of peak 
calling. C57 pups were not affected to the same degree. Exposure to oral Al caused a 
similar but less obvious trend towards a diminished calling. The inclusion of the 
recording of ultrasonic calling is recommended in any test battery aimed at assessing 
behavioural teratogenicity. 
Only slight changes to certain components of maternal behaviour were 
observed following exposure to Al via the i.p. route. Al-exposed CBA females spent 
less time nursing and were more involved in non pup-directed behaviours. 
Conversely, C57 females showed enhanced nursing. Thus, the alterations to pup 
development are unlikely to have resulted from any disruption to maternal behaviour. 
The route of administration proved to be an important factor in 
determining the toxicity of Al2 (SO4)3 and the effects of oral exposure were dose 
dependent. Orally exposed CBA pups had lower birth weights than controls but 
showed few further developmental or behavioural deficits. At the 750mg/L dose 
C57BL/6J pups reared by treated mothers were the heaviest throughout the 
experiment but at the highest dose (125(mg/L) the converse was true. More treated 
males completed the maze and were less affected by a scopolamine challenge than 
controls. The effect of oral Al on ChAT activity was sex, strain and treatment group 
dependent In general, the trend within CBA males, females and C57 females was 
towards a decrease in ChAT levels following oral Al exposure. The trend within C57 
males was more variable. 
These results demonstrate behavioural and neurochemical alterations in 
the offspring of mice exposed to aluminium during gestation. Further, the effects of 
such exposure are also present in the adult animal suggesting persistent changes to 
brain and behaviour following prenatal exposure. Such findings have serious 
implications for the currently assumed lack of risk associated with exposure to 
aluminium. 
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CHAPTER 1 
1.1 GENERAL INTRODUCTION 
Research over the last 50 years has shown that the human 
placenta does not provide an impermeable barrier to the entry of 
foreign agents and that many harmful substances can readily cross it, 
leading to accumulation within the foetus. 
The foetus is unable to metabolise or excrete substances as 
efficiently as the adult due to the immaturity of these pathways 
(Hammarstrm, 1966; Erikson and Yaffe, 1973; Spyker, 1975; 
Weaver, Laker and Nelson, 1984; Mirmiran and De Boer, 1988). 
The human foetal brain is also accessible as the blood-brain barrier is 
not fully developed until the end of the first year of life (Statz and 
, Felgenhauer, 1983). Since human brain development continues into 
infancy, noxious chemicals which can pass into the milk may 
continue to place the neonate at risk. Thus, prenatal exposure to 
chemicals can affect the developing foetus directly and the neonate 
may continue to be affected via the mother's milk. In an environment 
increasingly contaminated with chemicals, the developing foetus and 
neonate are particularly at risk. 
1.1.1 Background to drug testing 
The vulnerability of the developing human foetus has been 
highlighted by two disastrous events. Although research into the 
potential of certain substances to cause malformations in the foetus 
was under way by 1960 (see review by Wilson, 1979), it was not 
until the thalidomide tragedy (McBride, 1961; Lenz, 1962) that the 
susceptibility of the developing foetus was fully realised. During this 
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incident many of those pregnant women prescribed the drug during 
the first trimester of pregnancy (Lenz and Knapp, 1962), gave birth 
to children with severe congenital physical deformities 
(phocomelia). This event emphasised the need, and was undoubtedly 
the impetus, for vigorous and controlled experimentation of 
substances before their release into general circulation. The second 
incident occurred in Japan and involved the ingestion by pregnant 
women of food contaminated with methylmercury. The children of 
these mothers developed neurological and behavioural abnormalities 
as a result of this exposure (Takeuchi, Eto and Eto, 1979). The 
disease which resulted from this incident of methylmercury 
poisoning has become known as the Minamata disease and resulted 
from the disposal of industrial waste in the local river which was 
sequestered by the fish population and thus entered the food chain. 
Over the same period, animal experiments prior to 1960 had 
shown that congenital malformations could be produced in the foetus 
following exposure of the mother to diets deficient in vitamins 
(Warkany and Nelson, 1940), to viral infection e.g. the rubella virus 
(Gregg, 1941, cited in Wilson, 1979) or to radiation (Wilson, Jordan 
and Brent, 1953). Hence it was realised that exposure of the pregnant 
animal to certain substances could alter intrauterine development and 
lead to malformations within the foetus. Thus, the field of teratology 
i.e. the study of substances which can cause overt morphological 
deformities, developed. 
It is known that a considerable proportion of congenital 
anomalies are genetic in origin and this may also be true for 
behavioural abnormalities e.g. mental retardation which forms the 
largest category of defects among children and adults (Kopp and 
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Parmlee, 1986). However, the majority of behavioural anomalies 
have an unknown aetiology and thus it is plausible that some may 
result from teratogenic causes (Wilson, 1973). 
Alterations to brain development can have far reaching 
consequences on subsequent behavioural development even in the 
absence of visible morphological defects (Omoy and Yanai, 1980). 
For this reason, testing of potential teratogens in more recent years 
has considered doses much lower than those required to produce 
obvious morphological alterations within the developing foetus, but 
which may result in longterm subtle behavioural consequences. This 
sub-discipline has been called "behavioural teratology" (Werboff and 
Gottlieb, 1963). 
1.1.2 Behavioural teratology 
The CNS of the developing foetus is especially susceptible 
and is affected at doses far lower than those required to produce 
changes in the adult CNS (Kometsky, 1970; Vorhees and Butcher, 
1982; Riley and Vorhees, 1986). For example, exposure of four-day 
old Sprague-Dawley rats to cadmium chloride (4mg/kg body weight) 
by subcutaneous injection, resulted in lesions within the cerebral 
cortex, cerebellum and caudate-putamen of the neonatal brain and an 
increase in motor activity (Wong and Klassen, 1982). No such 
effects were found following exposure of eight-week old adults to 
the same treatment. The recognition of this point has stimulated 
research into postnatal effects of prenatal exposure to agents which 
can traverse the placenta. This has led to the identification of a wide 
range of substances in our modem environment which can act as 
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behavioural teratogens. Sette (1987) estimates that there are at least 
800 behavioural teratogens, including certain drugs, various food 
additives and contaminants and a range of industrial chemicals. 
Perhaps one of the first behavioural teratogens to be 
identified was alcohol. In 1973 Jones and Smith described a number 
of anomalies in the offspring of alcoholic mothers which included 
growth deficiency, characteristic facial changes and mental 
retardation. These abnormalities have collectively become known as 
the "Foetal Alcohol Syndrome" (FAS). Since its initial description it 
is estimated that the worldwide frequency of FAS is 1.9 in every 
1000 births (Abel and Sokol, 1987). Similarly, identification of the 
Foetal Hydantoin Syndrome resulted from the recognition of several 
abnormalities, including facial anomalies, limb defects and growth 
retardation, in children born to mothers who were prescribed 
anticonvulsants during pregnancy (Hanson and Smith, 1975). 
During this century social change has resulted in many 
more working women, so that their risk of occupational exposure to 
potentially harmful substances is great. Behavioural teratology has 
emerged as a prolific area of scientific research in response to the 
ever increasing number of new chemicals, and the levels of such 
substances, entering the environment and workplace. Between 200 
and 1000 new chemicals are introduced into the marketplace every 
year (Hemminki and Lindbohn, 1988), the behaviour of many of 
which is not fully understood, thus increasing the risk of significant 
human exposure. Hulebak (1987) estimated that 7.7 million 
American workers are exposed to at least 1 of the 67 substances 
which the National Institute for Occupational Safety and Health has 
recommended to be controlled. 
1.1.3 The need for animal studies 
Unfortunately in a number of cases there has been no 
recognition of potential risks to public health until a major human 
disaster has occurred, and animal studies have only been initiated 
afterwards. Further, in humans it is difficult to relate subtle 
behavioural consequences of prenatal exposure to adverse influences 
which may not become apparent until many years after birth. Since 
little is known at present about the effects of many chemicals in the 
environment on human health and, in particular, on the developing 
foetus, the development of animal models enables us to address 
specific questions. The need for adequate and reliable screening of 
new substances warrants urgent research to prevent further 
unnecessary exposures. 
Many test batteries have been recommended for the 
assessment of animals exposed to toxicants (Spyker, 1975; Buelke-
Sam and Kimmel, 1979; Zbinden, 1981; Vorhees and Butcher, 1982; 
Pryor, Uyeno, Tilson and Mitchell, 1983; Tilson and Mitchell, 1984; 
Adams, Buelke-Sam, Kimmel, Nelson, Reiter, Sobotka, Tilson and 
Nelson, 1985). Their underlying principle is that a variety of 
behaviours should be assessed, as it is unlikely that all possible 
toxicants will affect the same behaviour. Thus, any test battery 
should be reliable, reproducible and sensitive to even the most subtle 
of effects. 
The aim of the original project undertaken in this laboratory 
was to develop a rapid and cheap screen for potential behavioural 
teratogens. A number of tests were incorporated into the screen to 
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monitor a wide variety of behaviours. Reliability of this test battery 
in detecting developmental toxicity was established using the known 
behavioural teratogen phenobarbital (Sedowofia, limes, Peter, 
Alleva, Clayton and Manning, 1989). In this thesis the test battery 
has been used to investigate the behavioural teratogenicity of 
aluminium, a ubiquitous element which has been implicated in a 
number of human pathological conditions but whose effects on 
reproduction and teratogenic potential are not known. 
1.2 BEHAVIOURAL TERATOLOGY TESTING 
The main experimental variables which must be considered 
in the design of a behavioural teratological experiment are 
essentially the same as those which govern all experiments in 
teratology. For this reason examples will be drawn from both 
disciplines. These variables are outlined below:- 
i. Stage of gestation at exposure 
The period over which an animal is exposed to an insult 
determines the type of change which results. The importance of this 
principle was recognised as long ago as 1931 when Stockard noted 
that the induction of certain types of malformation was dependent on 
the time of exposure (cited in Wilson, 1979). In the human, Lenz and 
Knapp (1962) have estimated that the critical stage of pregnancy 
during which exposure to thalidomide results in physical deformities, 
is between postconception days 27-40. 
Eel 
It is considered that in the rodent exposure to an agent 
during the first or third week of gestation is without effect, but that 
the second week represents a time of vulnerability as it is during this 
stage that organogenesis occurs (Coyle, Wagner and Singer, 1976; 
Vorhees and Butcher, 1982; Kutscher and Nelson, 1985). Although 
this is generally true exceptions can be found. For example, the 
exposure of pregnant Wistar rats to vitamin A on gestation days 17 
and 18, following completion of organogenesis, resulted in learning 
deficits (Hutchings and Gaston, 1974). 
Prenatal exposure of Sprague-Dawley rat pups to 
l methylmercury (8mg/kg) on day 8 of gestation, increased the 
duration and decreased the frequency of ultrasonic calling during 
postnatal days 4-8. No differences were found if the same dose was 
administered on day 15 of gestation (Cagiano, Cortese, De Saliva, 
Renna and Cuomo, 1988). 
ii. Route of administration 
Toxic effects of substances may be altered markedly by the 
means by which they are introduced into the subject. For example, 
Kimmel (1977) exposed pregnant CD rats to disodium 
ethylenediamine tetraacetic acid (EDTA), a chelating agent, either in 
the diet, by gastric intubation or by subcutaneous (s.c) injection 
during days 7-14 of gestation. EDTA present in the diet did not 
result in any maternal deaths but did cause severe maternal toxicity; 
following gastric intubation three quarters of the exposed mothers 
died and EDTA proved to be lethal to some pregnant dams upon s.c 
injection (Kimmel, 1977). Conversely, EDTA caused a high 
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incidence of malformations within the offspring of dams exposed via 
the diet, fewer malformations if exposure was by gastric intubation 
and no signs of offspring malformations following administration by 
S.0 injection (Kimmel, 1977). 
W. Dose 
It may be presumed that any substance has the potential to 
be teratogenic if it is administered at a sufficiently high dose. It is 
not the aim of behavioural teratologists to use doses which result in 
physical malformations but rather to test a range of doses to assess 
their ability to cause more subtle behavioural anomalies. Hughes and 
Annau (1976) administered methylmercury (MeHg) hydroxide by 
intubation to pregnant CFW mice at a dose of 0, 1, 2, 3, 5 or 
10mg/kg body weight, and found that the litter size decreased as a 
function of dose. The mean number of pups per litter was 
8.55(±0.71) following exposure to methylmercury hydroxide at 1 
mg/kg, compared to a mean of 2.53(±0.94) after the 10mg/kg dose 
(Hughes and Annau, 1976). 
Exposure of Sprague-Dawley rats to MeHg at a dose of 
0.25, 1.25, 2.5 or 5.0mg/kg by gavage on gestation days 6-15, 
resulted in a delay in surface righting and an increase in the number 
of central squares entered by subjects exposed to the 2.5mg/kg dose 
only (Geyer, Butcher and Fite, 1985). 
nj 
Chemical nature of the agent 
The effects of exposure to a substance is determined by its 
chemical speciation. Exposure of pregnant Sprague-Dawley rats to 
vaiproic acid, an anticonvulsant commonly used in the treatment of 
epilepsy, at a dose of 300mg/kg during days 7-18 of gestation, 
resulted in reduced maternal and foetal weight and an increase in 
offspring malformations. When valproate was administered as trans-
2-ene valproic acid no such effects were seen (Vorhees, Acuff-
Smith, Weisenburger, Minck, Berry, Setchell and Nau, 1991). The 
absorption of mercury (Hg) is increased when it is in an alkylated 
form. Kutscher and Nelson (1985) have estimated that the absorption 
of Hg from the rat gut is 0.01%, 15% and 18% of the delivered dose 
for liquid Hg, inorganic Hg and MeHg respectively. 
Species susceptibility 
The thalidomide tragedy highlighted a major consideration 
for testing potential teratogens i.e. species differences in 
susceptibility to a substance, and it provides one of the most striking 
examples. Research into thalidomide was carried out only with rats 
which proved to be insensitive to its effects, whilst exposure of 
primates and rabbits can result in the characteristic phocomelia. 
Pharmacogenetic factors e.g. differences in rates of uptake, 
metabolism and excretion, are responsible for such differences 
(Clayton, 1980; Clayton and Zehir, 1982; Yanai, 1983; Shuster, 
1990). However, not only have studies investigating the effects of an 
agent on the developing foetus found large variations in the response 
of different species, but there are also considerable differences 
between strains of the same species. For example, following prenatal 
exposure to methylmercury (10mg/kg) on day 14, 15, 16 or 17 of 
gestation, 67, 88, 75 and 48% of B 10.D2 mice offspring were found 
to have developed hydrocephalus whereas offspring from the 
C57BL/6 inbred strain developed hydrocephalus following day 15 
exposure only and offspring from the DBA/2 strain never developed 
it (Inouye and Kajiwara, 1990). Finnell, Shields, Taylor and 
Chemoff (1987) found the LM/BC inbred mouse strain to be more 
sensitive to the effects of gestational oral administration of 
phenobarbital (240mg/kg) than the C57BL/6J strain. 47% of LM/BC 
foetuses exhibited congenital malformations compared to 29% 
within the C57BL/6J strain (Finnell, et al., 1987). 
In addition to the above variables, the effect of early environmental 
influences on postnatal development suggests further design 
requirements for good experiments. 
vi. Fostering 
The influence of the mother on postnatal pup development 
has proved to be a confounding variable in behavioural teratology 
experiments. Any alteration to the hormonal, nutritional or 
behavioural status of the mother following prenatal drug treatments, 
may alter her ability to maintain or initiate adequate maternal care, 
which will have consequences for the development of the offspring. 
In order to differentiate between the direct effects of a toxicant upon 
the developing foetus from indirect postnatal effects arising from 
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continued transfer to the neonate via the dam's milk, a fostering 
procedure should be included in the experimental design. Many 
authors have recommended this (Spyker, 1975; Coyle, Wagner and 
Singer, 1976; Hutchings, 1985; Chiarotti, Alleva and Bignami, 1987; 
Tilson, 1987), whilst others have questioned the validity of studies 
which have not included such a procedure (Abel, 1978; Tucker, 
1985). 
vii. Characteristics of the litter 
The litter in itself is a unit and a pup's behavioural 
development can be influenced by a number of factors relating to the 
characteristics of the litter in which it is reared. Thus, a pup can not 
be considered in isolation and the effect of such variables on 
development has been recognised as a source of variation which 
should be controlled for (Kimmel, Buelke-Sam and Adams, 1985; 
Chiarotti, Alleva and Bignami, 1987). A further advantage of 
incorporating a fostering procedure, especially one involving cross-
fostering during which pups are distributed between experimental 
groups, is that such effects are reduced (Ulbrich, Schreiner and Bass, 
1985). 
Further, the number of offspring present in a litter should be 
kept constant to even out litter effects and to avoid any nutritional 
stress. 
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1.3 WHY THE INTEREST IN ALUMINIUM? 
Aluminium (Al) is the third most abundant element in the 
earth's crust. It is ubiquitous in nature and because of its high 
reactivity and amphoteric properties it is usually found in 
combination with other elements especially oxygen. Al is not 
thought to have a biological function although it has been suggested 
that man has a definite need for it for normal metabolism (Sorenson, 
Campbell, Tepper and Lugg, 1974). For a long time it was presumed 
that exposure to Al was without toxic effect. As a result of this 
assumed safety, Al has become widely used in the food and food 
processing industries, in cookware, medicine, cosmetics and as a 
flocculant in water treatment, all of which increase the daily intake 
of Al. Greger (1985) estimates the daily adult Al intake to be 20-
40mg Al/day. This compares to an intake of between 840-5000mg 
following antacid ingestion (Lione, 1983). From these diverse routes 
of contact, exposure to Al is unavoidable. However, in contrast to 
this assumed harmlessness, Al has, in more recent years, been 
implicated as a causative factor in several human diseases. 
The lack of concern over the effects of Al ingestion 
probably resulted from the assumption that it was not absorbed from 
the gastrointestinal (GI) tract, and under normal conditions any Al 
which did enter the body would be effectively excreted by the 
kidneys (Lote and Saunders, 1991). It is now known that this is not 
the case and that Al can be absorbed both in rats, following ingestion 
of aluminium chloride (A1C13) (Berlyne, Yagil, Ben An, 
Weinberger, Knopf and Danovitch, 1972; Bowdler, Beasley, Fritze, 
Goulette, Hatton, Hession, Ostman, Rugg, and Schmittdiel, 1979; 
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Commissaris, Cordon, Sprague, Keiser, Mayor and Rech, 1982) and 
in humans e.g. from the ingestion of Al containing antacids used to 
prevent hyperphosphatemia in dialysis patients and in the treatment 
of gastric ulcers (Kaehny, Hegg and Aifrey, 1977; King, Savory and 
Wills, 1981). Moreover, the absorption of Al from the gut is known 
to be influenced by the presence of certain factors. Mayor, Keiser, 
Makdani and Ku (1977) found the Al concentration in muscle, brain 
and bone of rats fed a diet of rat chow containing 0.1% Aid3 and 
If injected with parathyroid hormone, to be greater than in rats fed only 
the diet. This is of importance for patients on dialysis where high 
levels of parathyroid hormone are common. 
Penetration of the body's barriers by Al has also been found 




, LooI f, Slorach and Cedergren (1986) have reported 
elevated blood Al levels in normal human subjects following 
ingestion of aluminium hydroxide (Al(OH)3) in the presence of 
citric acid. Similarly, Kruck and McLachlan (1989) found that three 
days following the administration of aluminium maltolate, 
commonly used in the food processing industry, the plasma Al level 
was still elevated in treated animals compared to controls. Moreover, 
possible sites and mechanisms of absorption of Al from the GI tract 
have been proposed (Savory and Wills, 1991). This evidence 
suggests that Al can indeed be absorbed and that this absorption is 
augmented by the concomitant ingestion of certain substances in 
common use. 
Al has been found to interfere with normal levels of some 
elements which perform essential functions within the body. A 
phosphor us-depletion syndrome involving such symptoms as 
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hypophosphatemia and osteomalacia (demineralisation of bone) has 
been correlated with the chronic ingestion of antacids (Bloom and 
Flinchum, 1960; Ondreicka, Ginter and Kortus, 1966; Lotz, Zisman 
and Bartter, 1968). Antacids have also been found to decrease the 
absorption of fluoride (Spencer, Kramer, Norrie and Wiatrowski, 
1980), which has further consequences for bone. Al combines 
competitively with calmodulin affecting calcium (Ca) regulation 
(Siegel and Haug, 1983) and Ca dependent processes e.g. within the 
1heart which is regulated by Ca dependent channels. 
Another possible route of entry to the human body is 
through the respiratory tract. Evidence for this has accumulated from 
the results of studies investigating the significance of industrial 
exposure to Al. McLaughlin, Kazantzis, King, Teare, Porter and 
Owen (1962) reported increased Al content in the lungs and brain of 
workers in an Al powder factory. Further, workers exposed to 
McIntyre powder (consisting of aluminium oxide), used in Canada 
up to 1979 to prevent lung disease arising from exposure to silica, 
did not score as well on tests of cognitive function as did unexposed 
workers (Rifat, Eastwood, Crapper McLachlan and Corey, 1990). 
During the last 20 years research involving Al has focused 
on its neurotoxic actions. Possible Al neurotoxicity was described as 
long ago as 1897 when Dlken found that injected aluminium 
tartrate produced neuronal degeneration in rabbits (cited in Boegman 
and Bates, 1984). However, it was not until more recently that Al's 
role as a potential neurotoxin was fully recognised. In their extensive 
review article concerning Al's role in the environment and human 
health, Sorenson, Campbell, Tepper and Lugg in 1974 concluded 
that :- 
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".... there is no need for concern by the public or producers of 
aluminium or its products concerning hazards to human health 
den ved from well established and extensively used products." 
Within two years of this publication a new clinical 
syndrome, dialysis encephalopathy which linked Al to a fatal 
dementia, had been described (Alfrey, LeGendre and Kaehny, 1976). 
In 1976 Aifrey, LeGendre and Kaehny found an increase in the Al 
content of brain gray matter of patients with dialysis dementia. This 
finding was supported by Dunea, Mahurkar, Mandani and Smith 
(1978) who reported an increased incidence of this condition in 
patients on long-term dialysis after a change in the method of water 
purification, which resulted in higher levels of Al. Again, 
postmortem autopsies revealed a raised brain Al content. This 
condition is now recognised as dialysis encephalopathy, i.e. a 
progressive, fatal dementia associated with long-term dialysis 
treatment (Aifrey, et al., 1976). 
In natural populations, a similar form of dementia has been 
described from regions where there are high levels of Al salts present 
in the soil e.g. Guam, and the Kii peninsula of Japan. Pen, Gajdusek, 
Garruto, Yanagihara and Gibbs (1982) were the first to recognise the 
high incidence of amyotrophic lateral sclerosis and Parkinsonian 
dementia in such regions. The most striking point inferred from these 
studies is that under conditions of excess Al exposure, and in 
contrast to the assumptions outlined above, Al can be absorbed into 
the body. 
Perhaps the most discussed neurotoxic effect associated 
with Al, is its implication as a possible causative factor in 
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Alzheimer's disease. Alzheimer's disease is a progressive 
neurodegenerative disorder which results in the gradual loss of 
cognitive abilities (Crapper, Krishnan and Dalton, 1973; Coyle, Price 
and DeLong, 1983; Mann, 1988). It is characterised 
neuropathologically by the presence of senile plaques (SP) (Kidd, 
1964), which consist of a central core of amyloid protein, and 
neurofibrillary tangles (NFT) which are dense tangles of 
degenerating nerve terminals and consist of paired-helical filaments 
(Kruck and McLachlan, 1988; Mann, 1988). Neurochemically, 
reductions in the enzymatic activities of choline acetyltransferase 
(ChAT) and acetylcholine esterase (AChE) can be measured, the 
extent of which varies in different brain regions (Davies and 
Maloney, 1976; Perry, 1978; Reisine, Yamamura, Bird, Spokes and 
Enna, 1978; Whitehouse, Price, Struble, Clark, Coyle and DeLong, 
1982). Changes related to other neurochemical systems in 
Alzheimer's disease are not as clearly defined. Davies (1979) found a 
small reduction in glutamine decarboxylase in 3 out of 20 brain 
regions investigated and decreases in -aminobutyric acid (GAB A) 
receptors have been reported (Reisine, et al., 1978). Increases in 
dopamine (Wenk and Stemmer, 1981) and noradrenaline (Yates, 
Ritchie, Simpson, Maloney and Gordon, 1981) have also been 
reported in Alzheimer's disease patients. However, despite the 
discrepanies with regard to other neurochemical systems, a 
considerable number of studies agree that the most extensive and 
specific neurochemical changes associated with Alzheimer's disease 
are within the cholinergic system. The reduction in ChAT activity 
and the morphological changes in Alzheimer's disease are correlated 
with the extent of impairment of cognitive abilities (Perry, 
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Tomlinson, Blessed, Bergman, Gibson and Perry, 1978; DeBoni and 
Crapper McLachlan, 1980). 
Since these initial findings studies have concentrated on the 
experimental induction of neurodegeneration similar to that found in 
the human brain. Crapper, Krishnan and Dalton (1973) induced 
NFTs following injection of Aid3 into the ventral hippocampus of 
the cat. Similarly, tangles have been induced in the brainstem and 
/ spinal cord of the rabbit after intracisternal injections of Aid3 
(Yates, Gordon and Wilson, 1976). It is of interest to note that rats 
do not develop NFT's even when the dose injected is 5 or 6 times 
greater than that required to induce them in the cat (King, DeBoni 
and Crapper, 1975). Adult animal models of neurodegeneration have 
been complicated by the development of other neurologic signs. 
Rabe, Lee, Shek and Wisniewski (1982) have developed a model in 
the immature rabbit, by intracranial injection of A1C13, which 
induces neurodegeneration and learning deficits but with no other 
neurological signs. 
However, these animal models have been considered 
limited in their application to the human situation, because the 
morphology of the tangles induced experimentally are not identical 
to those found in the Alzheimer's diseased brain (Kruck and 
McLachlan, 1988). Tangle production may vary between species but 
other neurochemicai changes seem to be consistent, as evidenced by 
the demonstration of a concurrent loss of ChAT in tissue containing 
tangles in the rabbit (Yates, Simpson, Russell and Gordon, 1980). 
The experimental induction of NFF's by the application of Al salts 
has provided evidence for a role of Al in the aetiology of 
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Alzheimer's disease. Despite their limitations these models provide a 
starting point for the development of possible therapies. 
The controversy remains whether Al is the primary 
causative factor in the aetiology of Alzheimer's disease or is 
secondary to pathological changes resulting from an insult which 
then cause Al to accumulate within specific susceptible brain 
regions. Further support for the association of Al with Alzheimer's 
disease has come from studies which have found Al in the SP and 
NFT of Alzheimer's diseased brains (Crapper, Krishnan and Dalton, 
1973; Perl and Brody, 1980; Candy, Oakley, Klinowski, Carpenter, 
Perry, Atack, Perry, Blessed, Fairbum, and Edwardson, 1986; Pen 
and Good, 1988) and from epidemiological evidence which links the 
levels of Al in water with the incidence of Alzheimer's disease 
(Martyn, Barker, Osmond, Harris, Edwardson and Lacey, 1989). 
However, more recently doubt has been cast on the involvement of 
Al in Alzheimer's disease as some studies, using a different 
experimental technique, have failed to confirm the presence of Al in 
SP and NFT of the Alzheimer's diseased brain (Chafi, Hauw, 
Rancurel, Berry and Galle, 1991; Landesberg, McDonald and Watt, 
1992) 
The propensity to develop Alzheimer's disease is not the 
consequence of any single factor but may result from exposure to 
environmental agents or from genetic susceptibility or an interaction 
of the two. 
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1.3.1 Aluminium and Behavioural Teratology 
The information reviewed above indicates that, under 
normal conditions, the body is effective in limiting the entry of Al 
but when Al levels are high this may not be the case. This points to a 
need for an increased awareness of the possible toxic role played by 
Al. There must be concern as the amounts of Al entering the 
environment are increasing. With the increase in the release of 
sulphuric and nitric acids into the atmosphere from industry there is 
a corresponding increase in Al being leached from the soil into 
surface water (Cronan and Scholfield, 1979; Savory and Wills, 
1991). Industry also causes increased levels of Al in the area 
surrounding Al smelters and there have been accidents with the 
content of aluminium sulphate (Al2(SO4)3 in domestic water 
supplies, several of which have been reported recently (see for 
example Cross, 1990). Moreover, Martyn, et al., (1989) have related 
the level of Al in the drinking water in England and Wales with the 
incidence of Alzheimer's disease. With this increase in 
environmental Al there is an increased likelihood of unknowingly 
being exposed to Al. This is of particular concern with respect to the 
developing foetus which is, as mentioned in chapter 1, in general 
more susceptible and is affected at doses far lower than those 
required to produce changes in the adult CNS (Vorhees and Butcher, 
1982; Riley and Vorhees, 1986). 
Of greater relevance to behavioural teratology is the 
accumulating clinical evidence which points to Al loading in infants 
(see the Introduction to chapter 6 for further details) following 
exposure to antacids containing high levels of Al (Griswold, Reznik, 
19 
Mendoza, Trauner and Aifrey, 1983; Andreoli, Bergstein and 
Sherrard, 1984), from intravenous feeding of infants (Sedman, Klein, 
Merritt, Miller, Weber, Gill, Anand and Alfrey, 1985) and from Al 
present in infant formula (Freundlich, Zilleruelo, Abitol, Strauss, 
Faugere and Malluche, 1985). Exposure via these routes is of 
particular concern considering the known immaturity of metabolic 
pathways (Weaver, Laker and Nelson, 1984) and the blood-brain 
barrier in infants (Statz and Felgenhauer, 1983). 
In the only documented study of accidental exposure of 
pregnant women to high levels of oral Al, Golding, Rowland, 
Greenwood and Lunt (1991) did not find a greater incidence of 
perinatal death, low birth weight, premature delivery or congenital 
malformations. There was an increased incidence of talipes (club 
foot) among exposed infants (4 cases compared to 1 control). 
However, this paper considered reproductive measures only and did 
not include any behavioural studies. 
Detailed studies on the consequences of exposure to Al 
compounds during pregnancy and the early postnatal period are still 
lacking. Indeed in a recent review (Savory and Wills, 1991) no 
reference was made to Al's possible effects on reproduction. In 
recent years some attention has been given to such effects on the 
developing foetus but a full evaluation of risk effects has not been 
undertaken. This is of concern since exposure of the developing 
nervous system to insults may have very different consequences .çrm 
those resulting from exposure of the adult nervous system (e.g. 
Wong and Kiassen, 1982). 
Proliferation of research within this field may have been 
hampered by the lack of precise knowledge of the pharmacokinetics 
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of Al and from the lack of a suitable radioisotope. In addition, early 
work in this area yielded few adverse effects of exposure (Myers and 
Mull, 1928; MacKenzie, 1932; and more recently Schroeder and 
Mitchener, 1975). For example, Myers and Mull (1928) fed albino 
rats a diet supplemented with 2mg of Al over 100 days. They did not 
find any differences in litter size or the number of stillborn. 
Schroeder and Mitchener (1975) exposed Long-Evans rats to 5ppm 
aluminium potassium sulphate in their drinking water throughout 
life. After exposure for one year, male rats were slightly heavier than 
controls and exhibited an increased incidence of tumors. This was 
not the case for females and no reproductive measures were reported 
(Schroeder and Mitchener, 1975). 
Although the literature is limited, some studies do exist 
which have considered the effects of exposure to Al compounds 
during pregnancy and the early postnatal period, and these are 
reviewed in the introductions to the relevant chapters (see chapters 3 
and 6). Within these studies it is difficult to draw conclusions, as 
different studies have employed different Al salts. Such salts have 
differential solubilities which can result in altered levels of Al in 
tissues even when the dose applied initially is similar (LeBlondel 
and Allain, 1980; Krueger, Morris, Suskind and Widner, 1985; 
Martin, 1986). As has already been noted, there are species 
differences in the sensitivity to Al which further complicates the 
issue. 
Of those studies which have addressed this question, most 
have been concerned with effects on reproduction only and have not 
followed subjects into adulthood to test whether in utero exposure to 
Al has persistent effects. There are no studies which have measured 
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any neurochemical changes occurring as a result of gestational 
exposure even though research has implied an association between 
Al and the cholinergic system. For this reason an assay for ChAT 
activity, as a cholinergic system marker, has been included in some 
of the experiments described in this thesis. Assays were performed 
on a number of brain regions because, as noted earlier, there are 
differences in the extent to which ChAT levels are affected in 
different brain areas and also at different ages. 
Al2(SO4)3 was used in the experiments reported herein 
because, unlike other Al compounds e.g. A1C13 and Al(OH)3, it is 
soluble in water although only over a limited pH range (pH 3-4.5; 
Martin, 1986), and because it has been directly implicated in recent 
environmental accidents. 
1.4 EXPERIMENTAL ANIMALS 
The house mouse (Mus musculus) has several 
characteristics which have made it the subject of choice in many 
research laboratories. They are cheap, breed throughout the year, 
reach reproductive age by 8 weeks, have short gestation lengths 
(19±2 days) and large litter sizes. They have an adequate repertoire 
of behaviours which can be measured and quantified. Moreover, a 
large literature exists which describes such behaviours and their 
ontogeny thus providing a reference against which any deviation can 
be assessed. Mice can be tested repeatedly throughout life to monitor 
the influence of age or developmental stage on the effects of 
exposure to an external variable. 
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In addition, and in more specific terms for teratology 
testing, the choice of rodents as experimental subjects is 
advantageous as they have the same placentation as primates, the 
haemochorial, in which the mother's blood system is in very close 
contact to that of the foetus. This implies that results of drug or 
chemical testing for teratogenicity in the mouse model are relevant 
and applicable to the human situation. 
Within inbred strains all individuals are virtually isogenic. 
Hay (1978) puts forward two main advantages of using such strains 
in the study of behaviour. Firstly, from a statistical point of view, the 
"error" i.e. the term used to describe the variation between 
experimental subjects, will be reduced by using individuals whose 
genetic variation is at a minimum with the result that smaller sample 
sizes can be used. This has obvious advantages from an ethical 
viewpoint which aims at reducing the number of animals used in 
scientific experiments. Secondly, the availability of these strains 
increases the universality of experiments across laboratories again 
with obvious advantages. Indeed, Festing (1975) found constancy in 
the openfield activity of 8 inbred strains of mice tested 13 years 
apart. 
Many groups of researchers have used rodents as subjects 
for experimental studies for potential behavioural teratogens for the 
reasons outlined above. Debate exists as to the comparability of 
results from-rodent experiments I with the human situation There is 
however considerable confidence in the validity of such studies 
substantiated by extensive comparisons of the effects of several 
established behavioural teratogens in rodents and humans. Adams 
(1986) has shown that the particular effect of a given teratogen on 
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nervous function in mice was essentially the same as those produced 
in humans exposed prenatally. Chen, Driscoll and Riley (1982), for 
example, have found that exposure of pregnant Long-Evans hooded 
rats to ethanol (35% ethanol-derived calories) during gestation days 
6-20, resulted in their offspring exhibiting increased latencies to 
attach to a nipple during days 6-12 postpartum. This suckling deficit 
within the treated group was not present at 13-21 days of age. This is 
consistent with clinical reports which have shown that human infants 
exposed to ethanol prenatally have similar transient alterations in 
suckling behaviour (Streissguth, Landesman-Dwyer, Martin and 
Smith, 1980). Similar examples of comparability exist for 
anticonvulsants (Adams, Vorhees and Middaugh, 1990), drugs of 
abuse (Hutchings, 1990), lead (Davies, Otto, Weil and Grant, 1990) 
and methylmercury (Burbacher, Rodier and Weiss, 1990). 
Since subtle behavioural and psychological changes are not 
always immediately apparent, the attribution of such an effect to a 
substance taken by the mother during pregnancy is difficult. Animal 
models can provide a starting point for the identification of such 
causal pathways. 
A further problem in identifing and assessing behavioural 
teratogenicity in humans is genetic variability. Genetically based 
differences in behaviour and in the rate of development must be 
taken into consideration when assessing the effects of exposure to 
teratogens. Again the use of inbred strains provides a clearer picture. 
As described in 1 .2v, investigations into the effects of an agent on 
the developing foetus have revealed large variations in the response 
of different species to a teratogenic agent and similar variations 
between strains of the same species. For this reason, two unrelated 
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strains of mice (CBA/T6 and C57BL/6J), which are known to differ 
in a variety of ways (van Oortmerssen, 1971; Stewart, Manning and 
Batty, 1980; Ammassari-Teule and Caprioli, 1985), were used in this 
study. They form a basic tool for investigating how far any effects of 
Al can be considered general or are of wide applicability. 
The experiments described in this thesis were of 
longitudinal design; testing of the same subject continued throughout 
the postnatal period and into adulthood, representing different 
developmental stages. This enables one to monitor whether effects 
from exposure are transient and may be recovered from, persist 
throughout life or whether normal decreases in abilities with age are 
enhanced. Moreover, it was possible to assess the presence of any 
delayed behavioural and neurochemical effects resulting from early 
prenatal exposure which may only arise late in development. 
1.5 AIMS 
The study aimed at investigating the effects of prenatal 
exposure to Al on aspects of behavioural development and 
neurochemistry of two inbred strains of mice. Al was administered 
via both intraperitoneal and oral routes to assess the contribution of 
the route of administration on effects resulting from exposure to Al. 
The protocol includes a wide range of behavioural tests carried out 
over a wide range of ages. When there were sufficient subjects to 
enable culling at different ages, ChAT activity was measured at 
different developmental stages to determine whether effects from 
exposure to Al are transient and ar e recoverable, or persist into 
adulthood. It was also hoped that any changes in behaviour could, at 
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least to some degree, be correlated with neurochemistry although it 
is recognised that there is no simple link between brain and 
behaviour and that a number of neurotransmitter systems may be 
involved in the expression of a particular behaviour. 
Unlike many other studies in behavioural teratology which 
have only considered one variable, this study aims at providing a 
broader view of possible effects of prenatal exposure to Al by taking 
behavioural, neurochemical and genetic aspects into consideration. 
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CHAPTER 2 
2.1 GENERAL MATERIALS AND METHODS 
A number of procedures are common to each experiment 
and these are presented below. Where methods are specific to a 
particular experiment they are described in the relevant chapter. 
2.1.1 Experimental animals 
Mice from two inbred strains (CBA/I'6 and C57BL/6J, 
from hereafter referred to as CBA and C57), were used as 
experimental subjects. These strains have been bred in the animal 
house of the Zoology Department since 1978. Virgin females 
between 10-12 weeks of age were mated with males from the same 
strain. Females were checked daily for vaginal plugs. On 
identification of a plug they were individually housed in standard 
plastic cages (31 x 13 x 12cm 3) lined with wood shavings. All mice 
were maintained in an air-conditioned room with a revers12 hour 
light/dark cycle (white lights on 21.00hr) and at a temperature of 
22±20C. Forced ventilation provided a constant background noise 
which minimised any disturbance to the mice caused by the 
experimenter's movements. Food (SDS breeding diet) and tap water 
with added chlorine were freely available. 
2.1.2 Treatment 
On gestation day 10 (GdlO), pregnant females were 
randomly assigned to one of two groups. The allocation of 
treatments was coded to minimise any observer effect. In each 
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experiment one group was administered Al2(SO4)3.18H20 either 
intraperitoneally (i.p.) or orally via the drinking water, at a particular 
dose and for a specific period of gestation. The exact treatment 
received is given in each experimental chapter. The control group 
received the equivalent volume of saline acidified to the same pH as 
the Al solution (pH=4.1). Maternal weights were recorded during 
gestation. On Gd18 half of the pregnant females were removed, their 
foetuses used for tissue culture in an experimental series which does 
not form part of this report. 
2.2 PROCEDURES 
The remaining pregnant females were checked twice daily 
for pups (09.30a.m and 17.00 p.m). On the day of birth (postnatal 
day 0, PdO) mothers were allowed to deliver their offspring 
normally, litter size was recorded and the sex of each pup was 
determined. On Pdl all pups born were weighed and each litter was 
culled to four pups, leaving two males and two females where 
possible. This litter size was considered sufficient to elicit normal 
maternal care but small enough to prevent competition between pups 
which may lead to undernutrition in large litters reared by inbred 
mothers. 
Each pup was toe-clipped for individual identification. 
Male pups were toe-clipped on digits 1 and 3, and females on digits 
2 and 4 of the left paw. The pups were cross-fostered using a 
balanced split-litter total cross-foster procedure (Chariotti, Alleva 
and Bignami, 1987), with other litters born within the same 12 hour 























I and 3 = male 	2 and 4 = female 
two treated pups from other litters and in this way none of them 
reared any of their own pups. Hence the pups could be divided into 
four experimental groups; control pups cross-fostered to control 
mothers (Cc), control pups fostered to treated mothers (Ct), treated 
pups fostered to control mothers (Tc) and treated pups fostered to 
treated mothers (Tt). 
2.2.1 Pup behaviours 
Each pup underwent two types of behavioural testing, 
which were carried out on every third day from Pd3 to Pd18, during 
the early part of the dark phase when pups are considered to be at 
their most active (Alleva, Aloe and Laviola, 1986). Firstly, the pup 
was placed in the centre of an openfield measuring 40 x 40cm 2, the 
base of which was divided into 10cm 3 squares. Uniform lighting was 
achieved by a 25W bulb suspended above and in the centre of the 
field. Observation was facilitated by using a mirror fixed above the 
openfleld which obscured the experimenter from view by the pups. 
The number of squares crossed and several items of behaviour were 
observed for three minutes and recorded on a keyboard linked to a 
computer. Squares were defined as crossed when two paws had 
crossed a line. The pup behaviours recorded were as follows :- 
Pivoting - The pup is attempting to crawl but due to the immaturity 
of its hindlimbs only manages a circular movement. 
Crawling - The pup is actively moving around the openfleld. 
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Rearing - The pup is standing on its hindlimbs. 
Edgeon - The pup is rearing against a wall of the openfleld. 
Grooming - The pup is licking any part of its body. 
Still - The pup is still and not involved in any of the other 
behaviours. 
Headup - The pup is still except for raising its head. 
Onback - During one of the other pup behaviours, the pup falls over 
onto its back. 
In addition, the pups underwent a modified version of the 
Fox battery of tests for sensory-motor development (Fox, 1965). The 
following tests were carried out :- 
Righting reflex - Pups were placed on their backs and the ability to 
reorientate themselves onto all four paws was scored. By Pd9 slow 
righting gives way to swift righting involving one continuous and 
co-ordinated movement. The change is unmistakable and for swift 
righting a measure of time to complete this movement was 
measured. 
Cliff aversion - Pups were placed with forepaws over the edge of a 
wooden block, the occurrence of a turning response away from the 
edge was recorded. 
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Forelimb grasping - The underside of a fore paw is gently stroked 
with a cocktail stick and the strength of flexion of the digits is 
scored. 
Pole grasping - The stick is placed under the forelimbs and slowly 
raised to measure the ability of the pup to hold on to the "pole". In a 
mature response the pup clambers up using its hind feet. 
Screen climbing - A pup is placed at the bottom of a horizontal wire 
mesh which is then moved to the vertical. The ability of the pup to 
hold on to the screen and climb to the top was measured. 
Eye opening - An adult response was recorded when both eyes were 
fully opened presenting a full circular appearance. 
This order of testing remained unchanged throughout the 
experiment and each pup was tested once per occasion. The pups 
were assessed on a scale from 0 to 3, 3 being the equivalent of a 
mature response. Finally, the pups were weighed and returned to the 
home cage. Individual litters were tested at a different time during 
each experimental day to counteract any circadian effects. Handling 
of the pups was kept constant and to a minimum throughout testing 
to prevent the enhancing effect this is known to have on pup 
development (Levine, 1958). 
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2.2.2 Tests at weaning 
On Pd21 each pup was observed in the openfield, this time 
for five minutes, again recording the number of squares crossed 
using a hand tally. At the end of this period, a novel object in the 
form of a white cube (65 x 65cm3 ), was introduced into the centre 
of the arena once the subject had moved into one of the corner 
squares. Latency to contact the object was recorded, each subject 
being given a maximum of three minutes to do so, after which the 
test was terminated. Timing was stopped when the subject made 
actual contact with the novel object, often with the tip of the nose 
first. The pups were then weaned into single sex cages in groups of 
2-3. Weekly weights were recorded throughout the duration of 
testing. 
2.2.3 Maze testing 
Ten week old male mice were tested in an 8-arm radial 
maze. Females were not used because it is known that males are 
superior in learning tasks of this kind (Schulze, 1976; Lamberty and 
Gower, 1988). This may be due to the possible effects of the 
oestrous cycle on performance in the maze (Tsujii and Hoshishima, 
1979) or because females may be less able to withstand the weight 
loss associated with food deprivation. The maze consisted of a 
circular base into which the arms were slotted. This formed an 
octagonal central platform (diam 100cm) from which eight arms 
(length 40cm, width 8cm) radiated. The walls of the arms were 
constructed from black plexiglass. Each arm was also covered with 
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clear plexiglass to prevent subjects from escaping or from passing 
from one arm to another without returning to the centre. Each arm 
was numbered to enable recording of arm entries. A food dish was 
placed at the end of each arm and was baited with a small piece of 
food pellet prior to each trial. A lamp (15W) 30cm above the central 
platform illuminated the maze. The maze was positioned on a table 
and its surroundings were rich in a variety of visual cues. 
2.2.3a Food deprivation 
Five days before the beginning of the experiment subjects 
were maintained on a restricted feeding schedule in which food was 
limited to 2 hr, out of every 24 hr period. By the start of testing this 
schedule had reduced their body weight by 10-15%. Weights were 
measured daily to ensure that weight loss was consistent between 
groups. If this was not the case the feeding schedule was altered 
accordingly. Subjects had unlimited access to water in their home 
cages throughout the experiment. 
2.2.3b Maze procedure 
The procedure was based on that originally used by Olton 
and Samuelson (1976). Mice were food deprived for three days prior 
to testing and on the day before testing (day 3) each subject was 
individually introduced into the apparatus for 10 minutes 
habituation, each arm having been previously baited. The experiment 
commenced on day 4 when each subject was tested in turn, once a 
day, until the majority of subjects had learnt the maze. The subject 
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was confined to the central platform by means of a cardboard 
container. After 90 seconds had elapsed the container was removed 
and the subject was able to freely explore the apparatus. The 
sequence of arm entries was recorded until the subject had entered 
either (a) all 8 arms once, (b) made 16 entries into arms or (c) until 
10 mins had elapsed, which ever condition was met first. An arm 
choice was considered to have occurred when the subject had run at 
least half way down an arm. An error was scored if the subject 
revisited an arm, failed to visit one of the arms or successfully 
entered a baited arm but did not eat. The overall criterion for 
completion of the test was based on that employed by Pick and 
Yanai (1983). A subject was judged to have reached criterion when 
it had entered all 8 arms on the first 8 visits on two consecutive days. 
This provided information on the number of correct entries made 
during the first 8 attempts, the number of visits required to enter all 8 
arms once, and the number of days to reach criterion. I considered 
that this criterion would be a more reliable one for learning ability 
than a perfect score on one day only which could result from chance. 
The maze was cleaned between trials to remove faecal boli, urine 
and odour cues, and washed with disinfectant at the end of each test 
day. Each subject was eliminated from the experiment when it had 
reached criterion. At the end of the experimental period all subjects 
were returned to their normal feeding regime. 
2.2.4 Activity testing at maturity 
Twenty-two week old female mice again underwent testing 
in the openfield. Each mouse was confmed in a holding box for 60 
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seconds after which a side door was lifted and latency to enter the 
openfield was recorded. The side door was closed after the animal 
had entered the openfield to prevent reentry into the holding box. 
The number of squares crossed per minute was noted over a five 
minute period on three consecutive days. On day 4 the same novel 
object as was used in the weaning tests was introduced into the 
centre of the arena at the start of the test. The subject was again 
placed in a holding box and released into the openfield, this time the 
latency to contact the object was recorded in addition to the latency 
to enter the openfield and the number of squares crossed. 
2.2.5 Assay for choline acetyltransferase (ChAT) activity. 
Animals were decapitated, the olfactory bulbs removed and 
the brains were dissected into eight regions - the brainstem, 
cerebellum, midbrain, hypothalamus, nucleus magnocellularis, 
hippocampus, striatum and cerebral cortex, using the diagram in 
Glowinski and Iversen (1965) as a reference (see Fig. 2.2). Each 
dissected portion was placed into labelled cuvettes and stored at - 
700C until assay. Tissue samples used for the assays represent 
pooled brains from 3-4 individuals not divided by sex. 
ChAT activity was assayed in each of these brain regions 
by the method of Glover and Green (1972). Tissue samples were 
homogenised in saline containing butan-1-ol. Separate 50il samples 
of the homogenate were pipetted into 3 test-tubes followed by 50*i1 
of the assay mix which contained 140M 14C acetyl CoA, 10mM 
choline, 200mM potassium chloride, 20mM phosphate buffer at pH 








essential for the reaction. This was then incubated at 37 0C for 20 
minutes. The 14CoA formed according to the equation below 
(Cooper, Bloom and Roth, 1981), was extracted with potassium 
mercuric iodide in octane. Aliquots of this were placed in 
scintillation tubes, scintillation fluid added and counted in a Packard 
Tri-Carb 460 scintillation counter at 80% efficiency. 
Acetyl CoA + choline ---------> acetylcholine + CoA 
The protein content of the brain homogenates was 
determined by the Biorad assay developed by Bradford (1976), to 
provide the standard against which activity could be related. 5,*il of 
each homogenate was placed in a cuvette to which 2.5mls of the 
Biorad solution was added. The standard was bovine serum albumin 
at 1mg/mi. Absorbance was read at 595nm. The activity of each 
tissue sample is expressed in pmoles per minute per mg protein. 
2.3 STATISTICS 
Pup behaviouicLdata was analysed using a programme, 
"Keytime", which provides information on the frequency and 
duration of each press made by the observer on the computer 
keyboard (Deag, 1983b). The normality of the data was analysed 
using the Nscores option in the Minitab statistical package and from 
histograms of the distributions (Ryan, Joiner and Ryan, 1985). 
Normally distributed data was analysed using the P2V programme 
for analysis of variance (ANOVA) on the B.M.D.P statistical 
package (Dixon, 1988) with prenatal treatment, foster mother 
treatment and sex as the dependent variables (all fixed effects, see 
Snedecor and Cochran, 1988 p322) and either postnatal day or 
minute of test as the repeated measures factor, using the Greenhouse-
Geisser correction. In experiments where a fostering procedure is not 
used, a dependent variable should be included to control for litter 
effects. As the design of the experiments described in this thesis 
incorporated a comprehensive fostering procedure, this was not felt 
to be necessary. 
Nonparametric tests in the form of the Kruskal-Wallis one-
way ANOVA were used when the data did not approximate to 
normality, using the B.M.D.P. 3S programme which includes a 
multiple comparisons option (Dixon, 1988). The total weight gained 
during gestation and birth weights were compared using Student's t-
test. Chi-square tests were used to analyse the categorical data 
generated by the Fox tests (Ryan, Joiner and Ryan, 1985). 
The neurochemical data presented in chapter 3 was 
analysed using Student's t-test and that described in chapter 6 by 
ANOVA. Significance was taken to be at the p<O.OS level and unless 
stated otherwise, the mean and standard error of data sets are given. 
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CHAPTER 3 
Effect of gestational exposure (Gd10-13) of CBA mice to injected 
aluminium sulphate. 
3.1 INTRODUCTION 
As discussed in chapter 1, studies exposing adult animals to 
Al, in an attempt to elucidate the mechanisms by which it exerts its 
neurotoxicity, are in abundance. In contrast, research into Al's 
potential as a physical or behavioural teratogen are rare. With the 
ever increasing amounts of absorbable Al entering our modem 
environment, it is surprising that more work on gestational exposure 
to Al has not been undertaken. 
Administering a substance by injection enables one to 
discharge a given amount accurately in relation to the body weight 
of the individual. In this chapter I describe experiments in which 
pregnant CBA mice were exposed to 200mg/kg body weight of 
aluminium sulphate (Al2(SO4)3) by repeated intraperitoneal 
injections during gestation days 10 to 13. The aims were to assess 
both the immediate and long-term effects of Al on the physical and 
behavioural development of the offspring. 
3.1.1 Exposure to aluminium compounds by injection 
It is important to note those studies we do know which have 
considered the effects of exposing the developing foetus to Al via 
injection. 
Acute intraperitoneal (i.p.) administration of MC13 at a 
dose of 40mg/kg body weight on gestationôday 9 or 13 only, to 
nrc 
female albino rats, did not produce any overt signs of toxicity to 
mothers or their offspring (Benett, Persaud and Moore, 1975). 
Conversely, daily i.p. injections of Aid3, at varying doses (75, 100 
or 200mg/kg body weight) to pregnant rats from days 9-13 or 14-18 
of gestation resulted in a higher occurrence of maternal and foetal 
deaths and increased foetal resorptions at the highest doses, 
irrespective of the period during which treatment was administered. 
The mean body weight of the mothers and their offspring, and the 
pup's crown-rump length, were reduced by the 75 and 200mg/kg 
doses of AlC13 between Gd9-13. Skeletal defects were greater in 
offspring of mothers treated at a dose of 100mg/kg during both 
periods of gestation when compared to control pups (Benett, Persaud 
and Moore, 1975). 
A further study involving exposure to A1C13 via i.p. 
injections at different doses (ranging from 100 to 300mg/kg body 
weight) during gestation days 7 to 16, increased the Al concentration 
in the maternal liver, placenta and in the foetuses of BALB/c mice. 
This led to an increase in foetal resorptions and reduced foetal 
weight even in the absence of any obvious toxic effects to the mother 
(Cranmer, Wilkins, Cannon and Smith, 1986). 
Yokel has carried out extensive work on the effects of 
systemic exposure to aluminium lactate (AlLact) on rabbits to 
investigate its toxicity during different developmental stages. 
Subcutaneous (s.c) administration of AlLact to lactating does during 
days 4-29 postpartum at different concentrations (0, 25, 100, 400 or 
800)imol/AlIkg), resulted in maternal weight loss and death in the 
highest dose group (Yokel, 1985). Interestingly, there was a biphasic 
effect of exposure to Al on weight gain of both does and their 
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suckling offspring; those exposed to 25 or 100,umol/Al/kg had a 
greater weight gain compared to controls, whereas those given 
AlLact at the higher doses gained less weight than controls. 
However, the tissue concentration of Al in the does did increase with 
dosage. Milk production, as measured by a decrease in offspring 
milk consumption, was lower in treated does. Yokel (1984) 
concluded that there was little toxic effect to suckling offspring from 
exposure of their lactating mothers to AlLact because of the 
estimated low levels of Al to which the offspring were actually 
exposed. Exposure to the highest dose (800,'umol/Al/kg) proved to 
be lethal. 
Gestational exposure of does to AlLact at a dose of 400 
,umol Al/kg/inj between days 2-27 of pregnancy resulted in a 
significant increase in stillbirths and postnatal mortality (Yokel, 
1985). The biphasic effect of Al exposure on weight gain was also 
present after gestational exposure. Moreover, in utero exposure to 
low doses of Al enhanced performance in a conditioned reflex 
learning test compared to an attenuated response when Al was 
administered at high doses. Tissue concentration of Al was 
correlated with the dose of Al to which the doe was exposed, but the 
effect on milk production was to lower it with increasing dose 
(Yokel, 1985). It is of interest to note that this is the only study 
which included a cross-fostering procedure, involving the rearing of 
3 fostered and 3 biological offspring per litter. It was not only the 
natural offspring of mothers exposed to 400 )umol/AlIkg which 
gained less weight but also control offspring fostered to them. 
In summary, it is clear that most studies of gestational 
exposure to Al have limited themselves to measuring the immediate 
toxic effects in terms of maternal growth rates and foetal weights. 
Yokel (1985) provides the only example of a longitudinal study of 
changes to exposed offspring with time. The work presented below 
aims to investigate any possible latent or continual effects of in utero 
exposure to Al. 
Some of the work described in this chapter has been 
published (Clayton, Sedowofia, Rankin and Manning (1992), see 
Appendix A). 
3.2 EXPERIMENT 1 
3.2.1 Treatment 
Batches of females exposed to males and found to be 
carrying a vaginal plug were randomly divided into two groups. One 
group was injected i.p. with 200mg/kg aluminium sulphate 
(Al2(SO4)3) daily from GdlO to Gd13 inclusive, whilst the control 
group received injections of the equivalent volume of saline acidified 
to the same pH (pH=4.1-4.3) as the Al solution with sulphuric acid. 
It had been intended to administer the Al from GdlO to 17, but 
obvious hardening of the skin around the injection site led to the 
decision to stop injections after four days only. 
3.3 GENERAL PROCEDURES 
The sequence of testing and the methods described in 
section 2.2 were employed in this experiment. Briefly, all pups were 
weighed on Pdl and cross-fostered with litters of the same age. 
Every third day from Pd3 to Pd18 pups were weighed, underwent 
tests for sensory-motor development and were observed in an 
openfield for 3 minutes. At weaning the number of squares crossed 
in the openfield were recorded and a novel object was introduced 
into the centre square at the end of the test. 
3.3.1 Maze testing 
Following completion of the 8-arm radial maze test (see 
2.2.3b) subjects were rested for 5 weeks and then retested in the 
maze, to investigate the effects of prenatal exposure to Al2(SO4)3 on 
learning and recall. They were food deprived for the same length of 
time but were not given a pre-test day for habituation. The procedure 
remained the same for the rest of the session. On completion of the 
second maze, half the control and treated subjects were sacrificed for 
neurotransmitter enzyme assay (see 2.2.5). 
Adult activity tests were carried out at 22 weeks of age and 
weekly adult weights were taken from weaning until this age. 
3.4 RESULTS 
The main ANOVA tables and median + lower and upper 
interquartile ranges are given in Appendix B. 
3.4.1 Estimated level of aluminium exposure 
With an average weight of 25g, pregnant females injected 
i.p. with Al2(SO4)3 received 0.4 1mg of elemental Al per day, a total 
of 1.64mg over the four days of treatment. 
3.4.2 Breeding performance 
Prenatal exposure of pregnant female CBA mice to 
Al2(SO4)3, at a dose of 200mg/kg body weight between gestation 
days 10-13, had no significant effect upon breeding pfprniance. 
The length of gestation was similar in control and treated groups; the 
mean time between detection of the vaginal plug and the day of birth 
was 20.73(±0.3) days for control females (n=1 1) and 20.38(±0.42) 
days for the treated group (n=8). The mean litter size for control and 
treated females was 5.27(+0. 65) and 5 57(±0 72) respectively. The 
sex ratio within these litters was also unaffected, and external 
examination of the pups did not reveal any morphological 
differences. Interestingly, in both groups, there was some mortality 
at birth from females who had a gestation length of less than 20 
days. After cross-fostering, 3 dams were eliminated from the 
experiment (2 control and 1 treated), as they had neglected or killed 
their fostered offspring. This left a total of 6 control and 7 treated 
dams, all except one had 4 pups, and no further postnatal mortality 
occurred. The number of pups in each experimental group was as 
follows:- Cc n=13, Ct n=14, Tt n=12 and Tc n=11. 
3.4.3 Maternal weight 
Analysis of variance (ANOVA) revealed a significant 
overall main effect of treatment on maternal weight during gestation 
(F(1,11)=5.05 p<O.OS). As expected there was no difference in 
maternal body weight on Gd 10. However, thereafter the mean body 
weight of the treated mothers (n=7) was reduced by 7.7% compared 
to that of the controls (n=6) by Gd12 (control =24.12(±0.45)g, 
treated =22.27(±0.37)g. Once treatment had ended, the treated dam 
weight recovered to a mean of 27.2g on day 18. Control mothers did 
not exhibit a corresponding reduction in weight during the treatment 
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period but continued to gain weight reaching a mean weight of 30.2g 
on day 18, 9.8% heavier than treated dams. The mean total overall 
gain in weight between GdlO and Gd18 was 7.02(±1.23)g for 
controls and 4.43(±1.04)g for treated mothers. This difference was 
not significant. 
3.4.4 Pup weight 
Mean birth weight was significantly lower among Al-
exposed offspring than controls between all pups born (control n=52 
=1.29(±0.02)g, treated n=38=1.21(±0.02)g; t(78)= 2.70 p<0.009). 
This effect held when only those pups which acted as experimental 
subjects were compared (control n=27 T=1.33(±0.03)g, treated n=25 
5Z=1.22(0.03)g; t(47)= 2.63 p<0.02). Treated pups weighed 6% less 
than control offspring. This implies that those pups which were 
randomly selected for behavioural testing were indeed representative 
of the population. Analysis was also carried out which considered 
the treatment the pup's future foster mother received during 
pregnancy to ensure that the fostering protocol distributed the pups 
evenly between control and Al-treated mothers. There was no such 
effect of foster mother treatment on birth weights. Thus, those pups 
who were of low birth weight to begin with, were not all being 
allocated to mothers who had received Al2(SO4)3 during gestation 
which might further hinder their development. 
Fig. 3.1 summarises the mean body weights during early 
development for male and female offspring of the four experimental 
groups. Male and female offspring weights were combined for 
analysis as there was no significant difference between the sexes. 
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Fig. 3.1: Effect of prenatal exposure to aluminium suphate 
(200mg/kg, GdlO-13) on CBA pup body weight during the 
preweaning period. 
One treated pup fostered to a treated mother (Tt) was removed from 
the analysis as I considered it to be a runt. There was no significant 
overall main effect of prenatal treatment on pup weights. However, 
the treatment groups began to diverge in body weight on Pd6 and 
this persisted until weaning. From the graph it can be seen that 
treated pups reared by control mothers (Tc) were the heaviest and Tt 
pups the lightest throughout the preweaning period. By weaning Tc 
pups were 13% heavier than Tt pups. Thus, the lower birth weight of 
the treated pups persisted only for treated pups reared by treated 
mothers. Comparing the results of the Tc pups with those of the 
control pups fostered to control mothers (Cc) does not suggest a 
profound effect of direct exposure to Al2(SO4)3 in utero. This was 
also the case when control pups reared by treated mothers (Ct) were 
compared with those of the Tt group. Considering the extreme 
groups, Cc with Tt, or Ct with Tc, gives an indication of the 
combined influence of prenatal and postnatal factors. There was no 
significant prenatal treatment by foster mother treatment interaction. 
Cc pups were consistently heavier than Tt pups, the greatest 
difference occurring on Pd9 when Cc pups weighed 14% more. 
Likewise Tc pups weighed consistently more than Ct pups. 
Despite the lack of a direct effect of prenatal exposure to 
2(SO4)3, the graph clearly illustrates that there is a profound 
maternal treatment effect on pup body weight which persisted until 
weaning (F(1,42)=1- 5.28 p=0.0003), the significant interactive effect 
of foster mother treatment and day shows that the extent of this 
effect varied with time (F(6,252)=14.58 p<0.0001). Cc pups and Tc 
pups are grouped in the same part of the graph as are Ct and Tt 
pups, i.e. by foster mother treatment. Thus, fostering a treated pup to 
a control mother seems to enhance development, by compensating 
for the effect of an initial low birth weight due to exposure to 
Al2(SO4)3 in utero. Alternatively, fostering a control pup to a 
treated mother adversely affects the physical development of the 
pup, illustrating that differences must exist in some aspect, or 
aspects, of the postnatal mother-infant interaction. It is not clear at 
this time exactly how this effect is produced. 
3.4.5 Adult weight 
From weaning onwards significant differences in weight 
between the sexes began to emerge and thus male and female 
weights were analysed separately. Male weights were not analysed 
during the periods of starvation prior to maze testing, although 
weights were recorded during this intervening period to ensure 
weight loss was consistent between the groups. Cc males were 
consistently heavier than the other groups which had not been the 
case up to weaning and Tt males were lighter. There was no overall 
main effect of prenatal or foster mother treatment, although there 
was a trend towards lower weights in mice fostered to treated 
mothers. 
Female offspring were weighed at weekly intervals 
throughout the experiment from weaning onwards. The trend which 
existed up to weaning, treated pups fostered to control mothers 
weighing the most and treated pups fostered to treated mothers the 
least, was present only up to 6 weeks of age after which the Cc and 
Tc females had comparable body weights. Tt females continued to 
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Fig. 3.2: Effect of prenatal exposure to aluminium sulphate 
(200mg/kg, GdlO-13) on CBA adult female body weight. 
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significant effect of foster mother treatment present from Pd6, 
persisted into adulthood in the case of female offspring 
(F(1,18)=9.52 p<0.007). 
Thus both male and female Tt pups continued to be lower 
in weight than the other groups throughout life with this effect being 
Tore pronounced among female mice. It would seem that exposure 
to Al2(SO4)3 may be sex-specific in its effects, being more toxic to 
fe ales. I 
3.4.6 Fox tests 
The effects on growth noted above were accompanied by 
delays in the maturation of some of the behavioural components 
measured by the Fox tests. There was a highly significant difference 
between the groups for both sexes in the attainment of a. mature 
response for forelimb grasping (X2(3)=11.901 0.01> .001) and 
pole grasping (X2(3)=24.674 p<0.001), both on Pd15 (see Figs. 3.3a 
and b). With regard to forelimb grasping, most of the pups had 
reached an adult response by Pd15 except for some pups in the Tt 
group. A maternal effect can be seen in the results for pole grasping 
as few Ct or Tt pups had reached a mature response by Pd15. 
Similarly, a significant difference between the groups was found for 
cliff aversion on Pd12 (X2(3)=10.669 0.02>p>0.01) and screen 
climbing on Pd18 (X2(3)=8.069 0.05>p>0.02), again fewer pups in 
the Ct and Tt groups had attained a mature response. 
Scores on the Fox tests which revealed significant group 
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Fig. 33: Percentage of CBA pups with an adult 
response by Pd15. 
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pup scores were correlated with weight for slow righting (Tt n=12, 
r=0.869 p<0.001) but this was the only significant correlation. 
3.4.7 Pup behaviours 
Pup behaviours were analysed from the day on which the 
particular behaviour was first expressed. Thus, for crawling, the 
behaviour was analysed from postnatal day 6-18, but for rearing 
analysis was from day 12 to 18. This accounts for the difference in 
the value for degrees of freedom. 
Activity - The effects of prenatal exposure to Al2(SO4)3 on the 
ontogeny of pup locomotor activity during postpartum days 9-18 is 
shown in Fig. 3.4. There was a marginally significant effect of foster 
mother treatment on pup activity; pups reared by treated mothers 
showed a trend towards diminished activity levels compared with 
controls. There was a highly significant interactive effect of day, 
prenatal treatment, foster mother treatment and sex (F(3,126)=4.58 
p<0.02). As expected all pups became progressively more active 
with age as confirmed by the significant effect of day of testing 
(F(3,126)=93.94 p<0.0001). 
Righting - Self righting behaviour was evident from Pd3 and 
successful righting was achieved by Pd9, reflected in the diminished 
frequency and time spent involved in this behaviour. There were no 
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Fig. 3.4: Effect of prenatal exposure to aluminium sulphate 
(200mg/kg, GdlO-13) on the number of squares crossed by 
CBA pups in a three minute openfield test. 
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Pivoting - There were no significant differences in the frequency or 
duration of episodes of pivoting which decreased gradually from Pd3 
to 12 for all pups, being replaced by crawling. 
Crawling - Pups from all four experimental groups commenced 
crawling on Pd6, although bouts of crawling at this stage were 
usually preceded by episodes of pivoting. From Pd9 onwards 
episodes of crawling increased in frequency and duration with age. 
There was no significant difference between experimental groups in 
the frequency of bouts of crawling, however there was a trend 
towards a reduced frequency by pups reared by treated mothers. 
Interactive effects on the duration of crawling were present. Day 
(D), prenatal treatment (PT) and sex (S) interacted to give a 
significant effect (F(4,168)=3.73 p<0.009), as did D, PT, foster 
mother treatment (FMT) and S (F(4,168)=2.79 p<0.04). Control 
pups spent more of their time involved in crawling compared to 
treated pups. Pups fostered to control mothers exhibited bouts of 
crawling with longer duration than those raised by treated mothers. 
Rearing - The ability to rear on hindlimbs was present from Pd9 
although some pups would rear onto the wall and remain still. The 
frequency and duration of bouts of rearing varied with postnatal day, 
pups becoming progressively more involved in this behaviour with 
time. There was a highly interactive effect of all variables (D x PT x 
FMT x S) on the frequency of rearing (F(2,84)=4.92 p<0.02). 
Grooming - Pups became involved in self grooming from Pd6 
although at this age it usually resulted in them falling over. By Pd12 
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full body grooming had been achieved and this behaviour increased 
with age. There were no significant group differences in the 
frequency or duration of grooming bouts. The frequency of 
grooming bouts during the later postnatal days remained low but 
were of longer duration. Pups fostered to control mothers had 
episodes of grooming with the longest duration. 
Headup - This behaviour was present from Pd3 and occurred 
throughout the preweaning period. There were no significant group 
differences in the duration of time spent or the frequency of headup. 
Still - There were no significant group differences in the duration of 
bouts of being still. There was a significant effect of foster mother 
treatment on the frequency of still bouts (F(1,42)=4.41 p<0.05); pups 
reared by treated mothers exhibited greater numbers of bouts of 
being still. 
Edgeon - Rearing against the walls of the openfield was evident from 
Pd9 and its occurrence increased with age. There were significant 
group differences in the frequency (H(3)=10.22 p<0.02) and duration 
of time (H(3)=8.34 p<0.04) involved in bouts of edgeon behaviour 
on Pd12; pups reared by treated mothers were less involved in this 
behaviour. Group differences were marginally significant on Pd 15. 
3.4.8 Activity at weaning 
Activity scores at weaning were examined by ANOVA with 
minute of test as the repeated measure. There was no effect of 
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prenatal or foster mother treatment on activity scores at weaning but 
they did vary with sex (F(1,42)=4.17 p<z0.05), female offspring 
being more active than males, and across minute of test 
(F(4,168)=3.46 p<0.02). In addition there was a significant 
interaction between prenatal treatment and sex (F(1,42)=9.9 
p=0.003). Hence the data for both sexes were reanalysed to establish 
whether prenatal treatment affected them both to the same extent. 
There was a significant main effect of prenatal treatment 
on male pup activity (see Fig. 3.5a); the activity of treated pups was 
enhanced compared to controls (F(1,22)=4.34 p< 0.05). 
In the case of female pups, the effect of exposure to Al in 
utero on activity was in the opposite direction (see Fig. 3.5b); pups 
having been exposed to Al in utero were less active than controls 
(F(1,20)=5.63 p<z0.03). Similarly, pups reared by treated mothers 
crossed fewer squares than their control counterparts. There was no 
significant interaction between prenatal and foster mother treatment. 
Thus, there was a differential effect of prenatal exposure to 
on male and female activity scores at weaning. 
Fig. 3.6 shows the median time taken to contact a novel 
object placed in the centre of the openfield at the end of the 5 minute 
activity test. The presence of a prenatal effect can be seen; Tt pups 
took less time to make contact and Cc pups the longest, although this 
was not significant. There was no correlation between scores in the 
activity test and latency to contact the object, illustrating that pups 
were not making contact by merely bumping into it. 
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Fig. 3.5: Effect of prenatal exposure to aluminium sulphate 
(200mg/kg, Gd] 0-13) on the number of squares crossed in a 











Fig. 3.6: Effect of prenatal exposure to aluminium sulphate 
(200mg/kg/GdlO-13) on the time taken by CBA pups 
to make contact with a novel object. 
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3.4.9 Maze test 
Only data from those mice which fulfilled the criterion of 
entering 8 arms out of 8 on 2 consecutive days were used for the 
analysis of the radial arm maze tests. The ability to learn the maze is 
reflected by: - 
the reduction in the number of trials needed to enter all 8 
arms (Fig. 3.7a) and 
an increase in the number of correct responses (see Fig. 
3.7b). 
There were no significant effects of prenatal or foster 
mother treatment for either of these measures. Similarly, there was 
no difference in the time taken to move around the maze suggesting 
that there was no impairment of motor capacities. 
A greater proportion of control animals reached criterion 
(10 out of 13, 77%, 5 in the Cc and Ct groups) than treated mice (6 
out of 11, 55%, 3 in the Tt and Tc groups) although chi-square 
analysis did not show this to be significant. Control mice took fewer 
days to complete the task (=6.6(±0.99) days) compared to treated 
subjects (=7.33(±1.20) days). 
By retesting the animals in the maze after an interval of 5 
weeks it was hoped to be able to assess the effects of treatment on 
the ability of subjects to recall a task in which they had been 
previously trained. The control group had a median of 8 visits during 
the last day of the first session and a median of 10.5 after the first 
trial of the second session. The treated animals were no worse at 
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Fig. 3.7: Effect of prenatal exposure to aluminium sulphate 
(200mg1kg, Gdl0-13) on performance of CBA males in 
an 8-arm radial maze. 
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session 1 and 9 on the first trial of session 2. There is no statistical 
significance between the groups in this respect. 
Testing for an individual stopped once it reached criterion. 
Thus the score allocated to it for the subsequent days, required for 
other subjects to reach criterion, was always 8. This is a weakness of 
the method, as some subjects received more experience in the maze 
than others, reflecting the highly diverse intra- and intergroup 
variances in the level of learning ability. However, exposing all 
subjects to the maze until the majority of subjects have learnt it, may 
have introduced the problem of overtraining. 
As expected, subjects required fewer trials to learn the maze 
during the second session and there were clear indications of 
savings. However, not all the subjects who completed the task in the 
first session had similar success in the second. 6 out of the original 
10 control animals reached criterion in the second session compared 
to 3 of the initial 6 treated mice. 
3.4.10 Adult activity 
Only adult female activity scores were analysed at week 22, 
because a sample of male mice were sacrificed at week 17 for 
neurochemical analysis. The small number of male subjects 
remaining (Cc n=4, Ct n=4, Tt n=3, Tc n=3) was insufficient for 
statistical purposes. Hence, it was not possible to examine whether 
the differential effects of prenatal treatment on male and female 
activity at weaning persisted into adulthood. 
There were few group differences in female adult activity 
levels during day 1 of testing. Group differences were more obvious 
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on days 2 and 3. On day 2, analysis of the number of squares crossed 
per minute of the test revealed a significant group difference in 
minute 2 (H(3)=8.898 p<0.03) and a marginally significant 
difference during minute 3. Again, during these minutes the maternal 
effect was evident, pups having been raised by Al-treated mothers 
having lower activity scores than pups fostered to control females. 
Similarly, there was a marginally significant difference in the total 
number of squares crossed on day 2. Cc females crossed a median of 
174.5 squares during the 5 minute test period compared to a median 
total of 89 for Tt females. 
During minute 1 of day 3 Cc mice crossed a median of 48 
squares and Tt only 21 (H(3)=10.35 p<0.02). Likewise it follows 
that there was a group difference in the total number of squares 
crossed, although this result was only marginally significant. 
Tt female mice took longer (median=59s) to enter the 
openfield at the beginning of the activity test on day 1. However this 
was not the case on any other day. There was also no significant 
difference in the time taken to contact the novel object placed in the 
centre of the openfield on day 4. 
3.4.11 ChAT activity 
Tables 3.1 and 3.2 summarise the activity levels of choline 
acetyltransferase (ChAT) in the different brain regions from 
postnatal weeks 3 to 44 for mice whose mothers were exposed to 
Al2(SO4)3 during gestation and for their corresponding controls. 
The most consistent findings within these brain regions are that 
ChAT activity levels varied as  function_of prenatal treatment but 
also declined with age. Levels of ChAT activity were found to 
- 	 - 
increase between weeks 3 and 1 -7-in the 4 regions examined and fell 
in all areas between 17 and 34 weic, although the extent to which it 
declined varied with brain region. For example, the ChAT level in 
the control hippocampus fell by 62% between weeks 17 and 34, 
whereas the midbrain's reduction was 18%. The changes in ChAT 
activity between weeks 34-44 were not as consistent as at earlier 
ages. In the case of the hippocampus and the cerebellum, ChAT 
levels were higher at week 44 than at 34 weeks of age. 
Disparities in levels of ChAT may exist at  weeks of age 
because the chohnergic system does not mature completely until 
around the third postnatal week (Campbell, Lytle and Fibiger, 1969; 
Alleva and Bignami, 1985). However when one compares the ChAT 
levels at 44 weeks with those at 17, ChAT activity in all regions had 
declined with age. ChAT levels in treated brains increased between 
weeks 3 and 17 and similarly declined by 34 weeks of age. Again the 
loss in ChAT activity varied with brain region. ChAT levels declined 
with age between weeks 34 and 44 in four of the six regions but 
increased in the cerebral cortex and to a greater extent in the 
hippocampus. Treated ChAT levels decreased to a lesser degree with 
time than controls although the levels to start with (at week 17) were 
lower. 
In the cerebral cortex, cerebellum and hippocampus the 
direction of change in ChAT levels between the control and treated 
subjects was the same at each time point, treated brains having a 
reduced level compared to controls. In the cerebral cortex the level 
of ChAT activity was 42% higher in the controls compared to treated 
animals at week 34. At week 44, the treated levels were still lower 
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Table 3.1: Effect of in utero exposure to aluminium sulphate (200mg/kg, i.p.) during 
days 10-13 of gestation on the level of choline acetyltransferase (ChAT) activity in 








17 weeks 	- 
Treated 
Cerebral cortex 213.4 ± 9.3 210.9 ± 4.8 440.3 ± 2.6 328.9 ± 8.3 
Cerebellum 433 ± 0.7 50.7 ± 3.1 98.5 ± 2.7 64.9 ± 1.9 
Hippocampus 744.4 ± 7.6 580.2 ± 8.2* 1015.6±31.0 917.9± 3.6 
Midbrain N.D. N.D. 7933 ± 13.1 856.6 ± 3.9 * 
Hypothalamus N.D. N. D. 665.7 ± 	19.9 573.9 ± 26.7 
Striatum 459.6 ± 9.7 251.5 ± 5.2 * 2141.7 ± 52.7 1871.4 ± 43.9 * 
Activity is expressed in picomoles/ mg protein/ minute and each result represents the 
mean (±S.E.) of six determinations. 
* p<o.05 
N.D. = not determined 
Table 3.2: Effect of in utero exposure to aluminium sulphate (200mg/kg, i.p.) during 
days 10-13 of gestation on the level of ChAT activity in different brain regions of 










Cerebral cortex 309.4 ± 22.0 180.6 ± 1.4 * 247.0 ± 5.3 215.4 ± 	2.5 * 
Cerebellum 50.9± 1.1 46.5 ± 0.9 * 73.2 ± 1.1 45.6 ± 1.0 * 
Hippocampus 381.1 ± 18.1 306.7 ± 1.4 * 567.2 ± 6.0 545.5 ± 10.0 
Midbrain 649.4 ± 7.8 552.1 ± 6.3 * 505.7 ± 15.0 439.8 ± 	3.8 * 
Hypothalamus 530.9 ± 2.1 433.8 ± 6.3 * 247.5 ± 2.4 342.2 ± 9.0 * 
Striatum 1047.7± 24.3 995.0± 7.0 431.7 ± 8.4 728.2± 16.0 * 
Activity is expressed in picomoles/mg protein/ minute and each result represents the 
mean (±S.E.) of six determinations. 
* p<o.05 
N.D. = not determined 
but the divergence was not as marked (13%). The reduction in the 
disparity between the two groups is probably due to the fact that 
ChAT levels were falling with age in the control group in any case, 
so that the effects of the initial Al insult were confounded by age-
related changes. The hippocampu expressed the highest levels of 
ChAT. At 17 weeks the difference between the control and treated 
groups was only 10% in this region. Levels of ChAT were lowest in 
the cerebellum. They peaked at 17 weeks and thereafter declined. 
Significant differences occurred between the control and treated 
groups during weeks 17, 34 and 44, the greatest difference occurring 
at 44 weeks (38%). 
The mid-brain and striatum were the exceptions. In the mid-
brain ChAT activity was raised in the treated brains at 17 weeks, a 
difference of 8%, but by the older ages levels in the treated group 
were reduced compared to controls. The overall loss in ChAT 
activity was greater in the treated group, being almost halved at 27 
weeks. Very high levels of ChAT were found in the striatum which 
may have resulted from this region containing the nucleus 
magnoceRularis—w.hich-has—the--richest source of ChATandwhich, 
was not dissected separately in this experiment. ChAT activity was 
reduced in treated brains at 17 and 34 weeks but significantly 
increased (4 1%) at 44 weeks. 
3.5 SUMMARY OF RESULTS 
Exposure of pregnant CBA females to injected Al over a 
limited period of gestation (GdlO-13), caused a reduction in 
maternal weight gain but did not affect breeding performance. 
Pups exposed to Al in utero had a reduced body weight at 
birth compared to controls; this difference persisted only for those 
pups fostered to treated mothers. This effect on body weight 
persisted into adult life in the case of female animals. Al-treated 
pups showed delays in the attainment of an adult-like response in 
several of the Fox tests. Although Al did not affect the overall 
expression of pup behaviours, it altered the frequency and duration 
of several behaviours n certain days. Activity scores at weaning 
were both treatment- and strain-dependent. Females exposed to Al 
were hypoactlyecQrnpared toçpntrols  whilst the effect on males was 
to increase activity levels. This effect on female activity was still 
present at 22 weeks of ae\A1 had only slight effects on cognitive 
ability as assessed in the radial maze. Treated animals showed 
deficits of ChAT activity in seral brain regions. 
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Effect of exposure of CBA mice to injected aluminium sulphate 
over five days of treatment. 
3.6 EXPERIMENT 2 
3.6.1 Background 
The effects of gestational exposure to injected aluminium, 
as described in experiment 1, were patchy but clear enough where 
they took hold. The treatment period was restricted in experiment 1 
due to the hardening of the skin around the injection site. In this 
second experiment a new batch of mice were given an extended 
treatment period of five days. 
3.7 GENERAL PROCEDURES 
3.7.1 Treatment 
Plugged CBA females were injected i.p. with 200mg/kg 
body weight Al2(SO4)3 but the dosing period was extended to five 
days from GdlO to Gd14 inclusive. 
Most of the procedures used in this experiment have been 
described previously (see section 2.2). 
3.7.2 Maze testing 
The same food deprivation procedure was undertaken as 
described in 2.2.3a. However, in this experiment the subjects were 
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tested twice a day for 6 days (in the morning and afternoon) instead 
of only once a day. A test for recall of maze learning was not 
measured in this experiment. 
The neurochemical data presented in tables 3.1 and 3.2 
suggests that exposing subjects to Al causes alterations in the 
cholinergic system, a result which has also been reported in other 
studies (McGurk, Levin and Butcher, 1988). Because of the well-
established role of acetylcholine in learning, ability, such, deficits 
might be expected to result in equivalent defects in the maze learning 
tests. However, experiment 1 (3.2) did not reveal any such effects, 
perhaps because the task was not sufficiently challenging to expose 
any differences between the groups. For this reason, an extra 
treatment is introduced here in the maze testing. All subjects were 
challenged with a muscarinic cholinergic antagonist, scopolamine 
(Brown, 1990), with the aim of augmenting any group differences. 
When the majority of subjects had reached the criterion of 
entering 8 arms in 8 visits, they were divided into two groups. Each 
animal was removed from the home cage, injected i.p. with either 
scopolamine hydrochloride (0.5mg/kg body weight), or saline. The 
subject was then placed in a new cage for 15 minutes, the time 
expected for scopolamine to take its effect, prior to being tested in 
the radial maze, following the same procedure as before (see 2.2.3b). 
On completion of the session, the subject was returned to its home 
cage and given access to food. The challenge with scopolamine took 
place on three alternate days (Mon, Wed, Fri), with maze testing 
occurring once on each of the intervening days (Tues, Thurs). 
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3.8 RESULTS 
From the outset, there was a low number of plugged 
females and only five mothers in the control and four in the treated 
group continued to term. It was not possible to ascertain with 
confidence whether this small number of litters resulted solely from 
the effects of treatment. However, as both control and treated 
females were similarly affected this suggests that the lowered 
number of litters was caused by the reduction in the number of 
females who were actually plugged, rather than a direct effect of 
exposure to Al. These mice were mated in February which has 
proved to be a time of year when matings are harder to obtain in 
Edinburgh. 
3.8.1 Estimated level of aluminium exposure 
Over the five days of treatment, pregnant CBA mice 
received a total of 2.0 1mg of elemental Al. 
3.8.2 Breeding performance 
Treating pregnant CBA mice with 200mg/kg Al2(SO4)3 
during gestation days 10 to 14 did not affect the length of gestation 
(control n=5 =21.0(±0.32), treated n=4 35=20.25(±0.25) days) or 
litter size (control =5.6(±0.6) treated 1=4.75(±0.85)). As in 
experiment 1, exposure to Al2(SO4)3 had a diminishing effect on 
maternal weight gain between gestation days 10 to 14, although this 
did not reach significance. The total mean weight gain of control 
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mothers during the treatment period was greater than that of treated 
mothers (control =2.96(±0.27)g, treated =0.7(±0.4)g t(5)= 4.69 
p<O.006). 
3.8.3 Pup weight 
As before, exposure to Al2(SO4)3 in utero significantly 
reducedkjijkweigbts of treate4 pups (control n=27 
=1.33(±0.03)g, treated n=19 	=1.05(±0.03)g, t(39)= 6.87 
OO1L 
Achieving a total split-litter cross-foster design was made 
possible only by including more control pups. This resulted in one 
litter being made up of four fostered control pups only, hence it 
could not be included in the testing. Within those litters that were 
cross-fostered, 2 treated mothers had killed 1 fostered treated pup by 
Pd3. This was the only group within which postnatal mortality 
occurred. There remained a total of 26 pups; Cc n=7, Ct n=9 and 
n=5 for both the Tt and Tc groups. 
During the preweaning period differences in the rate of 
growth were analysed as opposed to the actual weights because the 
litters were not all born within the same 12 hour period. The weight 
gains of the Tt group were not normally distributed so weight gain 
was analysed using the Kruskal-Wallis one-way ANOVA with 
multiple comparisons. Fig. 3.8 shows the median weight gain for 
male and female pups from days 6 to 21 postpartum. There was a 
significant group difference in weight gain between postnatal days 3 
to 6 (H(3)=14.89 p<0.002) and between days 6 and 9 (H(3)=12.36 
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Fig. 3.8 : Effect of prenatal exposure to aluminium sulphate 
(200mg/kg, GdlO-14) on CBA pup body weight gain. 
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the other groups during these days. From Pd9 onwards all pups 
gained weight at a comparable rate. 
3.8.4 Pup behaviours 
As expected the frequency and duration of bouts of each 
behaviour increased with age. The following pup behaviours showed 
differences between the experimental groups:- 
Crawling - Prenatal treatment significantly affected the frequency 
(F(1,16)=16.47 p<0.001) and duration (F(1,16)=13.04 p<0.003) of 
bouts of crawling, control pups exhibited a greater number of bouts 
and of longer duration. There was also an interactive effect of day 
and prenatal treatment on the frequency of crawling (F(4,64)=3.03 
p<z0.04). The trend towards increased activity in the case of control 
pups was also found in the analysis of square crossing, although this 
did not reach significance. 
Headup - There was a significant interactive effect of day, prenatal 
treatment and foster mother treatment on the frequency of headup 
behaviour, pups belonging to the Ct and Tc groups exhibited an 
increase in headup behaviour on certain days (F(5,85)=2.86 p<0.05). 
The duration of these bouts was significantly affected by prenatal 
treatment (F(1,17)=8.73 p<0.009), treated pups spent more of their 
time involved in this behaviour. 
Rearing - Fig. 3.9a illustrates the obvious treatment effect on the 
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Fig. 3.9: Effect of prenatal exposure to aluminium 
sulphate (200mg/kg, GdlO-14.) on CBA pup (a) 
rearing and (b) still behaviour. 
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diminished number of bouts (F(1,18)=6.77 p<0.02). There was a 
significant interactive effect of day and foster mother treatment on 
frequency (F(2,36)=4.74 p<0.02), pups fostered to control mothers 
exhibited more bouts of rearing. 
Edgeon - There were no effects on the frequency of edgeon 
behaviour but Kruskal-Wallis one-way ANOVA of the duration of 
time spent rearing against the wall, revealed a significant group 
difference on Pd15 (H(3)=9.19 p<0.03). There was a significant 
difference between Cc and Tc pups (p<0.05). 
Still - There was a significant effect of prenatal treatment on the 
frequency of bouts of being still (F(1,17)=7.96 p<0.02), treated pups 
showed a greater number of bouts as shown in Fig. 3.9b. Day and 
foster mother treatment significantly interacted to affect the 
frequency of bouts of this behaviour (F(4,68)=3.14 p<0.04), taken 
overall pups fostered to treated mothers displayed an increased 
frequency of being still. There were no effects on the duration of 
bouts of still behaviour. 
3.8.5 Fox tests 
Similar developmental delays in the Fox tests were found 
following five days of treatment with Al as occurred after the four 
days exposure of the previous experiment. Treated pups were slower 
to attain a mature response in swift righting on Pd12 (X2 (3)=9.857 
0.02>p>0.01); in cliff aversion on Pd15 (X2(3)=9.1 0.05>p>0.02); 
and in pole grasping on Pd18 (X2(3)=14.942 0.01>p<0.001); fewer 
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pups from the Tt group acquired an adult response in these particular 
tests. Performance on these Fox tests were not correlated with weight 
gain. 
3.8.6 Activity test at weaning 
There were no significant differences in activity at weaning 
between the sexes in this sample of pups. Likewise there were no 
significant group differences in the number of squares crossed during 
any minute of the test when male and female pups were analysed 
together or in the overall total number crossed. The number of 
crossings varied significantly with minute of test (F(4,72)=3.80 
p<0.02), pups were more active during minute 1 but thereafter they 
showed within-session habituation. 
Ct pups took the longest time to contact the novel object 
placed in the centre of the openfield at the end of the activity test 
(median=63s) and Tc the least time (median=32s), although this 
difference was not significant. 
3.8.7 Maze test 
In the maze testing for this experiment, subjects were 
trained twice a day for six days rather than once a day. It was hoped 
that this would reduce the length of time over which the animals had 
to be food deprived but still maintain motivation to learn the task. 
Animals were not removed from the testing schedule until the 
majority of mice had completed the task, thus equalising each 
subject's experience of the apparatus. As the sample size was small, 
subjects were not divided with respect to foster mother treatment. 
By trial 12 only 67% (6 out of 9) of the control animals and 
83% (5 out of 6) of the treated mice had reached criterion. Control 
subjects did not require as many trials to complete the task as did 
treated subjects (control median=4.5, treated median=9.0). There 
was a slight difference in the time taken per arm entry by control 
animals between the morning and afternoon training sessions during 
day 2. This may have been related to differences in hunger between 
the two training trials. The length of time without food, between 
taking the food away after the afternoon session and the morning 
trial, was greater than the time between the morning and afternoon 
trials. No differences as a result of time of day of testing occurred on 
any other measure taken. 
Increasing the dose period from four to five days did indeed 
seem to cause a greater disruption in maze performance. Fig. 3. lOa 
and  show the number of arms visited during each trial and the 
number of correct responses in the first 8 entries. Treated animals 
required a greater number of arm entries to complete the task during 
trials 1 to 5, although these differences did not reach significance. 
Treated animals also made significantly fewer correct responses 
during trial 3 (control median=7.5, treated median=6.0, U=27.0 
p=0.02) and to a lesser extent during trial 4 (control median=8.0, 
treated median=6.0, U=25.0 p<0.05). The time taken to complete the 
test did not differ significantly between groups, thus there were no 
differences in the subjects' overall ability to move around the maze. 
Statistical analysis of the scopolamine challenge data was 
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Fig. 3.10: Effect of prenatal exposure to aluminium sulphate 
(200mg/kg, GdlO-14) on performance of CBA males in 
an 8-arm radial maze. 
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this preliminary experiment suggest that scopolamine had the 
predicted effect on control animals i.e. caused a disruption of 
performance in the maze but this took longer to manifest in the 
treated animals. The intermediate test days, when subjects were 
tested in the maze but not exposed to scopolamine, indicates its 
short-acting nature as most subjects recovered to their baseline level 
of performance. 
There were insufficient mice to undergo adult activity tests. 
0 
3.8.8 ChAT activity 
A sample of control and treated male subjects was 
sacrificed at 14 weeks of age following the maze test for 
neurochemical analysis. The levels of ChAT activity in each brain 
region is given in table 3.3. 
Analysis of ChAT activity was undertaken only at the one 
age of 14 weeks. The direction of change in activity was dependent 
on brain region. The level of ChAT in the cerebral cortex, 
hippocampus and the nucleus magnocellularis of control brains was 
greater than that measured in treated brains. The difference was most 
pronounced in the nucleus magnocellularis (40%). This direction of 
change was similar to that found in 17 week old mice in experiment 
1 (see Table 3.1). Conversely, treated hypothalamus and striatum 
- 	 _------------.--------- --- - -- - 
contained higher levels of ChAT activity than controls, differences 
of 35 and 25% respectively. 	 - 
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Table 3.3: ChAT activity in CBA males whose mothers were exposed 
to Al (200mg/kg body weight) by i.p. injection during gestation days 
10-14. 
Brain Region Treatment Mean(±S.E) t-value p-value 
Cerebral Cortex Control 440.3± 2.6 6.02 <0.002 
Treated 328.9±18.3 
Cerebellum Control 61.2±4.6 N.S 
Treated 57.3± 2.2 
Hippocampus Control 618.5±50.5 2.78 <0.04 
Treated 471.7±15.3 
Midbrain Control 573.8±30.5 N.S 
Treated 618.7±12.1 
Hypothalamus Control 218.6± 7.4 -12.45 <0.0001 
Treated 335.4± 5.8 
Nucleus Control 2066.2±28.3 8.68 0.0003 
Magnocellularis Treated 1198.5±95.9 
Striatum Control 456.2±11.5 -10.35 <0.0001 
Treated 605.0+8.7 
Effect of gestational exposure of C57BL/6J mice to injected 
aluminium sulphate. 
3.9 Experiment 3 
As discussed in chapter 1, the susceptibility of an individual 
to a particular agent is greatly influenced by its genotype (see 1.2v). 
To test this with regard to possible behavioural teratogens, plugged 
females from the second inbred strain of mouse, C57BL/6J, were 
injected i.p. with either 200mg/kg body weight Al2(SO4)3 or the 
equivalent volume of saline on GdlO to Gd13 inclusive. 
Fifteen control and 16 treated C57 females were found to be 
pregnant. However, these mothers, who were considered to be 
pregnant as judged by the overall weight increase during gestation, 
nevertheless failed to produce any viable young. Only blood and pup 
carcasses could be seen in the cages on the expected day of birth. 
This was also the case for controls. Reducing the exposure period to 
one day only (Gd 10) resulted in five mothers in each treatment group 
producing viable young, although cross-fostering was not possible 
due to the small number of pups born and asynchrony in their times 
of birth. 
It is not clear whether the failure to produce sufficient 
viable young resulted form a direct effect of exposure to Al, or from 
the fact that, from the outset, an insufficient number of females had 
actually been plugged. 
3.10 DISCUSSION 
In utero exposure of CBA females to Al2(SO4)3 had a 
direct effect on the developing foetus resulting in lower birth weights 
of offspring from treated mothers, after four or five days exposure. 
This direct effect on body weight was transient as no significant 
effect of prenatal treatment was found after R0, What is clearly 
apparent from experiment 1 (3.2) is that from Pd6 onwards the 
previous treatment recived by the foster mother during her 
pregnancy, continued to influence a pup's physical deopinent. 
Fostering a control pup, which had had no contact with Al2(SO4)3 ---.--.----- 	-- 	- 
in utero, to a treated mother reduced growth - compared to control 
pups reared by control mothers: On the other hand, fostering a 
treated pup, which starts from a lower birth weight, to a control 
mother enables the pup to overcome this initial disadvantage and to 
restore its physical development to normal. 
The reduction in birth weight of rat pups exposed in utero 
has been reported previously. Benett, Persaud and Moore (1975) 
found an increase in the number of deaths and a diminution of body 
weight in both mothers and their offspring following i.p. injections 
of Aid3 at the same dose as used in this experiment (200mg/kg). 
Similarly, the offspring of BALB/c mice had a reduced birth weight 
after i.p. exposure to A1C13 during gestation days 7 to 16 (Cranmer, 
Wilkins, Cannon and Smith, 1986). 
The maternal effect on weight persisted into adult life for 
females, suggesting that the effects of exposure to Al are greater on 
female offspring and are not transient. The lack of significant effect 
on adult male weight may have resulted from the variance within the 
small sample but Al-expsed male mice may b-,-.better aletq 
recover 	insult. 
This maternal effect on pup growth is not obvious in 
experiment 2 (3.6) when CBA pregnant mice were exposed to Al for 
five days but it is difficult to interpret these results satisfactorily 
because of the small sample of treated pups. Loss of litters occurred 
in both control and treated groups. Thus one can not conclude 
unequivocally that Al alone caused the reduction in birth weight. 
However, there was a decrease in weight gain in the surviving 
treated offspring until Pd9. After this,exposed pups gained weight at 
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a rate comparable to that of controls although remained lighter 
throughout. This suggests that the treated pups could not completely 
overcome their reduced birth weight. 
The nature of this maternal effect is unclear and at present 
one can only speculate on possible mediating factors. The postnatal 
maternal influence may result from retention of Al within the 
mother's body which is subsequently released to the pups via milk 
This could occur if Al became bound to maternal tissues during 
gestation. Alternatively, it is possible that the injected Al binds to 
tissue surrounding the injection site and is slowly released during -------------------------------- 
actual treatment and for aiewdaysJo11owjng.Repeated 
administration of an agent extends the period over which the subject 
is exposed. Hence, Al could become available to the newly fostered 
pups via the dam's milk. Control pups, which had had no prenatal 
contact with Al, may have been exposed to it during the early 
postnatal days. Dobbing (1968) has shown that the rat brain is most 
vulnerable to experimental insult during the suckling period. Indeed, 
Yokel (1985) found that it was not only offspring of mothers 
M. 
exposed to 400 ,umol/Al/kg which gained less weight, but also 
control offspring fostered to these treated does. In the experiments 
reported in this chapter, Ct pups could have been exposed to Al only 
during suckling. Moreover, pups exposed to Al in utero will be 
further exposed during this time. Even if postnatal exposure to Al 
only lasts for 1-2 days, this mabe sufficient to affect the developing 
pup. Yokel and McNamara (1985) injected lactating rabbits with 
AlLact and found that seven days after the last injection 12% of the 
total injected Al was still present in the area of the injection site. It 
would be interesting to isolate tissue from the injection site at 
different ages following completion of treatment, and analyse it for 
Al content. 
The solubility of Al is greatly increased when it is 
complexed to organic compounds e.g. citrate (Slanina, Frech, 
Ekstr&m, Löf, Slorach, and Cedergren, 1986). Within the mother's 
body Al may bind to lactate in the milk. If Al does pass to the infant 
in the milk, this may be important if the gut epithelium of the 
perinatal infant is more susceptible to agents present in the mother's 
milk than is the postnatal pup. In addition, Al present in the maternal 
tissues may influence the quantity or quality of milk available to the 
offspring. This possibility remains hypothetical as neither milk 
output nor its Al content were measured. However, Yokel and 
McNamara (1985) found only low levels of Al present in the milk 
from does which had been exposed to AlLact during lactation. 
Other studies have definitely shown that Al administered to 
the mother can pass to the foetus. Cranmer, et al., (1986) found the 
Al content within the placenta of mice injected with AlCl3atadose 
of 100mg/kg/day from 0d7-16, to be ten times higher than control 
values and the total body Al in the foetuses of these mothers was 
three times higher. Thus, injected Al is available to pass via the 
placenta to the foetus and accumulate therein. Furthermore, research 
has shown that Al can cross the foetal blood-brain barrier (Petit, 
1988). A1C13 ingested by the rabbit resulted in an increased Al 
content of both the mother's milk and within the brains of suckling 
rabbits. Al is known to bind to albumin and transferrin within the 
body (Martin, 1986) and in these forms its solubility, and therefore 
its ability to cross membranes, is increased. 
A second possible explanation for the maternal treatment 
effect is a direct effect of gestational Al on maternal behaviour. 
External influences are known to alter maternal behaviour which in 
turn has consequences for offspring development. Barnett and Burn 
(1967) found that handled pups received more maternal care on 
return to the home cage. Pups in the experiments reported herein 
were repeatedly removed and then returned. Control mothers may 
have given more care to their fostered young after they had been 
tested than did treated mothers. The contribution of alterations in 
maternal care to the maternal effect could be ascertained by 
observing maternal behaviour directly in an observational study (see 
chapter 5). 
The young of a variety of diverse rodent species are known 
to emit calls within the ultrasonic range in circumstances of distress 
e.g. as a result of cold, isolation and hunger. Exposure to Al2(SO4)3 
during gestation may have affected the ability of treated mothers to 
respond adequately to the ultrasonic calls of their fostered pups. 
Alternatively, the treated pups themselves may have been less 
efficient at producing these calls. A pup previously disadvantaged by 
being exposed to Al during gestation and then fostered to a treated 
mother, would be expected to be the most severely affected by any 
neglect in postnatal maternal behaviour, and this was indeed the 
case. 
It is unclear whether the lack of viable C57 young after i.p. 
injections of Al2(SO4)3, at the same dose as that administered to 
pregnant CBA mice, can be attributed to an increase in resorptions or 
spontaneous abortions during pregnancy or to an increased tendency 
of these mothers towards infanticide. Maternal behaviour is thought 
to be triggered by hormonal changes at the time of parturition 
(Rosenblatt and Siegel, 1983). Perhaps these changes are not 
sufficient in the nulliparous C57 female to elicit maternal care. 
Infanticide has been associated with the culling of weak or 
malformed young (Labov, Huck, Elwood and Brooks, 1985). 
Prenatal exposure to Al may alter the development of the foetus 
rendering it physically inferior, thus initiating natural infanticidal 
tendencies in the mother. Alternatively, the stress associated with i.p. 
administration may have affected these mothers more than the CBA 
strain. As pup killing occurred in both treatment groups this is a 
more plausible explanation. 
Other aspects of development were altered by exposure to 
Al2(504)3. Treated pups were slightly behind controls in attainment 
of the righting, forelimb and pole grasping reflexes. These tests are 
measures of the ability to orientate and of motor coordination and 
strength. Other agents have been found to have similar effects on 
these tests e.g. methylmercury and tetraethyltin (Pryor, Uyeno, 
Tilson and Mitchell, 1983). However, Tsujii and Hoshishima (1979) 
found that female CFW mice exposed to Al were accelerated in 
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achieving a screen climbing test compared to controls. Similarly, 
Donald, Golub, Gershwin and Keen (1989) reported greater fore and 
hindlimb strengths after weaning in pups whose mother was fed Al 
in the diet. It could be argued that the differences in the attainment of 
adult responses in this experiment may have resulted from the lower 
weight of the pups reared by treated mothers than from direct effects 
of Al on mastering this reflex. However, body weight and 
performance in the Fox tests did not reveal significant correlations 
suggesting this explanation to be unlikely. 
The developmental profile of pup behaviours was similar 
across all groups, with the majority of pups commencing each 
behaviour on the same day. However group differences did emerge 
in some of the behaviours recorded, reflecting differences in the 
ontogeny of the behavioural repertoire. This was more evident after 
exposure to Al2(504)3 over 5 days. In particular, treated pups 
displayed a reduction in the frequency and duration of bouts of 
rearing within the openfield and assisted rearing against the walls. 
This may have resulted from a delay in the maturation of hindlimb 
strength in the treated pups which is substantiated by the delay in 
attainment of an adult response in forelimb and pole grasping, both 
of which require muscular strength. 
Group differences were found in locomotor activity as 
measured in the openfield. At weaning, female pups were more 
active than males. This sex difference in activity levels has also been 
reported in rats. Bronstein, Wolkoff and Levine (1975) found that 
30-40 day old female rats were more active than males during 
repeated trials in the openfield. Additionally, Al-exposed females 
were less active than control ones. This hypoactivity was still present 
at 22 weeks of age when the total squares crossed by treated female 
mice were significantly lower than for controls. Differences in 
activity were not obvious during day 1, the openfield representing a 
new environment to the mice, increasing their curiosity and 
decreasing their activity, but they were present during days 2 and 3. 
Conversely, treated males were more active than control ones at 
weaning. This further suggests that Al affects female animals to a 
greater extent than males. 
Results from the radial maze tests certainly yield signs that 
Al exposure has effects on learning in this situation, although none 
-- 	-. 
of the differences reach a satisfactory level of statistical significance. 
One interpretation of the maze data is that differences resulted from 
impairments in motor rather than cognitive abilities. However, the -----=-- - 
time taken to complete each trial did not show any significant 
differences between control and treated males. Although males 
exposed to Al prenatally over four days required more days to 
complete the task, few differences in the number of arm entries were 
seen. Similarly, Alfano and Petit (198 1) found that exposure to 
heavy metals led to deficits in some measures of learning ability but 
not in others. They exposed Long-Evans hooded female rats to lead 
carbonate at a level of 4% or 0.4% in their diet during postnatal days 
1 to 25. The offspring were tested at 65 days of age in a 8-arm radial 
maze. Animals in both lead groups required more days to reach 
criterion than controls but did not show any differences in the 
number of correct choices made in the maze (Alfano and Petit, 
1981). However, in the experiments described in this chapter, Al-
treated males did require more arm entries to complete the maze task 
compared to controls, when the exposure period was extended to five 
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days. Unfortunately the sample size was inadequate for definitive 
conclusions to be drawn. 
Evidence from a number of studies has shown that an intact 
hippocampus is essential for learning and memory (Olton and 
Samuelson, 1976; Olton, Walker and Gage, 1978; Olton and Papas, 
1979; Becker, Walker and Olton, 1980). In section 3.4.11 (p58) 
control and treated animals were sacrificed after completion of the 
maze tests. There was only aiO% difference in ChAT levels within 
the hippocampusat 17 weeks of age which was not significant and 
this lack of any effect on ChAT may explain why only slight 
differences were found between control and treated subjects in maze 
performance. However, in section 3.8.8 (p73) it is reported that, 
following five days of exposure to Al, the difference in hippocampal 
ChAT levels between control and treated males was 24%. In this 
case. as noted above, slight deficits in performance by treated 
animals were also evident. 
Scopolamine is a centrally-acting muscarinic cholinergic 
receptor antagonist, and thus challenging subjects with scopolamine 
will help to give an estimate of the contribution of muscarinic 
cholinergic receptors to learning. In experiment 2, there was a 
suggestion that differences existed between the saline- and 
scopolamine-treated groups but these were not substantial. It took 
longer for the effects of scopolamine to be manifested in the treated 
mice. The challenge was hindered by the small sample size and more 
work will be necessary before satisfactory conclusions can be drawn. 
Levin, Castonguay and Ellison (1987) have shown that blockage of 
central nicotinic-cholinergic receptors also impairs maze 
performance. Perhaps challenging with scopolamine antagonises the 
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remaining muscarinic receptors which are still present after exposure 
to Al, but as scopolamine does not act on nicotinic receptors, these 
receptors remain unaffected and are sufficient to maintain 
performance in the previously learnt test. Any differences between 
the control and treated animals in the maze may be brought out by 
the co-administration of scopolamine and a nicotinic receptor 
antagonist e.g. mecamylamine. Alternatively, altering the exact time 
at which scopolamine is injected may reveal greater group 
differences. Buresova and Bures (1982) introduced a delay between 
trials 6 and 7 of a 12-arm radial maze task, then injected subjects 
with scopolamine and found an increase in the number of errors 
made during choices 7 to 12. They concluded that continuous 
performance in the is not affected by scopolamine bu storage 
of information after a delay is 
Tilson (1987) injected rats with low levels of colchicine, a 
neurotoxin, and found a disruption in maze performance. Animals 
injected with a higher dose did not show any further deficits. This 
finding was explained in terms of reaching a ceiling effect i.e. the 
maximum number of cholinergic receptors had been lost so 
increasing the dose had no effect. In experiment 2, exposure to Al 
may have caused maximum deficits in the cholinergic system so that 
challenging with scopolamine had no further disrupting effect on 
maze performance. 
The picture is complicated further by the fact that, through 
studies involving blockage of different receptor types, other 
neurochemical systems have been identified as playing a role in 
cognitive processes. McGurk, Levin and Butcher (1988) found that 
exposure to scopolamine resulted in the expected deficit in the 
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ability to make correct responses in a maze but that this deficit was 
attenuated by administering the dopamine receptor antagonist 
haloperidol. Furthermore, Decker and Gallagher (1987) found that 
injection of 6-hydroxydopamine, which causes a depletion of 
noradrenaline, together with scopolamine led to an increased deficit 
in the ability to complete accurately an 8-arm radial maze. Thus, the 
mammalian brain which has suffered an insult may be able to initiate 
compensatory mechanisms to overcome any cholinergic deficit and 
can mediate adequate maze performance. For example, dopamine 
fibres from the ventral tegmental area exert an inhibitory influence 
on acetylcholine cells in the hippocampus (Robinson, Malthe-
Sorenssen, Wood and Commissiong, 1979). Perhaps after an insult, a 
compensatory mechanism may result in this inhibition being 
reduced. 
The results of the ChAT assays show that injected Al is able 
to enter the brain of the developing foetus and in some way affect the 
developmental timetable of the cholinergic system. This is perhaps 
not surprising when one considers the known immaturity of the 
rodent's blood-brain barrier during the foetal and perinatal period 
which creates the possibility of exposure of the foetal brain to agents 
within the mother's system. ChAT activity consistently increased in 
all brain regions studied between weeks 3 and 17 postpartum, then 
fell consistently during weeks 17-34. The levels of ChAT present in 
the oldest tissue samples between 34 and 44 weeks did not conform 
to such a predictable trend across brain regions or between 
experimental groups. Thus, the direction of change in ChAT levels 
was not always consistent in each brain region at each age, the 
greatest disparity occurring within the midbrain. This inconsistency 
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is difficult to explain but similar findings have been reported. Gulya, 
Rakonczay and Kasa (1990) reported decreases in the level of ChAT 
activity in the frontal cortex, parietal cortex, hippocampus and 
striatum of female Wistar rats exposed to A1C13 for either 5, 15 or 25 
days. This decrease in activity not only varied from region to region 
but also showed inconsistent trends within the same region as a 
function of exposure time. For example, ChAT activity in the 
hippocampus, although consistently reduced compared to control 
levels, increased from 455±40 pmol/min/mg protein after 15 days of 
i.p. exposure to 507±30 pmol/min/mg protein after 25 days of 
exposure (Gulya, et al., 1990). 
The loss of ChAT activity in the various brain regions as a 
result of prenatal exposure to Al is complicated by the natural fall in 
ChAT activity and other markers of the cholinergic system with age. 
For example, Williams (1991) found age-related decreases of 15- 
30% in ChAT activity in the septum, hippocampus, frontal cortex 
and striatum of 24 month old Fisher 344 male rats compared to 4 
month old counterparts. Gilad, Rabey, Tizabi and Gilad (1987) 
reported a reduction in choline uptake and acetylcholine release in 
24 month old compared to 3 month old Wistar-Kyoto rats. Thus, 
there is a natural age-dependent degeneration of cholinergic neurons. 
Animal studies involving surgical lesions of specific brain 
regions or damage induced by neurotoxins, have established the 
plasticity, both morphologically and biochemically, of the adult 
central nervous system to such injury (Cotman and Nieto-Sampedro, 
1984). Steward and Messenheimer (1978) found an increase in the 
level of acetylcholine esterase, the enzyme responsible for the 
degradation of acetylcholine, 10 days after lesion of the entorhinal 
cortex, the region from which the extrinsic input to the hippocampus 
arises, reflecting sprouting of the remaining septohippocampal 
fibers. Therefore, the lack of difference between control and treated 
groups at the oldest age in some brain regions may have resulted 
from the initiation of compensatory mechanisms which either 
increase the level of enzyme produced or enhance the sensitivity of 
the remaining neurons to the enzyme activity available, with the net 
result of little overall functional change. 
Thus compensatory adaptations are initiated as a result of 
injury and aging. The experience of an insult during development 
may have initiated these responses earlier in the Al-treated animals 
so that modification of the neuronal circuitry was already underway 
by the time the stimulus for modifications induced by aging set in. 
The disparity between the extensive effects of prenatal 
exposure to Al on ChAT levels and the relatively modest effects on 
behaviour has been reported elsewhere. Bartus, Flicker, Dean, 
Pontecorvo, Figueiredo, and Fisher (1985) found a profound effect 
of ibotenic acid (an excitotoxin) lesions of the nucleus basalis 
magnocellularis of male Sprague-Dawley rats on memory which 
gradually completely recovered despite continued cholinergic 
deficits. Interestingly, in agreement with the ChAT results reported 
here, these authors did not find a compensatory increase in ChAT 
levels with age. Further, Loesche and Steward (1977) correlated the 
recovery of performance in a T-maze with the reinnervation of the 
dentate gyms following lesion of the entorhinal cortex by remaining 
neurons of the contralateral entorhinal cortex. Moreover, Gilad, et 
al., (1987) have shown that loss of hippocampal pyramidal neurons 
is accompanied by an increase in muscarinic binding by remaining 
neurons. Thus several compensatory mechanisms have to be 
exhausted before behavioural deficits are induced. Furthermore, 
Lippa, Pelham, Beer, Critchett, Dean and Bartus (1980) have 
suggested that memory impairment may not be detected until 20 
months of age in rats. Although a decrease in latency to enter the 
shock compartment in a passive avoidance test was evident at 15 
months of age, maximal effects were not reached until after 20 
months (Lippa, et al., 1980). Perhaps this represents a critical level 
before which the degree of loss of neurons or enzyme activity is 
balanced by continuing compensatory adaptations to such deficits. It 
is not until this critical point has been traversed that behavioural 
deficits are induced. 
Overall the behavioural effects are not as consistent as the 
loss of ChAT activity. In terms of learning tests, Lochry, Hoberman 
and Christian (1985) have emphasised the importance of selecting an 
appropriate criterion to differentiate control and prenatally treated 
subjects. This disparity may have been reduced by incorporating 
further behavioural tests. For example, rats (no strain given) treated 
from postnatal day 2-3 to day 20-21 with lead acetate at a dose 
81mg/kg, performed at comparable levels to controls on a one-way 
shuttle-avoidance test but learning deficits were seen in a two-way 
task (Sobotka, Brodie and Cook, 1975). 
Finally, this disparity may also be explained in terms of 
information redundancy within the brain. Two and four exposures of 
rats (no strain given) to X-irradiation resulted _ina59 and 77% 
reduction respectively in granule. cells  of the dentate gyrus of the 
hippocampus compared to controls, but no differences in behavioural - 	-- 
performances between exposed and control rats (Bayer, 1989). This 
led Bayer (1989) to conclude that there is "a cushion of neuronal 
redundancy in mammalian brains." Thus a certain degree of loss in, 
for example, cell number can be resisted before any behavioural 
changes are evident. This is interesting from a clinical point of view. 
It is known that the symptoms of Parkinson's disease are not 
manifested until the reduction in cell number within the substantia 
nigra is 80% relative to controls (Bayer, 1989). 
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CHAPTER 4 
Effect of prenatal exposure to aluminium sulphate on ultrasonic 
calling in two inbred strains of mice. 
4.1 INTRODUCTION 
The experiments presented in this chapter and the next, 
describe in more detail aspects of behaviour which have proved to be 
sensitive to prenatal drug treatments. 
The dialogue between a mother and her offspring involves 
delicate and highly complex interactions (Rosenblatt and Lehrman, 
1963; Robinson and D'Udine, 1982). Although a number of studies 
have concentrated on the behaviour of the mother or the pups in this 
relationship, its intricacy, as pointed out by Robinson and D'Udine 
(1982), is probably reflected in the fact that both mother and infant 
contributions must be considered together rather than in isolation. 
Smith and Sales (1980) have emphasised the importance of this 
relationship, involving the continual exchange of stimuli between 
mother and young, in the successful shaping of the physical and 
behavioural development of the offspring. 
It is probably due to their apparent immaturity that the 
contribution made by the infant to the mother-young relationship has 
been underestimated, although the newborn of altrical animals are 
quite adept physiologically and behaviourally. Nevertheless, it is 
difficult to define adequate measures of the behaviour of neonates 
which are both quantifiable and reliable, and which accurately reflect 
changes resulting from alterations to environmental variables. 
However, infant rodents do possess the ability to emit calls within 
the ultrasonic range, which are given in response to a variety of 
stimuli. As pointed out by Zbinden (1981), and confirmed by 
Cuomo, De Salvia, Maselli, Santo and Cagiano (1987), this response 
may function as a reliable indicator of subtle behavioural effects 
caused by prenatal or postnatal drug treatments. 
Anderson (1954) was the first to record ultrasonic 
emissions from adult laboratory rats placed alone in their cages. In 
1956 Zippelius and Schleidt (cited in Noirot, 1966) described the 
production of ultrasounds by young from different rodent species. 
The production of ultrasounds by a number of rodent species is now 
well established (e.g. Sewell, 1967; Okon, 1972; Sales and Smith, 
1978; Elwood and McCauley, 1983). Fthermore, since these initial 
descriptions research has concentrated on factors affecting ultrasonic 
output, analysis of the physical characteristics and the possible 
function of these calls. 
For the purposes of this chapter I will concentrate on infant 
ultrasonic calling although several circumstances exist during which 
adult animals will emit similar calls and these are discussed briefly. 
4.1.1 Adult ultrasonic calling 
Sewell (1967) and Sales (1972a; 1972b) described the 
emission of ultrasounds when an adult male rat was introduced into 
the cage of a conspecific, of a lactating or pregnant female and also 
during episodes of mounting. She concluded that these calls were 
important in the social life of adult rodents. Additionally, Okon 
(1972) noted that nursing mice produced ultrasounds similar to those 
emitted by infants. Further, Lewis and Schriefer (1982) found that 
pregnant Sprague-Dawley rats exhibited a higher rate of calling than 
controls (non-pregnant rats) on the day before gestation. Thus, in the 
areas of aggressive and sexual behaviour, ultrasounds are important 
in the adult animal. 
4.1.2 Ultrasonic calling by neonates 
Since its initial description the production of ultrasonic 
emissions by a number of neonatal rodent species as a form of 
commication between young and mother has been well 
characterised. Several circumstances have now been found which 
evoke calling in infant rodents. Calls may be elicited as a result of 
gentle handling (Okon, 1970b; Bell, Nitschke and Zachman, 1972), 
during isolation (Noirot, 1968; Robinson and D'Udine, 1982), under 
cold stress (Hart and King, 1966; Noirot, 1968; Okon, 1970a; Okon, 
1972;), or from exposure to unusual tactile (Okon, 1970b) or 
olfactory stimuli (Oswalt and Meier, 1975; D'Amato and Cabib, 
1987). 
As pups develop from birth characteristics of their 
ultrasonic vocalisations change. Noirot (1966, 1968) found that 
isolated albino mouse or rat pups show a large increase in calling on 
day 4 postpartum, corresponding to the opening of the ears. There is 
a decrease in calling on day 13 which coincides with eye opening. 
Noirot and Pye (1969) also found regular changes in ultrasonic 
emissions with successive days. 
These ontogenetic changes in ultrasonic output have been 
related to the development of thermoregulation. With a decrease in 
ambient temperature the rate of calling characteristically increases 
with age to a peak and subsequently falls until it eventually ceases 
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completely. The exact time course of these events is dependent on 
the species and strain of the subjects. Lagerspetz (1962) 
simultaneously recorded ultrasonic emissions and body temperatures 
from mice of the inbred Swiss albino strain at various ambient 
temperatures. He found that during the first few days of life rodent 
pups are entirely poikilothermic; as the ambient temperature drops so 
does the pup's internal temperature. At this age rodent pups are 
extremely resistent to cold; a decline in temperature causes the pup 
to become comatbsed and hence it ceases to produce calls. As 
homiothermy develops the pup reacts to a drop in temperature by 
intensive calling. Okon (1970a) found this phase to be around days 
6-7 postpartum for the Swiss albino mouse. At a later stage, when 
the development of thermoregulation is complete, a reduction in 
ambient temperature is not such a strong stimulus and calling is 
again reduced. 
Although Noirot (1966) related the cessation of calling to 
the stage of eye opening, Okon (1970b, 1972) has elicited calls from 
pups after this by handling. It is more likely that alterations in calling 
in response to a reduction in ambient temperature are related to the 
development of homiothermy and will cease when this has been 
achieved. 
Young rodent pups have been found to respond to tactile 
stimuli by calling although the pattern of calling is not the same as 
that evoked by temperature reduction. Okon (1970b) found that, in 
response to handling, albino mouse pups have the greatest rate of 
calling during days 1-3 postpartum after which the rate declines until 
day 14 when no further calls are elicited. This profile of calling is 
also highly dependent on species and strain. Even using similar 
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methods to elicit calling, different researchers have reported varied 
profiles of calling. For example, Noirot and Pye (1969) described a 
high rate of calling on Pdl in response to chilling which was 
followed by a decrease over the next 6-7 days, the reduction in 
temperature compared to the maternal nest being the stimuli for 
calling. On the other hand, using the same mouse strain, Okon 
(1970a) found that pups exhibited a low response until day 6 after 
which there was a large increase in the rate and intensity of calling. 
In most experiments there is an inevitable confounding of 
stimuli on the pups. In order to isolate a pup one must handle it to 
remove it from the nest which in turn lowers the pup's temperature 
and so on. Noirot and Pye (1969) reported deliberately having gently 
handled the pups to elicit calls during recording, thus complicating 
the interpretation of their results of calling elicited by temperature 
reduction whereas Okon's (1970a) pups, once removed from the 
nest, were exposed solely to a decrease in ambient temperature. 
Despite the difficulties in isolating stimuli which elicit 
calling, two different patterns of ultrasonic calling have been 
described; one produced in response to handling and one resulting 
from being isolated. These are thought to correspond with the 
different communicative functions of calling. Ultrasounds elicited by 
handling are thought to inhibit the mother's continuing rough 
handling of the pup during retrieval or rough grooming (Noirot, 
1966; Sewell, 1970). Those resulting from isolation elicit maternal 
care from the mother (Zippelius and Schleidt, 1956 cited in Noirot, 
1966; Beach and Jaynes, 1956; Sewell, 1970; Allin and Banks, 
1972). Noirot (1966) found that mothers would actively search for 
isolated pups and retrieve them in response to these calls. Moreover, 
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Reisbick, Rosenblatt and Mayer (1975) have shown that fostering 
younger litters to lactating females prolongs the time over which 
these females respond maternally. Allin and Banks (1972), using 
playback of recorded pup calls, found that ultrasounds elicited the 
response of head orientation from males, virgin females and lactating 
females but it was only the latter group which actually left the nest 
and exhibited searching behaviour. They concluded that ultrasounds 
were important in providing information on the direction of the 
scattered pup. Similarly, Noirot (1974) found that virgin females 
would alter their behaviour on exposure to an inaccessible litter 
exposed to a reduced temperature. Smotherman, Bell, Starze, Elias 
and Zachman (1974) reported that both pup odour and ultrasonic 
calling were the strongest stimuli for accurate and rapid retrieval of a 
lost pup. 
Characteristics of ultrasonic vocalisations have not only 
been found to be quite different between species but also between 
subspecies. For example, Hart and King (1966) found that under 
conditions of cold stress young from two species of deermice 
(Peromyscus maniculatus bairdii and P. m. gracilis) differed 
significantly in all of the physical measures recorded. Wistar rat pups 
emit few calls in response to handling until days 4-5 postpartum 
when the rate of calling increases until days 14-15. On the other 
hand, bank vole pups (Clethrionomys) appear to be completely 
insensitive to calling evoked by tactile stimuli (Okon, 1972). 
There are clear examples of genetic differences in calling 
from comparisons of pups from various strains within the same 
species. Bell, Nitschke and Zachman (1972) recorded ultrasounds 
from three different strains of mice (C57BL/6J, BALBc/J and 
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C3HIHe) upon removal from the nest every third day from postnatal 
day 3 to 18. Characteristically the ultrasonic emissions differed with 
age but further the timing of the peak frequency and duration of 
calling differed significantly between strains. Similarly, Robinson 
and D'Udine (1982) measured the effects of isolation alone on 
calling in three inbred lines (BALB/c, SEC and C57BL/6J). Each 
pup was placed on a heated blanket and ultrasonic output was 
recorded over five minutes. BALB/c and SEC mice produced 
significantly more calls on each day and for a longer period than 
pups of the same age belonging to the C57 strain. 
Relatively few studies have investigated the effects of 
prenatal drug treatment on the maternal-infant relationship. To my 
knowledge even fewer have recorded changes in ultrasonic output as 
a result of such exposure, despite the reliable and stable pattern of 
ultrasonic calling by rodent neonates. This is perhaps more 
surprising in the light of research which has shown that alterations in 
maternal care can affect the subsequent behaviour of the offspring 
(e.g. Deitchman, Kapusinski and Burkholder, 1977) and that pup 
stimuli are responsible for eliciting adequate maternal 
responsiveness. Within the studies which have incorporated this 
technique, both increases and decreases in calling have been 
reported. Wistar rat pups treated chronically with haloperidol, a 
dopamine antagonist, during the early postnatal period (days 2 to 16) 
exhibited a reduced rate and frequency of calling when they were 
isolated (Cagiano, Sales, Renna, Racagni and Cuomo, 1986). 
Conversely, Adams (1982) found that Sprague-Dawley rats treated 
prenatally with vitamin A palmitate (8o,000 lU/kg), a known 
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behavioural teratogen, called at a significantly higher rate than 
controls. 
It is clear from chapter 3 that there  isahigh1y significant ---
effect of the treatment, received by a pup's foster mother during 
gestation on aspects of a pup's physical and behavioural 
development. The pattern of ultrasonic emissions has been recorded 
in this experiment in an attempt to investigate a further, and more 
detailed aspect of the mother/pup inter-relationship. 
It must be noted that removing a pup from the nest and 
placing it alone at a lower temperature is potentially stressful. The 
calls produced in this experiment have probably resulted from a 
reaction to a compound of changes, the drop in temperature, being 
isolated from the normal tactile and olfactory stimuli of the mother 
and littermates, and maybe even from hunger as pups suckle 
continuously during the early postnatal period. However, this 
experimental design does not aim to investigate the factors which 
cause calls to be emitted but whether pups in the four experimental 
groups have the same pattern of calling, and what its effect is upon 
their mothers. 
As reported in section 3.9, several attempts were made to 
produce enough C57 pups to enable cross-fostering between litters 
but C57 females failed to continue to term probably because few 
were actually plugged rather than as a direct result of exposure to Al. 
Thus, the results for C57 ultrasonic calling presented in this chapter 
are infact the results from the offspring of the mothers observed for 
maternal behaviour in chapter 5. For this reason only pup weights 
and ultrasonic calling were measured so as not to cause further 
disturbance to these mothers. 
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Some of the work described in this chapter has been 




Plugged CBA and C57 females were randomly divided into 
two groups which received either i.p. injections of Al2(SO4)3 or the 
equivalent volume of saline at the same pH, on gestation days 10 to 
13. 
4.2.2 Procedure 
Due to the differences in the pattern of ultrasonic calling of 
the two strains, recording took place over 6 days (on Pd3,4,5,6,9,12) 
for the CBA strain and on 4 days (Pd3,4,6,8) for C57 pups. These 
days were chosen on the basis of pilot studies and from previous 
work which typically showed that few calls are emitted at birth by 
either strain and C57 pups have ceased calling by PdlO and CBA 
pups by Pd12-13. 
The litter was removed from the home cage and placed in a 
glass crystallising dish lined with nesting material (dish 1), which 
had previously been warmed to a comparable temperature as the 
maternal nest (34-36 0C) with a lamp (25W). Each pup was then 
removed individually from dish 1 and placed in a second dish (dish 
2) which was far cooler (24-26 0C) and acted as a mild thermal 
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stressor. Ultrasounds were recorded using a QMC Mini-2 Bat 
detector set to receive a frequency band of 70-80 kHz (see Noirot, 
1966; Okon, 1970a; Robinson and D'Udine, 1982), and mounted 10 
cm above dish 2. The detector is equipped with a microphone and 
headphones. The number of calls emitted was counted using a hand 
tally and noted at the end of each minute for a period of 5 minutes. 
Scoring of ultrasounds was begun 1 minute after placing the pup in 
dish 2 to allow any immediate response to handling to die down. The 
same type of nesting material as used for the maternal nest was 
placed in dish 1 to reduce sound emissions due to unusual tactile 
stimuli (Noirot and Pye, 1969; Okon, 1970b) although odours from 
the mother and littermates were not present. 
Recording over five minutes was thought to be sufficient to 
even out stort-term fluctuations in calling output. It is not uncommon 
for mouse pups from certain strains to produce calls at a rate greater 
than 250/minute (Noirot and Pye, 1969). In these instances the 
method of recording may have underestimated the number of calls 
produced, although this will have been the case across all 
experimental groups. After recording the pup was replaced into dish 
1 and the procedure repeated for each pup in the litter. Individual 
pups were not returned to the home cage until all pups in the litter 
had been tested. The order of testing of both litters and individual 
pups was randomised on each test day. 
4.2.3 Maternal Retrieval 
This was carried out for CBA mothers only. On completion 
of recording of ultrasonic calling the four pups were replaced into 
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the home cage at the opposite end from the maternal nest. The time 
taken to return one of the pups to the nest was recorded. 
4.2.4 Pup measures 
Body weight was recorded on every third day from Pd3 to 
weaning at Pd21 for CBA and C57 pups. On these days CBA pups 
underwent the modified version of the Fox tests for sensory-motor 
coordination (Fox, 1965), as reported in the general methods chapter 
(section 2.2.1). 
4.3 RESULTS 
The main ANOVA tables and median + lower and upper 
interquartile ranges are given in Appendix D. 
4.3.1 Breeding Performance 
Prenatal exposure to Al2(SO4)3 during gestation days 10-
13 had no effect on breeding performance in either strain. The mean 
gestation length for control CBA mothers (n=10) was 19.9(±0.23) 
days and 20.0(±0.37) days for those CBA females exposed to Al 
(n=9). C57 Al-exposed females (n=1 1) had a slightly shorter mean 
gestation length (=20.73(±0.56) days) compared to C57 controls 
(n=8, =21.13(±0.85) days), although this difference was not 
significant. Pup mortality occurred in both control and treated groups 
in the CBA and C57 strains at birth, as was confirmed by the 
presence of blood and from the body weight records taken during 
pregnancy. Although control females from both strains were found 
to have larger mean litter sizes (CBA =6.0(±0.71); C57 
=6.75(±0.37)) compared to Al-treated females (CBA =4.8(±0.8); 
C57 =5.82(±0.48)), these differences were not significant. 
4.3.2 Maternal weight 
There was no significant effect of prenatal treatment on 
CBA maternal weight during gestation, although there was a 
significant day and prenatal treatment interaction (F(3,24)=10.66 
p=0.004). The overall weight gained by CBA treated mothers was 
significantly less during gestation days 10-18 than CBA control 
mothers (control =8.69(±0.7)g, treated =5.65(±0.81)g, t(16)= 2.84 
p<0.02). C57 maternal weight gain was largely unaffected by 
gestational exposure to Al2(SO4)3, although the total mean weight 
gain for control females (n=8 K=10.18(±1.11)g) was slightly greater 
than Al-exposed females (n=1 1 =8.98(±0.66)g). 
CBA maternal weights were largely unaffected by treatment 
during the preweaning period, except for a marginally significant 
interaction between day and prenatal treatment, control CBA 
mothers being slightly heavier during the latter days of the 
preweaning period. C57 females gained weight at a comparable rate. 
4.3.3 Pup weight 
A total of 46 control and 25 Al-treated CBA pups were 
present at birth. There was a highly significant difference in the 
mean birth weights of control and treated CBA pups (control 
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=1.35(±0.02)g, treated 5=1.19(±0.03)g, t(37)= 3.95 p=0.0003), 
pups exposed to aluminium being 12% lighter. After cross-fostering 
there was a total of 40 pups, 2 pups were neglected by their foster 
mothers and one pup was not included in the analysis as it was a 
runt, leaving a total of 37. The remaining pups were distributed 
within the experimental groups as follows:- Cc n=10, Ct n=10, Tt 
n=9 and Tc n=8. 
Within the C57 strain, 49 control and 57 treated pups were 
present at birth. As with CBA pups, C57 controls weighed more at 
birth than treated offspring (control i=1.5(±0.02)g; treated 
5E=1.36(±0.02)g, t(103)= -5.37 p<0.0001). Pup sample sizes in the 
C57 strain were:- Cc n=13, Ct n=16, Tt n=16 and Tc n=1 1. 
As in experiment 1 of chapter 3, there was no effect of sex 
on CBA pup body weights up to weaning. There was a highly 
significant effect of prenatal treatment (F( l,29)=3O.74p<0.000l) 
and foster mother treatment (F(1,29)=30.34 p<0.0001) on pup 
weight during the preweaning period. As can be seen from Fig. 4. 1, 
Cc pups Were fàüñd to be the heaviest group and Tt pups weighed 
the least, a difference of 20% by Pd21. Again, as in experiment 1, 
the experimental groups run parallel with their foster mother's 
treatment; those pups fostered to control mothers weighed more than 
pups reared by mothers who had been exposed to Al. For example, 
by weaning Ct pups weighed 11% less than their control 
counterparts (Cc) and similarly Tt pups were 14% lighter than Tc 
pups. There were also significant interactions between day and 
prenatal treatment (F(6,174)=4.61 p<0.004), and day and foster 
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Fig. 4.1. Body weights of CBA pups whose mothers 
received intraperitoneal injections of either aluminium 




In the C57 strain, male and female pups were separated for 
analysis due to the influence of sex on body weight (F(1,47)=5.83 
p<0.02). Figs. 4.2a and b summarise male and female pup body 
weight change during the preweaning period. One can see that Cc 
pups weighed the most and Ct and Tt pups, whose lines are almost 
overlapping, the least. This difference was most pronounced by Pd 12 
when Cc pups were 10% heavier than Ct or Tt pups. There was a 
significant overall effect of foster mother treatment on C57 male pup 
weights (F(1,26)=4.83 p<0.04), although the day and -foster mother 
treatment interaction was only marginally significant. C57 pups 
fostered to treated mothers had lower body weights than pups 
fostered to control mothers, the extent of this difference declined 
with age. 
The divergence in body weight between C57 female pups 
was greater than for C57 males and increased with age (see Fig. 
4.2b). As with C57 males, there was a significant effect of foster 
mother treatment (F(1,21)=7.94 p=0.01) and an interactive effect of 
day and foster mother treatment (F(6,126)=5.25 p=0.01) on female 
body weight, females raised by treated mothers weighed less than 
those reared by control females, a difference that increased with 
time. 
Thus, in the two strains the lower weight of treated pups at 
birth continued throughout the postnatal period for those pups 
fostered to treated mothers only. 
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Fig. 4.2: Body weights of CS 7BL16J pups whose mothers 
received intraperitoneal injections of either aluminium 
sulphate (200mg/kg) or saline during Gd10-13. 
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4.3.4 Fox tests 
Chi-square analysis of the 7 Fox tests employed revealed a 
highly significant difference between CBA pups in forelimb 
grasping on Pd12 (X2(3)=20.401 p<0.001), with only 2 out of 9 Tt 
pups having reached an adult response, and in screen climbing on 
Pd15 (X2(3)=11.16 0.05>p<0.02). Performance in the other tests 
was not found to differ significantly between the groups and the 
differences in the two tests above were not correlated with weight. 
There is no data available for performance of C57 pups in 
the Fox tests. 
4.3.5 Ultrasonic calling 
Figs. 4.3a and b summarise the changes in the total median 
number of ultrasounds emitted on each test day by the four 
experimental groups for CBA and C57 pups respectively. In the case 
of CBA pups, calls were most vigorously emitted during the earliest 
postnatal days, reaching a peak which then steadily declined so that 
by day 12 very little calling was evoked by the drop in temperature, 
as the development of adequate homiothermy was finally achieved. 
It is not possible to say when calling ceased completely as no further 
measurements were taken after Pd 12. Unlike pup weights there was 
no influence of sex on C57 calling. C57 pups did not exhibit as clear 
a pattern of calling with age on exposure to a drop in temperature. 
The most striking observation from the CBA data is that, 
throughout the test period, the total number of calls emitted was 
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Fig. 43: The total median number of ultrasonic calls emitted 
by (a) CBA and (b) CS 7BL/6J pups in a five minute test. 
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difference was especially pronounced on Pd3 (H(3)=12.79 p=0.005), 
Pd4 (H(3)=20.95, p=0.0001) but only reached marginal significance 
on Pd6. The rate of calling of Cc pups increased to a peak on Pd4 
(204.5 calls/mm) and then slowly declined to a median of less than 2 
calls/minute by Pd12. Ct and Tc pups produced their greatest 
median number of calls on Pd5 (196.5 and 114.5 calls/mm 
respectively) and Tt pups on Pd6 (128 calls/mm). Although control 
pups from both groups emitted more total calls than treated pups, Ct 
pups had a considerably lower initial rate of calling on Pd3 than Cc 
pups. Their rate of output reached comparable levels to that of Cc 
pups only by M. The decline in calling was also more dramatic for 
this group. Thus, being raised by a treated mother dampened the rate 
at which these pups called. The multiple comparisons option 
revealed that on Pd3 and 4 Cc pups emitted significantly more calls 
than the Tt group (at the p<0.05 level) and on day 4 groups Cc and 
Tc differed significantly. No other comparisons were significant. 
In summary, prenatal Al exposure caused two effects; it 
resulted in a reduction in the rate of calling and altered the day on 
which pup calls reached a maximum. 
Any disruption to the ultrasonic calling of C57 pups by in 
utero exposure to Al is not as clearly apparent. Cc pups decreased 
their total median number of calls between days 3 and 4, then 
increased by Pd8. Tc pups displayed a similar pattern of calling as 
that of Cc pups although their initial median total was greater. Ct 
pups exhibited a fairly constant low level of calling of a median of 
30 calls/5 minutes. Pups in the Tt group had a more irregular pattern; 
the total median number of calls decreased between Pd3 and 4, 
increased to Pd6 and then fell again. Kruskal-Wallis ANOVA 
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revealed a marginally significant difference between experimental 
groups on Pd8 only, pups fostered to control mothers calling more 
than those reared by treated mothers. 
4.3.6 Maternal retrieval 
CBA control mothers had a reduced latency to retrieve the 
first pup back to the nest on Pd3 (control n=5 median=24.0s, treated 
n=5 median=54.0s) but this was not found to be significant. As pups 
grew older both groups tended to reduce their latency to contact the 
pup. Maternal retrieval was not tested on Pd12 as pups were capable 
of homing to the nest before the mother could pick them up. 
Maternal retrieval was not recorded for C57 mothers so as 
not to disturb them during the maternal behaviour experiment 
undertaken in chapter 5. 
4.4 DISCUSSION 
Some of the trends recorded in this experiment for the CBA 
strain are in agreement with those previously described in chapter 3. 
In that experiment the treatment received by a pup's foster mother 
during gestation was found to have a marked effect on pup body 
weight up to weaning. Al-treated pups also exhibited developmental 
- 	 - 
delays in several of the Fox tests and activity levels at weaning were 
found to be both sex and prenatal treatment dependent. By contrast, 
the results of the experiment reported in this chapter show that pup 
weights were not only influenced by foster mother treatment but 
additionally by direct exposure to Al prenatally. Similar maturational 
117 
delays were present in both experiments. Additionally, the 
implication of the results on CBA ultrasonic calling is that, unlike 
pup weights, the production of ultrasounds is largely unaffected by 
foster mother treatment but is strikingly reduced by exposure to - 
Al2(SO4)3 in utero. On the other hand, any alteration to ultrasonic 
calling of C57 pups is harder to discern because of the low response 
level of this strain to a reduction in temperature, although there is a 
slight suggestion of an influence of maternal treatment. The lack of 
differences between the C57 experimental groups probably results 
from a floor effect; the baseline level of calling is so low that any 
disruption is unlikely to be evident. 
The strain differences in ultrasonic calling are quite obvious 
from figures 4.3a and b, in particular the greatly diminished number 
of calls produced by C57 pups which never exceeded a median total 
of 80 calls in a five minute period. Robinson and D'Udine (1982) 
found that C57 pups never produced calls at a median rate greater 
than 30 calls in 5 minutes, with a peak between days 2-4 postpartum 
and a cessation of calling by Pd 10. In this experiment, peak calling 
for Cc pups occurred on Pd8, Pd4 for Ct, Pd6 for Tt pups and Pd3 
for the Tc group. 
A limitation in the method of recording is that it does not 
provide information on the mode of calling i.e. whether one group 
called more frequently in bursts whilst the other called continuously. 
However, examination of the data minute by minute revealed that 
treated pups exhibited both fewer bursts and a lower number of calls 
within these bursts compared to controls. 
It was suggested in the introduction to this chapter that 
recording of ultrasonic calling might provide a reliable measure of 
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toxicity following exposure to drugs or other toxicants. In the light 
of the results presented herein, it must be noted that the strain of the 
subject is an important consideration and the reliability of this 
measure will be greater for those strains with a high level of calling. 
Thus, the following discussion refers to the alterations in the calling 
pattern of CBA pups. 
It is not possible to determine with confidence whether the 
disparity in the production of ultrasonic calls by CBA pups was due 
to effects of exposure to Al on the vocalisation system per se, or on 
its rate of maturation. It is unlikely that this difference can be 
explained in terms of a damaged vocalisation apparatus as pups from 
all the experimental groups did exhibit the ability to call. The peak 
calling occurred a day later for treated CBA pups than controls. It 
would certainly seem possible that the mechanisms of sound 
production matured more rapidly in control pups. Alternatively, the 
calls elicited by the treated pups may have been weaker or of lower 
intensity than those produced by control pups. Although unlikely, 
calls from treated pups may have had differing physical 
characteristics outside the range of the detector. Thus, prenatal 
treatment may have in some way shifted the acoustic parameters of 
the calls from CBA pups. 
The results of the sensory-motor tests, in which CBA pups 
exposed to Al prenatally were, in some respects, slower to mature 
than control pups, gives some support to this idea that the differential 
profiles of calling for each experimental group may have resulted 
from a delay in the maturation of the mechanisms responsible for 
ultrasonic vocalisations. 
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However, other possible explanations must be considered. 
The differential calling profiles may be related to changes in the 
pup's detection of, or response to, chilling. As discussed in the 
introduction to this chapter, several investigators have established a 
correlation between the emission of ultrasonic calls and the 
development of homiothermy (Lagerspetz, 1962; Sewell, 1968; 
Okon 1970a; Allin and Banks, 1971). The typical age profile for 
calling when exposed to a decreased ambient temperature is one of 
few calls immediately after birth, coinciding with the period of 
poikilothermy, followed by a greater intensity of calling 
corresponding to the initial development of thermoregulatory ability 
and finally a subsequent decrease in the rate of calling as 
thermoregulation is achieved. This is the calling profile followed by 
Cc pups, whereas treated pups did not exhibit the characteristic 
changes with age. Perhaps exposure to Al had in some way 
prolonged the period of poikiothermy which prevented them from 
calling. To eliminate this possibility would require investigations 
into the processes underlying temperature regulation. However, to 
help focus the effects of Al on the vocalisation system it would be 
interesting to record calling ouput following a different method of 
induction e.g. by tactile or olfactory stimulation. 
Prenatal exposure to M2(SO4)3 did not dramatically alter 
the pattern of the distribution of calls over the. 12 postpartum days ---.-.-.-- 	 - ------ - 	- -- 	- 
but significantly reduced the number of-.calls--,pro uced. .Thus, in 
utero Al dampened the call profile of the treated pups. This 
experiment aimed at assessing the alteration in infant ultrasonic 
emissions as a measure of their responsiveness to a mildly stressful 
situation. If ultrasonic calling functions to elicit maternal responses, 
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as has been proposed by several workers (Noirot, 1972; Sewell, 
1970) and alterations in maternal behaviour are known to affect 
infant development (Laviola, Sedowofia, limes, Clayton and 
Manning 1990), it would seem pertinent to establish what effect 
differences in ultrasonic output are exerting on maternal behaviour 
(see chapter 5). 
Such differences in ultrasonic calling may result in treated 
pups being less than optimal stimuli for eliciting maternal care. 
Alteration in the pattern of maternal care might explain why Ct 
pups, who were found to emit a similar profile of calls although at a 
lower level compared to their Cc counterparts, had body weights 
notably reduced to that of Cc pups. Similarly, Tc and Tt pups had 
comparable profiles of calling but Tc pups were of greater body 
weight. In the case of Tt pups, the diminished number of calls may 
have affected the ability of the treated mother to provide adequate 
maternal responses even in the presence of calls from control pups. 
Tc pups had a similiar reduced profile of calls to that of Tt pups, the 
difference being that these treated pups were raised by control 
mothers. These mothers may have been in finer tune to their pups so 
that even a diminution in the number of calls was not sufficient to 
alter maternal responsiveness. However, despite the altered level and 
pattern of calling in treated pups, these results do not reveal any 
change to the mother's responses although maternal retrieval was the 
only maternal measure undertaken in this experiment. 
As discussed in the Introduction, ultrasounds are thought to 
evoke searching and retrieval of lost pups by the mother to the 
security of the nest. Having pups which exhibit weak or low 
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numbers of calls would have serious repercussions in terms of 
survival of the litter. 
It was suggested in chapter 3 that the body weight 
differences between CBA pups may be accounted for in terms of 
alterations in the output of ultrasonic calls by pups fostered to treated 
mothers. However, in the light of the ultrasonic data presented here, 
this no longer seems to provide an adequate explanation. If this had 
been the case CBA pups in the Tc treatment group, which exhibited 
a low rate of calling, should have had far lower body weights than 
controls but they clearly do not. Further, the body weights of male 
and female C57 pups showed similar impairments to that found in 
the CBA strain, namely fostering pups to mothers exposed to Al 
during gestation resulted in a diminished body weight. As little 
difference was found in C57 pup calling it is unlikely that alterations 
in ultrasonic calling contributed greatly to this reduction in body 
weight. 
Terkel, Damassa and Sawyer (1979) claim that ultrasonic 
calling stimulates the release of prolactin from the mother's anterior 
pituitary (although Stem, Thomas, Rabii and Barfield (1984) do not 
confirm this). The primary stimulus for its secretion is probably 
suckling although several other features of the pup have been found 
to increase its release. If ultrasounds are indeed one such feature then 
the increase in sound emissions by Cc pups could have the effect of 
augmenting the nourishment available for them, which has obvious 
consequences for growth. 
Results from the maternal retrieval tests showed that 
treatment of the young did not reduce their effectiveness as 
retrieving stimuli. This is perhaps not surprising for three reasons. 
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Firstly, although the procedure used to test maternal retrieval was a 
standard design employed by most studies, it may not have 
discriminated between experimental groups as the distance over 
which the females had to travel was small. Secondly, some mothers 
were seen to be having difficulty seizing a pup as it was moving 
especially during the later test days. During these episodes the 
mother would wander back and forth to the nest and eventually 
ended up dragging the pup to it. Finally, Beach and Jaynes (1956) 
have described a number of stimuli to which mother rats respond 
when retrieving their pups. For example, they showed that if the 
olfactory characteristics of a pup are altered (by covering it with 
perfume) the pup is still eventually retrieved although control pups 
are retrieved preferentially. Thus, even if Al affected one aspect of 
the pup's stimulus quality other sensory modalities would remain to 
evoke a normal reaction. 
The exact mechanisms underlying the regulation of 
ultrasonic calling are not known and several systems including 
endogenous opiates (Cuomo, Cagiano, De Saliva, Restani, 
Galimberti, Racagni and Galli, 1988) the dopaminergic (Cagiano, et 
al., 1986) and the benzodiazepine receptor complex (Insel, Hill and 
Mayor, 1986) have been implicated. However, Brudzynski and 
Bihari (1990) have suggested the involvement of the cholinergic 
system in their production. In chapter 3 (see section 3.4.11) a 
reduction in ChAT activity was found in brains of mice exposed to 
Al in utero. That such treatment led to a reduction in calling is at 
least consistent with Brudzynski and Bihari's (1990) hypothesis. As 
there is only direct evidence for the cholinergic system the 
involvement of other neurotransmitter systems cannot be ruled out. 
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Finally, the results reported in this chapter certainly suggest 
that ultrasound recording should be included in any battery of tests 
aimed at assessing possible behavioural teratogenicity. 
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CHAPTER 5 
Effect of gestational exposure to aluminium sulphate on the 
maternal behaviour of two inbred strains of mice. 
5.1 INTRODUCTION 
As discussed in the introduction to chapter 4, the mother-
infant relationship involves the active participation of both members. 
Since prenatal exposure to Al reduced calling output in treated pups 
and also delayed the onset of peak calling, the observations 
undertaken in this chapter aimed at assessing the effect of gestational 
exposure to Al on the mother. 
Females from a number of rodent species display a 
characteristic sequence of behaviours towards their young which is 
collectively referred to as maternal behaviour (Rosenblatt and 
Lehrman, 1963; Noirot, 1972). These behaviours are thought to be 
initiated by the hormonal changes which occur at the time of 
parturition, namely an elevation in the amount of circulating 
oestradiol which follows a decline in the level of progesterone 
(Rosenblatt and Siegel, 1983). However, maintenance of maternal 
care depends not only on hormonal influences but also on the 
efficiency of the bidirectional exchange of a number of sensory cues 
between the mother and her offspring, both playing an important 
active role. For example, as discussed in the previous chapter, 
ultrasonic vocalisations emitted by pups play an important 
communicative role in this relationship, specifically as cues to direct 
the mother to a strayed pup (Noirot, 1972). Further, olfactory stimuli 
are important in pup recognition, as evidenced from lesions of the 
noradrenergic projection to the olfactory bulbs in nulliparous 
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BALB/c females before parturition, which resulted in cannibalistic 
behaviour (Dickinson and Keverne, 1988). 
More specifically, maternal behaviour is sensitive to subtle 
stimulus changes which can alter this behaviour and in turn may 
have long-term effects on the development of the offspring. For 
example, it has been suggested that the enhancing effects of early 
handling procedures on pup development may be explained in terms 
of changes in maternal behaviour; several studies have described 
increased licking behaviour by mothers following handling of their 
young (Lee and Williams, 1974; Priestnall, 1983). 
Postnatal social influences have also been found to modify 
maternal behaviour. Alleva, Caprioli and Laviola (1989) 
demonstrated the influence of the sex composition of a litter on 
maternal behaviour; litters comprised solely of male offspring 
received more pup-directed maternal activities than litters made up 
of all females or with equal numbers of male and female offspring. 
Recently, studies which involve the investigation of the 
effects of administration of drugs or toxicants during pregnancy on 
offspring development, have examined the effect of such treatments 
on the expression and pattern of maternal behaviour. Alcohol-
exposed CFW females were found to exhibit an increase in the 
frequency of exploratory behaviour one day after birth (Ewart and 
Cutler, 1979). Interestingly, Hard, Musi, Dahigren, Engel, Larsson, 
Liljequist and Lindh (1985) found that female Wistar rats, exposed 
in utero to ethanol (16% ethanol solution), took longer to retrieve 
their pups and built nests of a lower depth than controls. 
Enhancements of maternal behaviour have also been 
reported following prenatal treatments. Outbred female mice 
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exhibited an increased duration of time involved in nursing and an 
increased frequency and duration of Social Investigation of their 
young on Pdl following exposure to phenobarbitone (PhB) in their 
drinking water (120-190mg/kg daily) throughout gestation and 
lactation (Chapman and Cutler, 1983). At Pd21 PhB-treated females 
were still actively engaged in nursing behaviour (a mean duration of 
61s for treated females compared to a mean of 0.4s for the control 
group). Furthermore, Laviola, Sedowofia, limes, Clayton and 
Manning (1990) have demonstrated strain-specific differences in the 
influence of prenatal exposuretQjhB (60mg/kg by i.p. injections 
during days 10-16 of gestation) on maternal behaviour. CBA treated 
females continued to nurse their offspring for longer than controls 
whilst C57 PuB -exposed dams exhibited less nursing behaviour 
(Laviola, et al., 1990). 
These studies have shown that certain drugs disrupt 
maternal behaviour and imply that disturbance to maternal care or 
the delicate mother-pup relationship may be the cause of differential 
patterns of behaviour in the offspring rather than direct effects, of 
prenatal exposure to atoçjcant. 
- 	Alterations to the quantity or quality of maternal behaviour 
following exposure to Al during pregnancy was suggested as a 
possible explanation for the maternal treatment effect on pup weight 
reported in chapter 3. Only one previous study has included 
simultaneous recording of maternal behaviour after prenatal 
exposure to Al (Bernuzzi, Desor and Lehr, 1986). These authors 
reported no significant differences between treatment groups in nest-
building, retrieval of pups to the nest or time spent with the young 
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following exposure to Aid3 (160 or 200mg Al/kg body weight/day) 
in the dam's diet from day 8 to 20 of gestation. 
The experiment presented in this chapter was undertaken to 
characterise any changes to the pattern of maternal behaviour of 
control and Al-treated mothers. A comprehensive array of 
behaviours was considered to enable assessment of the effects of Al 
exposure not only on the overall pattern of maternal behaviour but 
also on individual components of it. 
Some of the work described in this chapter has been 
submitted for publication (Rankin, Laviola, Valanzano, Alleva and 
Manning, submitted, see Appendix E). 
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5.2 MATERIALS AND METHOD 
5.2.1 Animals and treatment 
All mice were maintained in an air-conditioned room at 
21±1 0C and 60±10% relative humidity, with a 12 hour light cycle. 
Pellet food (enriched standard diet purchased from Piccioni 1-2500 
Brescia, Italy) and tap water were freely available. 
Pregnant females from the two inbred strains were 
randomly divided into control and treated groups. Treated females 
were exposed to Al2(SO4)3 by intraperitoneal injection, at a dose of 
200mg/kg body weight during gestation days 10 to 13 inclusive. 
Maternal weights and the amount of food and water ingested were 
determined during this period. 
5.2.2 Maternal Behaviour 
Following cross-fostering on Pdl, as described in chapter 2 
(see section 2.2), each mother was housed in a clear plastic cage to 
facilitate the observation of maternal behaviour. The cage contained 
wood shavings and ig of nesting material consisting of strips of 
paper. The cages were not cleaned until maternal behaviour 
observations were completed. The procedure employed for maternal 
behaviour observation was based on that described by Laviola, et al., 
(1990), with 10 minute recording sessions twice daily (during the 
initial and final hours of the dark phase) under, red light and 
randomised so that the observation of different treatment groups 
were equally represented at all times of the day. Dams were placed 
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in the experimental room 30 minutes prior to commencement of 
recording and remained there until the end of the day. The cage lids 
were not replaced by perspex for the observation periods for two 
reasons. Firstly, pilot studies showed that the changeover disturbed 
the mother and increased her exploration of the new cage lid. 
Secondly, leaving the standard lid made it possible to include the 
recording of eating and drinking behaviour. Although these 
behaviours are clearly not part of the maternal behaviour repertoire, I 
considered it important to record them in relation to the assessment 
of any influence of Al on milk production. Recording was continued 
to include a later age, day 18 postpartum, to investigate whether 
exposure to Al during gestation prolonged the expression of any 
behaviours. 
Observations were made on postnatal days 2, 3, 5, 7, 10, 14 
and 18 but not on Pdl due to the possible disturbance of cross-
fostering. These time periods are thought to correspond with major 
developmental and neurochemical changes within the infant mouse 
(Wahlsten, 1974). Behaviour was recorded on a keyboard linked to 
a computer using the programme "Key behaviour" (Deag, 1983a). 
The information was stored on computer discs for subsequent 
analysis (Deag, 1983b). The following elements of maternal 
beviour were recorded: 
Pup-directed behaviours 
Nursing - The mother adopts the classic lactation position, arching 
her body over the pups. Nursing was recorded even when the mother 
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was seen in the nest grooming herself but having at least one pup 
attached to a nipple. This was common during the later ages. 
Licking - Scored when the mother is solely actively engaged in 
licking any part of a pup's body. 
Nest-building - This is recorded when the mother is in the nest and 
pulling shavings into it, is carrying material to the nest or is using 
her forepaws to push material towards it. 
Retrieving - The mother returns a pup which had wandered from the 
nest site. In a laboratory situation such as this, retrieval of a pup is 
rarely seen. 
If the mother was nursing but also engaged in one of the other pup-
directed activities, the former was scored. I felt it was important to 
record any actual nourishment received by the pups in preference to 
other maternal activities occurring at the same time, to estimate if the 
pups were being affected by postnatal events. 
Non pup-directed activities 
Active - The mother is out of the nest and is moving around the cage. 
Rearing - The mother is on her hind legs leaning against the cage 
walls. 
Grooming - The mother is licking any part of her own body. 
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Still - The mother is lying still with no pups attached either beside 
the nest or at the other end of the cage. 
Eating and Drinking - The mother is eating from the food hopper or 
drinking from the water bottle. 
At the end of the 10 minutes recording period the quality of the nest 
was scored on a scale of 0 to 4; a score of 0 was given when there 
was no discernible nest site and the pups were scattered, and a nest 
was judged to have a score of 4 when it was well constructed and the 
pups were not obviously visible. 
5.3 RESULTS 
5.3.1 Estimated level of aluminium exposure 
Pregnant females injected i.p. with Al2(SO4)3 received 
0.4 1mg of elemental Al per day, a total of 1.64mg over the four days 
of treatment, as reported in chapter 3. 
5.3.2 Maternal weight 
In the CBA strain there were 14 control and 15 treated 
pregnant females and 9 control and 12 treated females in the C57 
strain. The greater number of CBA females resulted from the 
experiment being set up twice due to cannabalism of fostered young. 
For both strains weight gain during the treatment period (Gd 10 to 
13) was slight but increased greatly after its termination. Control and 
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treated females gained weight at a comparable rate in both strains, 
although CBA control females weighed about 5% more than treated 
females by day 18 of gestation. 
As with prenatal weights, the weights recorded for control 
and treated dams from day 3 postpartum to weaning were not 
significantly different either between control and treated groups or 
strains. 
Following injection of Al some CBA females showed 
dragging of the hindlimb, although this paralysis was temporary and 
the limb recovered a few days after treatment ended. This was not 
observed in C57 females. 
5.3.3 Food and water intake 
There were no differences in the amount of food and water 
ingested by control and treated CBA females during gestation days 
10-18. Food intake was similar for control and treated C57 females. 
However water consumption was slight'y reduced for treated C57 
females (control 	n=9 i=77.39(±2.80)g, treated 	n=12 
=68.23(1.77)g, t(14)= 2.76 p<0.02). 
5.3.4 Maternal Behaviour 
For purposes of analysis, maternal behaviour scores for the 
two daily sessions were combined, although there was a slight 
tendency towards an increase in nursing behaviour during the 
morning session. Figs. 5.1 - 5.6 summarise the most important 
differences in maternal activities for control and treated mothers over 
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the 7 test days for CBA (7 control and 6 treated) and C57 (6 control 
and 8 treated) females. The graphs represent the mean duration and 
frequency of bouts. Although individual comparisons of each 
behaviour between treatment groups were analysed using 
nonparametric tests (Mann Whitney U-test), means are presented 
rather than the medians due to the frequent occurrence of zero 
scores. Pup retrieval was not observed on any test day. 
As with the Laviola, et al., (1990) study and others (Ewart 
and Cutler, 1979; Chapman and Cutler, 1983) maternal care was, in 
general, more pronounced during the first few days after birth in 
both groups and for both strains, and subsequently declined as the 
pups matured, being replaced by non pup-directed activities. 
Although there were few significant differences between control and 
treated mothers for any of the behaviours measured, the graphs 
reveal some clear and consistent trends which will be described 
below. 
Nursing - The frequency of bouts of nursing was similar for control 
and treated CBA females during the test period. The duration of 
nursing behaviour decreased as a function of time in both treatment 
groups. However, control CBA dams spent an increased amount of 
time nursing their offspring compared to treated females; this 
difference was more pronounced during the later test days (see Fig. 
5.1). 
From days 3 to 10 postpartum Al-exposed C57 mothers 
showed an increased number of bouts of nursing which were of 
longer duration than control mothers reaching marginal significance 
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Fig. 5.1: Effect of gestational exposure to aluminium 
sulphate (200mg/kg, Gd10-13) on the nursing behaviour 
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Fig. 5.2: Effect of gestational exposure to aluminium 
sulphate (200mg/kg, GdlO-13) on the nursing behaviour 
of C57BL16J mothers. 
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Licking - Figs. 5.3 and 5.4 show that low levels of licking behaviour 
were recorded for both control and treated mothers in both strains 
throughout the test period. On PdlO and 14 CBA treated females 
exhibited an increased number of bouts of licking of longer duration 
than control CBA females, which were significantly different on 
Pd14 (frequency U=56.0 p<0.03; duration U=56.0 p<0.03). 
The frequency and duration of licking behaviour on all test 
days except Pd18 were slightly greater for treated C57 mothers than 
controls. For both control and treated mothers licking behaviour 
increased as a function of age and peaked on Pd 10. 
Nest-building - Very low levels of this behaviour were exhibited by 
either control or treated females from either strain. 
As described earlier, non pup-directed behaviours were rare during 
the first postnatal week but became more predominant thereafter. 
Active - The frequency and duration of bouts of active behaviour 
increased from Pd7 onwards for both control and Al-exposed CBA 
females. On Pd14 treated CBA females showed an increased number 
of these bouts which were of longer duration. 
C57 mothers did not show such a clear pattern of active 
behaviour, although the frequency and duration of this behaviour 
was greater from PdlO onwards. As with CBA Al-exposed females, 
treated C57 females showed an increase in the number and duration 
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Fig. 52: Effect of gestational exposure to aluminium 
sulphate (200mg/kg, GdlO-13) on the licking behaviour 
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Fig. 5.4: Effect of gestational exposure to aluminium 
sulphate (200mg/kg, Gd10-13) on the licking behaviour 
of C57BL16J mothers. 
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Still - Mothers of both strains and both groups all showed an 
increased frequency and duration of bouts of still behaviour during 
the second postnatal week. Control CBA females tended towards a 
greater amount of this behaviour during Pd7, 10 and 14. 
The frequency of still behaviour was similar for C57 control 
and treated mothers, although control C57 females spent more time 
involved in this behaviour. 
Groom - The frequency and duration of bouts of grooming behaviour 
increased as a function of age for CBA control mothers. However, 
Al-exposed CBA females showed a significant increase in the 
frequency (U=42.0 p<0.03) and duration (U=39.5 p<0.02) of 
grooming behaviour during Pd5. 
The frequency and duration of grooming behaviour was 
similar throughout the test period for control and treated C57 
females except on Pd5 when control C57 mothers spent more time 
involved in grooming (U=133.0 p< 0.04). 
Rearing - The frequency and duration of rearing behaviour increased 
from Pd3 onwards for CBA mothers and both control and treated 
groups showed similar levels of this behaviour. However, on Pd14 
Al-exposed CBA mothers showed a significantly greater number of 
bouts of rearing (U=43.0 p<0.03) and of longer duration (U=41.0 
p<0.02) than controls. 
The frequency of rearing for both C57 control and treated 
groups declined between Pd2 to 7 and then increased. Treated C57 
females showed a greater number of bouts of rearing which were of 
longer duration than control mothers. 
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Eating and Drinking - Control and treated CBA mothers showed 
similar frequency and duration of bouts of eating and drinking which 
increased slightly from Pd3 to 18 (see Fig. 5.5). However, on PdlO 
treated CBA females exhibited an increased frequency of bouts of 
eating and drinking which were of longer duration, but this latter 
difference was only marginally significant. 
The frequency of food and water ingestion increased from 
Pd2 to 7 and then declined for C57 control females but steadily 
increased from Pd5 for Al-treated C57 mothers (see Fig. 5.6). 
Control C57 females ingested more food and water during Pd5-10 
than treated females. 
5.3.5 Nest quality score 
The total scores of nest quality over the 7 test days showed 
that both control and treated CBA and C57 mothers built nests to a 
similar standard (CBA control =39.71(±1.29), treated 
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Fig. 5.5: Effect of gestational exposure to aluminium 
sulphate (200mg1kg, Gdl0-13) on the eating and drinking 
behaviour of CBA mothers. 
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Fig. 5.6: Effect of gestational exposure to aluminium 
sulphate (200mg/kg, GdlO-13) on the eating and 
drinking behaviour of C57BL16J mothers. 
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5.4 DISCUSSION 
The results of this set of observations, which examined the 
effects of exposure to Al during a limited period of gestation on a 
number of maternal activities, revealed only slight differences 
between control and Al-treated mothers- -and then only on certain 
- 	 -. - -- 	a 
days. When a large number of comparisons are made on a varied set 
of data, some significant differences are bound to occur by chance. 
The pattern of some components of maternal behaviour 
depended both on prior treatment and on the strain of the mother, 
whilst others were only treatment dependent. Al-exposed CBA 
mothers spent less time involved in nursing their offspring whilst 
C57 treated dams showed enhanced nursing behaviour compared to 
controls. However in the case of licking, the Al-treated mothers from 
both strains spent more time involved in this behaviour. The low 
level of licking behaviour may have resulted from the preferential 
recording of nursing behaviour if both behaviours occurred 
simultaneously. CBA treated mothers tended towards increased 
involvement in non pup-directed activities. 
Hence, only slight differences in certain elements of 
maternal behaviour were found which are unlikely to reflect 
alterations in the ability of the mother to respond maternally towards 
her young. Exposure to Al did not affect the mechanisms responsible 
for the expression and organisation of maternal behaviour, which is 
in accordance with the results of Bernuzzi, et al., (1986). Presumably 
the level of pup stimulation was equal for control and treated dams 
as each litter consisted of two control and two Al-treated pups. There 
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is no evidence to suggest a decrease in the ability of the pups to elicit 
adequate maternal responses. 
The impairment in weight gain by CBA pups fostered to 
treated mothers described in chapters 3 and 4 can not be explained 
by deficits in availability of nourishment, as treated CBA mothers c 
showed similar levels of nursing, eating and drinking - 
behaviour-to-the controls. Indeed, the lower weight of C57 pups found in the 
experiment reported in chapter 4, can certainly not be explained in 
this way, as C57 treated mothers actually spent more time nursing 
and eating and drinking. However, although mothers were seen in 
the nursing position, lying with an arched back over the pups, the 
possiblity exists that the pups were not always actively engaged in 
suckling or that the milk is of the same quality. 
There was only a slight difference in the amount of food 
and water ingested by control and treated CBA and C57 mothers. 
Thus, the body weight differences did not result from 
undernourishment of the treated mothers which has been shown to 
result in less efficient retrieval of young and in a reduction in licking 
(Smart and Preece, 1973). 
Some studies involving prenatal exposure to alcohol, have 
found the greatest disturbance to certain components of maternal 
behaviour on Pdl (Abel, 1978; Ewart and Cutler, 1979). In this study 
observations were not made on Pdl as it was considered that the 
cross-fostering procedure may have disturbed the mother and altered 
the natural pattern of maternal behaviour on this day. Perhaps further 
group differences would have been found if this day had been 
included. 
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Despite the lack of significant effects of exposure to Al 
during gestation on maternal behaviour, Al had toxic effects on other 
maternal characteristics. In both this experiment and the one 
described in chapter 3, pregnant CBA females exposed to Al via i.p. 
injection gained less weight during gestation than did the control 
females, although this difference was not significant in this 
experiment. In addition, a temporary hindlimb paralysis was 
observed in some CBA females following i.p. injection with Al. This 
has been previously reported in Swiss-Webster mice following 
exposure to 1000ppm aluminium lactate in the diet from day 0 of 
gestation to weaning, although it was not evident until days 12-15 
postpartum (Golub, Gerschwin, Donald, Negri and Keen, 1987). 
The degree of maternal care was not detectably different 
between control and treated mothers using these measures. This 
leads to the conclusion that the impairments in body weight and 
neurobehavioural development of pups reared by treated mothers are 
unlikely to be explained in terms of an alteration to the mother's 
behaviour alone. Due to the impairment in maternal weight gain 
during gestation for Al-exposed females, one can not exclude the 
possibility that these differences resulted from this initial impairment 
in maternal weight. Ness and Franchina (1990) have suggested that 
any dimunition in female body weight and nutritional intake may be 
of more consequence to the offspring if it occurs during lactation. 
Control and Al-treated maternal weights did not differ during the 
postnatal period, so perhaps the influence of any decrease in body 
weight which occurred prenatally was overcome. 
The unlikely contribution of differences in maternal care 
points to a direct effect of Al on the physiology of the mother. 
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Exposure to Al during pregnancy has been shown to reduce milk 
consumption of rabbit offspring in a dose-dependent manner (Yokel, 
1984; Yokel, 1985). This is the case for both treated and control 
pups suckling from Al-exposed lactating does. Thus, the maternal 
treatment effect is not likely to be mediated via changes in the ability 
of the Al-exposed mothers to care for their young but effects of Al 
on milk production may be of greater relevance. Moreover, the 
nutritional value of the milk produced by Al-exposed mothers may 
be inferior to that produced by control mothers. 
Another possible explanation for the decreased body weight 
of pups reared by treated mothers is that Al exerts its effects directly 
on the pup. A decrease in milk yield may be accompanied by a 
decline in suckling attempts by offspring fostered to treated mothers. 
As milk output and Al content were not assessed during this 
experiment these possibilities remain speculative. 
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5.5 EXPERIMENT 2 
Effect of a scopolamine challenge on CBA and C57BL/6J pup 
locomotor activity at weaning. 
5.5.1 Introduction 
Experiment 2 of chapter 3 (section 3.6) described the use of 
a challenge with scopolamine to bring out any differences in maze 
learning between control and Al-treated CBA male mice. In this 
experiment it is used again but this time to investigate differences in 
the locomotor activity of control and treated mice. 
The use of pharmacological challenges to uncover 
behavioural differences resulting from prenatal drug treatments 
which are too subtle to be detected using conventional behavioural 
tests, has become common practice in behavioural teratology (Walsh 
and Tilson, 1987; Hannigan and Blanchard, 1988; Spear, 1990). As 
discussed in chapter 3, behavioural differences may not become 
manifest due to the inherent plasticity of the CNS, referred to as "the 
functional reserve" by Walsh and Tilson (1987), which may obscure 
differential responses unless the system is further stressed. For 
example, the activity levels of CD-1 mice, whose mothers were 
exposed to 0.5% lead acetate in their drinking water during lactation, 
was similar to that of controls when tested at 211 days of age. 
However, the hyperactive response following a challenge with 
apomorphine (4.0mg/kg) was attenuated compared to that of controls 
(Rafales, Bomschein, Michaelson, Loch and Barker, 1979). 
Both the cholinergic and dopaminergic neurotransmitter 
systems are important in the control of movement (McGreer, 
Boulding, Gibson and Foulkes, 1961). A reciprocal balance exists 
between these two systems which if disturbed results in recognised 
clinical disorders e.g. Parkinson's disease and Huntington's chorea 
(Levin, McGurk, Rose and Butcher, 1990). The most commonly 
used pharmacological agents in drug challenges are amphetamine, 
apomorphine and scopolamine, all of which induce hyperactivity 
following exposure. The first two agents cause this enhancement of 
activity by stimulating dopamine release and the latter by reducing 
the inhibitory control of the cholinergic system on activity (Laviola, 
Renna, Bignami and Cuomo, 1988). Scopolamine is the agent of 
choice in the experiment reported herein. 
As the pharmacological action of the agent on specific 
neurotransmitter systems is known, drug challenges not only play a 
role in unmasking behavioural differences, but also help to further 
understand the neurochemical basis of such differences. 
The aim of the experiment described here was to further 
investigate the effects of Al on locomotor activity in the two inbred 
strains of mice by challenging these mice with scopolamine. As 
previous studies have shown that the characteristic hyperactivity 
induced by scopolamine is not evident until the end of the third 
postnatal week (Campbell, Lytle and Fibiger, 1969; Alleva and 





The subjects for this experiment were the offspring of the 
dams used as experimental subjects in the maternal behaviour 
observations reported in chapter 5. At weaning (Pd21) subjects were 
randomly divided into two groups one of which received a single 
intraperitoneal injection of scopolamine hydrochloride (0.5mg/kg 
body weight), and the other received the equivalent volume of saline. 
The dose of scopolamine was chosen on the basis of previous studies 
(Alleva and Bignami, 1985; Alleva, Aloe and Laviola, 1986). 
5.6.2 Procedure 
Pup activity was recorded for three minutes on Pd15 and 18 
as described in chapter 2 (2.2.1). On Pd21 mothers were removed 
from the cages and each subject injected as designated. Following 
injection the animal was placed in a cage in the experimental room 
for 15 minutes and then into a clean cage in a Varimex activity meter 
apparatus (4 units Columbus Instruments) set at a standard level. The 
recording session lasted for 15 minutes, with activity being recorded 
automatically and printed out in 3 minute blocks. 
5.7 RESULTS 
The main ANOVA tables are given in Appendix F. 
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5.7.1 Pup activity 
In all groups activity significantly increased between Pd15 
and 18 as shown by the significant effect of day. The activity of 27 
CBA pups (15 males and 13 females) was recorded. In contrast to 
the results presented in chapter 3 (see section 3.4.8), the effect of 
prenatal treatment with injected Al on CBA activity was not sex 
dependent. There was a slight trend towards treated pups being less 
active than controls but this was not significant (see Fig. 5.7). There 
was a significant interaction between day, prenatal treatment and 
foster mother treatment on CBA activity (F(1,19)=6.47 p<0.02). 
There was a total of 55 pups of the C57 strain, 30 males and 
25 females. The activity of these pups is shown in Figs. 5.8a and b 
respectively. There was a significant interactive effect of prenatal 
treatment and sex on C57 pup activity (F(1,47)=5.63 p<0.03) and of 
these variables and postnatal day (F(1,47)=6.69 p<0.02). Separating 
the data by sex revealed that males exposed to Al in utero were less 
active than controls, although this difference only reached marginal 
significance. There was a significant interactive effect of day and 
prenatal treatment on male activity (F(1,26)=4.22 p=0.05), this 
difference in activity was more pronounced on Pd18. In the case of 
C57 females, there were no differences in activity levels on Pd15 but 
on Pd18 the trend was in the opposite direction from that of males; 
prenatally Al-treated females were more active than controls, 













Fig. 5.7: Effect of prenatal exposure to aluminium sulphate 
(200mg/kg, Gdl0-13), on the number of squares crossed by 













 40 +1 
15 	 18 
Postnatal day 












Fig. 5.8: Effect of prenatal exposure to aluminium sulphate 
(200mg1kg, Gd10-13) on the number of squares crossed by 
C57 BL16J pups in a three minute openfield test. 
5.7.2 The effect of scopolamine on activity at weaning 
All subjects showed within-session habituation, irrespective 
of strain or treatment, as evidenced by the decrease in activity levels 
as the test proceeded. Activity was recorded in 3 minute blocks and 
this was the repeated measure. 
As noted in section 5.3.2, the experiment was set up twice 
in the case of the CBA strain. The first group of CBA animals were 
not tested at Pd15 and 18 but all were exposed to scopolamine. 
There were a total of 38 CBA animals. A challenge with 
scopolamine produced the expected enhancement of activity in each 
of the CBA experimental groups (F(1,30)=64.91 p<0.0001, see Fig. 
5.9). There was a significant interaction between prenatal treatment 
and the drug challenge (F(1,30)=5.19 p=0.03), the potentiation of 
activity being less in those pups which had been exposed to Al in 
utero. There was a significant interactive effect of scopolamine and 
the repeated measure (total activity in 3 minutes) (F(4,120)=3.3 
p<0.02), the effects of scopolamine declining with time. The 
significant effect of the repeated measure (F(4,120)=23.33 
p<0.0001) shows a within-session habituation, as activity decreased 
with time. 
Within the C57 strain, male and female pups were analysed 
separately due to the significant interaction between prenatal 
treatment and sex (F(1,39)=8.94 p<0.005) and between these and the 
repeated measure (F(4,156)=2.82 p=0.04). 
Figs. 5.10a and b summarise the effects of scopolamine on 
C57 male and female activity respectively. There was a significant 
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Fig. 5.9: Effect of a scopolamine challenge on 
CBA pup activity at weaning. 
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p<0.04), treated males exhibited diminished activity levels compared 
to controls, and a significant interactive effect of the repeated 
measure and prenatal treatment (F(4,88)=2.93 p<0.04). The 
scopolamine challenge had a significant effect on male activity 
(F(1,22)=1 1.72 p<0.003), but interestingly the direction of influence 
was opposite to that found in the CBA strain; scopolamine failed to 
produce the expected enhancement in activity but rather reduced 
activity levels in all experimental groups. This effect of scopolamine 
diminished with time, as shown by the significant interaction of the 
challenge and the repeated measure (F(4,88)=6.02 p<0.002).  Foster 
mother treatment, the challenge and the repeated measure had a 
significant interactive effect on C57 male activity (F(4,88)=3.58 
p<0.02); the reduction in activity was less pronounced for those pups 
fostered to control mothers. 
The influence of prenatal exposure to Al on C57 females at 
Pd21 tended towards an increase in activity levels, although this 
difference was only marginally significant. As with C57 males and 
the CBA animals, C57 females showed within-session habituation 
(F(4,68)=14.19 p<0.0001). There was a significant effect of 
scopolamine on C57 female activity (F(1,17)=6.15 p<0.03), again 
scopolamine caused a reduction in activity compared to saline-
exposed counterparts (see Fig. 5.10b). Although there was no 
significant interaction between prenatal treatment and the challenge, 
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Fig. 5.10: Effect of a scopolamine challenge on 
C57BL16J pup activity at weaning. 
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5.8 DISCUSSION 
The results reported in chapter 3 suggested a differential 
effect of pleatal exposure to injected Al on CBA pup activity 
depending on sex, Al-exposed CBA females were less active than 
controls, whils ate males exhibited enhanced activity levels. 
However, this finding was not repeated in the experiment reported 
hereIiiiact, there was a trend towards Al-treated CBA pups being 
less active than controls. This may have resulted from differences in 
sample size as there were fewer females in this experiment. 
Although scopolamine produced the expected hyperactivity 
in control and prenatally Al-treated CBA animals, the enhancement 
was less for treated subjects, as revealed by the significant 
interaction between prenatal treatment and scopolamine. Perhaps in 
the case of treated subjects, prenatal exposure to Al resulted in a loss 
of muscarinic cholinergic (mCHOL) receptors so there were fewer 
present to be occupied by scopolamine. The levels of ChAT activity 
within the CBA strain were significantly reduced in the hippocampus 
and striatum at 3 weeks of age (see Table 3.1), which suggests that 
deficits within the cholinergic system had indeed occurred. 
Sex differences in activity levels were found within the C57 
strain; male pups were more active than females. C57 males exposed 
to Al in utero were hypoactive compared to controls. Conversely, 
treated C57 females were more active than controls. This hypo- and 
hyperactivity for C57 males and females respectively, was also 
present at Pd21. 
In contrast to the effect on subjects within the CBA strain, 
exposing C57 animals to scopolamine resulted in a decrease in 
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activity levels. This hypoactivity was more pronounced for controls. 
Further, there was a maternal treatment effect on the diminution of 
activity; male pups fostered to control mothers showed a lower 
detriment in activity levels following exposure to scopolamine. 
Clearly, the response to scopolamine was highly dependent 
on the genetic strain. Similar strain differences in susceptibility to 
scopolamine have been noted previously, van Abeelen and 
Strijbosch (1969) found that C57BL/6J animals exhibited a decrease 
in exploration following exposure to scopolamine at a dose of 
1.25mg/kg, whilst mice from the DBA/2J and SEC/1ReJ inbred 
strains responded in the opposite direction to the same exposure. 
As noted in chapter 1 (1.2v), pharmacogenetic factors 
influence the response of different inbred strains to drugs. As well as 
differences in behaviour between inbred strains of mice, there are 
also differences in brain chemistry. For example, Pryor, Schlesinger 
and Calhoum (1966) measured brain acetylcholine esterase activity 
(AChE) in five inbred strains of mice. These authors found higher 
AChE activity within the brains of animals from the DBA/2 strain 
compared to C57BL/1O animals. Similarly, Tunnidiff, Wimer and 
Wimer (1973) reported an increase in whole brain ChAT levels in 
mice from the BALB/c and DBA/2 inbred strains and lower levels in 
C57BL/6J mice. Thus, the strain differences in response to 
scopolamine present in this experiment may be explained in terms of 
strain differences _in_brain neurotransmitters. For example, Kempf, 
- 	 --
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Greilsamer, Mack and Mandel (1974) found that the levels of 
noradrenaline were higher in the whole brain of C57BL/6J mice 
compared to DBA/2J and SEC/1ReJ animals. 
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Challenging animals with scopolamine provides 
information on the functional status of the mCHOL system only. As 
only slight differences were found between prenatally Al-treated 
animals and controls, one must conclude that Al did not appreciably 
alter the maturation of the mCHOL receptors. On the other hand, 
there is no information concerning the functional maturation of the 
nicotinic cholinergic (nCHOL) system. Thus, it is conceivable that 
nicotinic receptors may have been compensating for any alterations 
due to Al treatment. Combined treatment with a muscarinic and 
nicotinic receptor antagonist may provide more detailed information 
concerning the maturation of the cholinergic system at this age 
following exposure to Al. 
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CHAPTER 6 
Effect of gestational exposure to oral aluminium sulphate on 
CBA and C57BL/6J pup development. 
6.1 INTRODUCTION 
The most likely route of entry of Al into the human body is 
by oral exposure, which can come from several sources. Al is added 
as a flocculant in the treatment of water, the majority of 
pharmaceutical preparations containing Al are taken in the form of 
tablets and any addition of Alto food following cooking in Al 
utensils (Trapp and Cannon, 1981) will be ingested orally. In recent 
years several accidents have occurred in the U.K. (Cross, 1990) 
which have resulted in the levels of Al in domestic water supplies 
rising to between 30 and 620mgfL (Eastwood, Levin, Pazianas, 
Taylor, Denton and Freemont, 1990), far beyond that recommended 
by the EEC (approximately 0.2mg/L). As little is known about the 
bioavailability of. orally ingested Al, the consequences of such 
exposure will only be fully recognised through future 
epidemological studies when any long-term problems have become 
manifest within the human population. One study of a human infant 
population reported an increased incidence of talipes among Al-
exposed infants, but no differences in other measures of pregnancy 
outcome (Golding, Rowland, Greenwood, and Lunt, 1991). This 
paper did not report on any behavioural measures and further studies 
will be needed to assess any latent effects. 
The effects of oral exposure to Al are of particular concern 
considering the mounting clinical evidence of Al loading in infants 
who are not receiving dialysis but were given antacids containing Al 
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(Griswold, Reznik, Mendoza, Trauner and Aifrey, 1983; Randall, 
1983; Andreoli, Bergstein and Sherrard, 1984; Chedid, Fudge, 
Teubner, James and Simmer, 1991). In addition, Sedman, Klein, 
Merritt, Miller, Weber, Gill, Anand and Aifrey (1985) have shown 
that intravenous feeding of premature infants resulted in high plasma 
and urinary Al concentrations and a 10-fold increase of Al in bone. 
Further, the urinary Al concentration did not reach the control level 
until several weeks after parenteral feeding was stopped, suggesting 
that there had been an accumulation of Al in the infant's body. 
However, this finding in premature infants was not confirmed by 
Puntis, Hall and Booth (1986) who examined the plasma Al 
concentration in older infants (5-22 weeks of age) receiving 
parenteral nutrition. This suggests that it is only immature infants 
and those with inefficient renal functioning who are at risk from Al 
toxicity via this route. Infant milk formula has been implicated as 
another possible source of Al to which infants may be exposed 
(Freundlich, Zillerueló, Abitbol and Strauss 1985; Bishop, McGraw 
and Ward, 1989): the Al content of infant formula per litre has been 
estimated to be 165 times that of breast milk (Weintraub, Hams, 
Meerkin and Rosenberg, 1986). Hence, young children may be 
susceptible to Al intoxication from these various sources which are 
in common clinical use. As Marquis (1982) recommends, the 
consequences of exposure of the developing foetus to oral Al 
warrants urgent investigation. 
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6.1.2 Oral exposure to aluminium compounds 
The introduction to chapter 3 reviewed the literature on 
exposure to Al via intraperitoneal injection, this chapter considers 
effects on the developing animal of exposure to oral Al. When 
aluminium nitrate (Al(NO3)3) was administered by gavage to 
pregnant Sprague-Dawley rats during days 6-14 of pregnancy, a 
decrease in maternal weight gain and in foetal body weight resulted. 
In addition, the incidence of skeletal malformations was higher 
among treated foetuses (Paternain, Domingo, Llobet and Corbella, 
1988). Similar results were reported when oral doses of A1(NO3)3, 
at levels not toxic to the mother, were administered to Sprague-
Dawley rats during pregnancy and lactation, resulting in a decreased 
number of litters and surviving offspring and increased pup 
mortality. Body weight and length were reduced in the treated 
groups from birth to weaning (Domingo, Paternain and Llobet, 
1987a; Domingo, Patemain, Llobet and Corbella, 1987b). Exposure 
of pregnant outbred Wistar rats to AlC13 in their diet from day 8 of 
gestation to birth (Bemuzzi, Desor and Lehr, 1986) or throughout 
gestation (Bernuzzi, Desor and Lehr, 1989), resulted in a decrease in 
maternal weight during gestation, increased pup mortality, reduced 
pup body weight and caused a transient delay in the maturation of 
negative geotaxis and the righting reflex. On the other hand, Muller, 
Bemuzzi, Desor, Hutin, Burnel and Lehr (1990) did not find any 
differences in maternal weight gain, postnatal mortality or pup body 
weight following exposure to aluminium lactate (AlLact) at a dose of 
400mg/kg/day. However, Al-treated pups showed delays in the 
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righting reflex test, in locomotor coordination and in an operant 
conditioning test. 
Toxic effects from gestational exposure to oral Al have also 
been found in the mouse. Exposure of pregnant mice of the Dobra 
Voda strain (a strain bred in this Polish laboratory) to A1C13 in their 
drinking water (19.3mg Al/kg/day) resulted in a dose-dependent 
retardation in growth of the offspring but no difference in the 
number of litters (Ondrieka, Ginter and Kortus, 1966). These 
offspring were exposed to Al at 4 weeks of age in a similar manner 
to their parents. The growth retardation was more pronounced in the 
second and third generation mice (Ondrieka, Ginter and Kortus, 
1966). Oral administration of AlLact in the diet of pregnant Swiss-
Webster mice (S-W) produced maternal toxicity and reductions in 
growth and developmental delays of treated offspring (Golub, 
Gerschwin, Donald, Negri and Keen, 1987). In a follow up study, S-
W mice were exposed to AlLact in a supplemented diet, which did 
not cause a reduction in maternal weight gain during gestation and 
lactation. Treated offspring showed developmental delays in a 
vertical screen test, had greater foot splay distances at weaning, 
indicating muscle weakness, and a reduced thermal sensitivity 
(Donald, Golub, Gerschwin and Keen, 1989). 
The following chapter presents the results of a series of 
experiments exposing pregnant mice to Al2(SO4)3 in their drinking 
water. Zbinden (198 1) has argued that in any teratological 
investigation of a substance, several doses must be considered before 
an adequate picture of an agent's potential teratogenicity can be 
drawn. It was hoped that this route of administration would not cause 
maternal weight loss and, in the case of the C57 strain, would 
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increase the number of mothers who continued to term so that a 
clearer estimate of Al's effects could be made. 
Administering an agent via the oral route is bound to 
increase the variability between the doses taken in by each subject. 
For this reason the water bottles were weighed daily to calculate the 
amount consumed. In this chapter the results of exposure to oral Al 
at three different doses (750, 1000 and 1250mg/L) during gestation 
are presented. Not all the same behavioural and neurochemical 
measures were taken for each dose due to practical and time 
limitations, so details are given in each section. 
6.2 METHOD 
6.2.1 Treatment 
Al was dissolved in water taken from the Mouse House at a 
dose of either 750, 1000 or 1250mg/L. The pH of the resulting 
solution was measured using a pH meter and control water was 
acidified to the same pH using a few drops of sulphuric acid 
(pH=4.1). Plugged females were randomly divided into two groups 
receiving either the Al solution or the acidified control water in their 
water bottles during gestation days 10-16 inclusive for the 750mgIL 
group, and from days 1 to 20 of gestation for animals exposed to the 
1000 and 1250mg/L dose. Fresh Al solutions were prepared every 
other day to prevent Al aggregation, as has been reported to have 
occurred in other studies (e.g. Gulya, Rakonczay and Kasa, 1990). 
The water bottles were weighed daily in order to calculate water 
intake. Pre- and postnatal maternal weights were monitored. 
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6.2.2 Maternal behaviour 
As the maternal behaviour observations conducted in 
chapter 5 revealed few differences between the pattern of maternal 
behaviour during the morning and afternoon sessions, the system 
was simplified here with only one set of observations in the morning 
but extended to a duration of 15 minutes. Nest quality score was not 
recorded. 
6.2.3 Scopolamine challenge 
The procedure for the scopolamine challenge described in 
section 3.7.2 was repeated here. Briefly, after reaching the criterion 
of two consecutive errorless trials in the maze, subjects were injected 
i.p. with scopolamine hydrochloride (0.5mg/kg body weight) 20 
minutes prior to being retested. 
6.2.4 Assay for choline acetyltransferase (ChAT) activity. 
The results of experiments conducted in chapter 3 revealed 
an influence of foster mother treatment on body weight and several 
other developmental landmarks. For this reason, animals treated with 
oral Al at the 1000mg/L dose were divided into the four 
experimental groups and separated by sex, for analysis of ChAT 
activity at 23 weeks of age. 
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6.3 RESULTS 
The following section incorporates the results of three 
separate experiments during which pregnant females from the two 
genotypes were exposed to oral Al at three doses (750, 1000 and 
1250mg/L). The results are difficult to comprehend due to the 
number of strain and treatment comparisons as well as the diverse 
range of measures. With such a large number of comparisons 
involved, it is inevitable that significant differences may arise on, for 
example, one day only. This section aims at presenting the most 
important effects of exposure to oral Al, whilst the discussion will 
concentrate on general trends. The main ANOVA tables and median 
+ lower and upper interquartile ranges are given in Appendix G. 
6.3.1 Water and food intake 
A summary of water intake is presented in table 6.1. 
Adding Al2(SO4)3 at a dose of 750 and 1000mgfL to the drinking 
water of pregnant CBA mice caused a significant reduction of 18% 
in the total volume of water consumed by treated mothers over their 
respective treatment periods (750mgfL control n=15, treated n=17, 
t(24)= 5.58 p<0.0001; 1000mg/L control n=4, treated n=5 t(6)= - 
3.48 p<0.02).  Treated CBA females exposed to the highest dose 
(1250mg/L) consumed slightly less than controls, although this 
difference was not significant. 
Drinking at these levels means that the approximate average 
Al intake for CBA females exposed to the 750mgIL dose was 2.0mg 
over the 7 days. This is similar to the estimated amount of Al taken 
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in following four days of exposure via i.p. injection. CBA females 
exposed to the 1000 and 1250mgfL dose of Al for 20 days, 
consumed an estimated mean total of 7.6mg and 11.6mg elemental 
Al respectively. This represents a four- and sixfold difference 
respectively compared to administration by the i.p. route. 
As with CBA females, C57 treated mothers drank 
significantly less water during the treatment period than controls, a 
difference of 15% in the total water consumed for females exposed 
to Al at 750mg/L (control n=15, treated n=18, t(29)= 4.36 
p=0.0002). Again, no significant differences existed between control 
and treated females in their water intake at the highest dose. 
The total mean amount of elemental Al ingested over the 7 
days by C57 pregnant females was calculated as 2.5mg. The total 
water consumption was reduced when females were exposed to Al at 
1000mg/L (control n=5, treated n=5, t(6) 3.77 p<O.Ol). C57 females 
in the 1000 and 1250mg/L groups consumed a total mean of 8.7mg 
and 13.5mg of Al respectively. 
C57 mothers exposed to the 1250mgfL dose of Al 
consumed significantly more food during gestation than controls 
(control n=8 =104.22(±3.0)g, treated n=5 5=1 17. 14(±1 .6)g, t(9)= - 
3.79 p<0.005). As the total maternal weight gain and litter size were 
not influenced by treatment with oral Al, the increased food intake 
can not be accounted for in these terms. No other differences in food 
intake were recorded. 
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Table 6.1: Water intake and estimated amounts of Al ingested by 
CBA and C57pregnanrfemales. 
Strain 	Group 	Mean 	Range Equivalent Al 
	
(±S.E.) consumed (mg 
CBA 750 Control 	40.1(+1.1) 	33.5- 45.4 
Treated 32.9(±0.7) 29.5- 38.6 	1.8- 2.4 
1000 Control 114.5 (±3.5) 105.0-120.2 
Treated 	94.2(+4.7) 	84.7-111.0 	6.9- 9.1 
1250 	Control 128.3 (±6.1)  107.0-162.9 
Treated 114.7(±3.3)  101.4-119.7 	10.3-12.2 
C57 750 	Control 48.6(+1.2) 41.4- 55.9 
Treated 41.1(+1.3) 35.4-51.0 	2.2- 3.1 
1000 Control 145.2 (±9.0)  110.7-159.2 
Treated 106.8 (±4.8) 97.1-124.8 	7.9-10.2 
1250 Control 139.5 (±6.9) 119.0-152.6 
Treated 132.9(±9.3) 103.9-157.7 	10.6-16.1 
6.3.2 Breeding performance 
AdministeringAl via the oral route did not produce any 
significant differences in litter size or gestation length in either strain ............
or at any dose. 
After cross-fostering, three CBA litters in the 750mgfL 
group were lost, two from the control and one from the treated group 
due to neglect or killing of the pups by the mother, which reduced 
the litter size to less than three. This left four control and five treated 
litters in this group. No pup mortality occurred in the CBA 
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1000mgfL (5 control and 4 treated mothers) or 1250mg/L groups (10 
control and 10 treated females). 
There was a total of 62 control and 63 treated C57 pups at 
birth within the 750mg/L group. Oral administration of Al to this 
strain greatly improved the number of mothers who continued to 
term in comparison with those given i.p. Al (see section 3.9). 
However one control litter was lost (on Pd17) and two treated litters, 
one on PdlO and the other on Pd 17, due to leakage from the water 
bottles. These losses are reflected in the differing values for degrees 
of freedom in those measures taken between Pd3 and 21. One 
control litter and two treated pups were killed in the C57 1000mgfL 
group by Pd3. Pup mortality in the C57 1250mg/L group also 
occurred in both experimental groups; two treated and three control 
females lost pups after cross-fostering. 
Litter compositions following cross-fostering for all 
experimental groups are shown in Table 6.2. 
Table 6.2: Litter composition for each strain and each experimental 
Strain 	Treatment 
mg/L 
Cc Ct Tt Tc 
CBA 	750 8 9 8 10 
1000 8 9 11 8 
1250 20 19 20 20 
C57BL/6J 	750 14 13 14 15 
1000 10 9 9 9 
1250 13 6 10 12 
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6.3.3 Maternal weight 
CBA mothers exposed to 1000mg/L gained more weight 
during GdlO to 18 than controls (control n=7 =7.79(±1.08)g, 
treated n=5 =9.2(±0.86)g), although this difference was not 
significant. Postnatal CBA maternal weight was not influenced by 
prenatal exposure to oral Al. Similarly, C57 maternal weight gain 
during gestation and the suckling period was largely unaffected by 
oral exposure to Al. 
6.3.4 Maternal behaviour 
At the 750mg/L dose Mann-Whitney U-tests revealed only 
slight differences between control and Al-treated CBA mothers in 
the pattern of maternal behaviour. Control CBA mothers exhibited 
an increased frequency of nursing on Pd2 (control median--5.5, 
treated median=O, U=20.0 p<0.02), and an increase in the number of 
bouts of licking which were of longer duration than those of Al-
exposed CBA females on Pd2 (frequency control median=5.5, 
treated median=O, U=20.0 p<z0.02; duration control median=234.9s, 
treated median=O.O, U=20.0 p<0.02). Al-treated mothers had a 
greater frequency and duration of nest-building behaviour than 
control mothers on Pd7, although this difference was only 
marginally significant. On Pd14 control females spent less time 
involved in active behaviour (control median=120.0s, treated 
median--457.7s, U=1.0 p<0.05). 
As with CBA mothers, the pattern of maternal behaviour of 
control and treateCC57. mothers was largely unaffected. by exposure 
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to the 750mg/L dose. Table 6.3 summarises the only differences 
between C57 control and treated dams all of which occurred on 
Pd 10. It can be seen from this that C57 control mothers were more 
involved in nest-building and in non pup-directed maternal activities 
than treated mothers on this day. 
Table 63: Effect of gestational exposure to oral Al (750mg1L) on 
C57 maternal behaviours on postnatal day 10. 
KEY: C=control T=treated 
Maternal 	Median 	U-value 	p value 
Behaviour 
NESTB UILD 
Duration 	C 25.8 	47.0 	=0.02 
ri, 
Frequency 	C 3:0 	48.5 	<0.02 
T 0.0 
ACTIVE 
Duration 	C 270.3 	50.5 	<0.009 
T 34.3 
Frequency 	C 16.5 	46.5 	=0.03 
T 	6.0 
row 
Duration 	C 72.8 	46.0 	<0.04 
T 19.1 
Frequency 	C 15.5 	49.5 	<0.02 
T 5.0 
GROOM 
Frequency 	C 	3.0 	46.5 	<0.03 
T 1.0 
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Maternal behaviour observations were not undertaken at the 
1000mgfL dose. Only those maternal behaviours for which group 
differences were found at the 1250mg/L dose are described below. 
Nursing - In general, CBA control dams (n=10) exhibited a greater 
number of bouts of nursing than treated mothers (n=10). This 
difference was significant only on Pd3 (control median=2.5, treated 
median=l.O, U=86.0 p<0.005). 
C57 treated mothers (n=5) spent little time involved in 
nursing until Pd7. On Pd2 control mothers (n=7) spent significantly 
more time nursing compared to treated females (control 
median=245.0s, treated median=O.O, U=31.0 p<0.03). In contrast to 
control C57 mothers, who exhibited the expected decline in nursing 
with time, treated C57 females increased the amount of time spent in 
this behaviour as the pups got older. 
The frequency of nursing behaviour was lower in treated 
females on Pd2, although this difference was marginally significant 
on Pd2 but reached significance on Pd3 (control median=2.0, treated 
median=O.O, U=19.0 p<0.03); control mothers exhibited an increased 
number of bouts. 
Licking - Although the occurrence of licking behaviour was rare in 
both strains, control C57 mothers showed a greater frequency 
(control median=2.0, treated median=O.O, U=30.5 p=0.03) and 
duration (control median=104.2s, treated median=O.O, U=32.0 
p<0.02) of bouts of this behaviour on M. There were no group 
differences within the CBA strain. 
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Grooming - Treated CBA females spent more time self-grooming 
during the first five test days but this effect was reversed on Pd 10, 
when CBA controls spent significantly more time grooming than 
treated mothers (control median=173.3s, treated median=90.9s, 
U=84.0 p=O.Ol). 
Eating and Drinking - The duration of bouts of eating and drinking 
was greater for treated CBA females during the first postnatal week, 
a difference which was marginally significant on Pd3. I4fact, CBA 
control females were not observed in these behaviours until Pd7, and 
on PdlO the difference was reversed (control median=3 17.8s, treated 
median=35.5s, U=79.0 p<0.03). There was also a significant 
difference in the frequency of this behaviour on PdlO (control 
median=3.5, treated median=1.5, U=84.5 p<0.009). 
6.3.5 Pup Weight 
In utero exposure to oral Al resulted in a significantly lower 
birth weight within the treated CBA 750mg/L group only (control 
n=29 =1.36(±0.02)g, treated n=49 =1.28(±0.02)g, t(75)= 2.97 
p=0.004), with control pups weighing 6% more at birth. Although 
CBA control pups weighed more at birth than pups treated at a dose 
of 1000mg/L, this difference was not significant (control n=26 
=1.4(±0.02)g, treated n=29 =1.36(±0.03)g). At the 750 and 
1000mg/L doses, there were no effects of prenatal or foster mother 
treatment on CBA pup growth up to weaning. Thus, the lower 
weight of the treated pups in the 750 and 1000mgIL groups did not 
persist beyond birth. 
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CBA pups exposed to the 1250mgfL dose had comparable 
weights at birth to controls. However, there was a marginally -- 
significant effect of foster mother treatment on CBA pup weight up 
to weaning, pups reared by treated mothers were heavier than pups 
fostered to control mothers. 
C57 birth weights were unaffected by prenatal exposure to 
oral Al either at the 750 or 1250mg/L doses. There was only a small 
sample of pups from the 1250mgfL dose and this may explain why 
no significant effect could be detected. However, Al-treated 
1000mg/L C57 pups weighed 5% less than controls at birth (control 
n=46 i=1.38(±0.02)g, treated n=30 5i=1.31(±0.02)g, t(55)= 2.15 
p<O.O4). 
There was a highly significant effect of foster mother 
treatment on C57 pup body weight during the preweaning period 
when pups were exposed to Al at the lowest dose (750mg/L) 
(F(1,36)=5.68 p<0.03); pups reared by Al-exposed females weighed 
more than pups fostered to control females (see Fig. 6.1). The 
divergence in pup weights began as early as Pd3 and increased with 
age. From Fig. 6. la Ct pups were the heaviest and Cc the lightest 
group, a difference of 6% by Pd2 1. Although the Tt group weighed 
more the Tc group this difference was only slight. 
There were no significant differences in C57 pup body 
weight following exposure to Al at a dose of 1000mg/L. However, 
there was a significant effect of foster mother treatment on pup 
weight when Al was administered at 1250mg/L, interestingly, in this 
case pups fostered to control mothers weighed more than those 
reared by treated mother (F(1,33)=9.71 p<z0.004, see Fig. 6.1b). The 
175 






















01 	I -- - - - i- 
0 3 	6 	9 	12 	15 	18 	21 
Postnatal day 
Fig. 6.1: Effect of prenatal exposure to oral aluminium 
sulphate on C57BL16J pup body weight. 
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difference between Cc and Ct pups was greatest on Pd9 (17.6%) and 
on Pd3 for Tt and Tc pups (15.9%). 
6.3.6 Adult weight 
Separate ANO VA's of CBA adult male and female body 
weights did not reveal any significant differences between 
experimental groups at the 750 or 1000mgfL doses of oral Al. 
At the lowest dose there was a marginally significant effect 
of foster mother treatment on C57 adult male weights, the increase in 
body weight of animals reared by treated mothers persisted into 
adulthood. This was also true for C57 adult females as ANOVA 
revealed a significant interaction between week and foster mother 
treatment (F(12,156)=2.57 p<0.04), the divergence in female weight 
was not clearly evident until after 13 weeks of age. 
At the 1000mg/L dose there was a significant interactive 
effect of week, prenatal treatment and foster mother treatment on 
C57 adult female weights (F(11,176)=2.2 p=O.OS). C57 adult male 
weights were unaffected by treatment at this dose. 
Subjects exposed to the 1250mg/L dose were not followed 
up into adulthood. 
6.3.7 Ultrasonic calling 
Unlike the effects of i.p. Al, the total number of ultrasonic 
calls emitted by CBA pups was largely unaffectd.byoralexposure 
to Al at 1000mg/L. Treated pups produced a low constant level of 
calling throughout the test period compared to Cc pups (see Fig. 
177 












4 	6 	8 	10 	12 
Postnatal day 
 






Cc Ic' -A--  Ct 















o 	 0 
	
0 I 	• 	 • 	I 	• 	I 	• 	I 	• 	I 
2 4 	6 8 10 12 
Postnatal day 
Fig. 6.2: The total number of calls emitted by CBA pups in a 
five minute test following prenatal exposure to oral aluminium 
sulphate at a dose of (a) 1000mg/L and (b) 1250mg/L. 
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6.2a). Similarly, output from Ct pups was constant but at a higher 
level than treated pups. Cc pups exhibited an increase in calling to a 
peak on Pd5 followed by a subsequent decline. Although Ct, Tt and 
Tc pups seemed to peak on Pd4, a day before the Cc group, it is 
unlikely that this implies a difference in the achievement of 
thermoregulation as their overall production of ultrasounds followed 
a fairly constant pattern. On Pd5 there was a significant group 
difference in calling (H(3)=8.68 p<0.04), with Cc pups having a 5-
fold difference in calling rate compared to the other three groups. 
Similarly, at 1250mgfL, CBA control pups called more than 
treated pups, a difference which was marginally significant on Pd4. 
Cc and Ct pups reached peak calling on Pd4 (125 and 119 calls/5 
min respectively), whilst Tt pups peaked on Pd5 (97 calls/5 mm) and 
the Tc group on Pd6 (92 calls/5 mm), two days later than control 
pups (see Fig. 6.2b). 
Turning to the C57 strain, we can observe from Fig. 6.3a 
that Cc pups called more than the other groups following exposure at 
the 1000mgfL dose. However, it is difficult to pick up any clear 
differences resulting from prenatal treatment as the range of calling 
is so narrow. Conversely, following exposure to Al at 1250mg/L, 
there is a trend towards treated C57 pups calling more than controls. 
Pups from all experimental groups produced a maximum number of 
calls on Pd5 (see Fig. 6.3b), followed by a sharp decline. 
179 




















-- •D-- Tt 
-- -0-- Tc 
	
0 I 	• 	• 	• 1 	D 
2 4 	6 	8 10 	12 
Postnatal day 
Fig. 6.3: The total number of calls emitted by C57BL16J pups in 
a five minute test following prenatal exposure to oral aluminium 
sulphate at a dose of (a) 1000mg/L and (b) 1250mg/L. 
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6.3.8 Fox tests 
The percentage of pups judged as_  having _acquired a mature 
response in the Fox tests did not differ significantly between the 
750mg/L CBA experimental groups. At the 1 000mgfL dose the only 
difference occurred in swift righting on Pd12; more CBA pups 
fostered to treated mothers had acquired a mature response by this 
day (X2(3)=14.924 0.01>p>0.001). 
There was a significant group difference in the number of 
CBA 1250mg/L pups reaching an adult response in forelimb 
grasping on Pd12 (X2(3)=16.466 p<0.001), pups fostered to treated 
females petformed better than those reared by control mothers. At 
this dose the performance of Cc pups was correlated with body 
weight (r=-0.636 0.005>p>0.002). There was a maternal effect on 
performance in cliff aversion on Pd9 (X2(3)=9.131 0.05>p>0.02), a 
greater number of pups fostered to control mothers achieved an adult 
response on this test. Fox test score was correlated with weight for 
Cc and Tc pups (r=-0.542 0.02>p>0.01; r=-0.85 p<0.001 
respectively). 
Treated 750mg/L C57 pups performed better in the slow 
righting test on Pd6 (X2(3)=13.6, 0.01<p>0.001), and in eye opening 
on Pd15 (X2(3)=14.56, 0.01<p>0.001). Tt pup scores in both these 
measures were correlated with body weight (slow righting n=12 
r=0.697 0.02<p>0.01; eyes open r=0.697 0.02>p>0.01) and Tc 
scores in eyes open (n=15 r=0.756 0.002>p>0.001). 
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6.3.9 Pup behaviours 
Pup behaviours were observed following the 750mg/L 
treatment only. There were no significant prenatal, maternal or sex 
effects on the frequency or duration of any of the pup behaviours 
recorded for the CBA strain. However, C57 pups showed significant 
group differences in the following pup behaviours:- 
Righting - Kruskal-Wallis one-way ANOVA revealed a significant 
group difference in the duration of time spent righting on Pd3 
(H(3)=8.9 p=0.03), with treated pups spending more time in this 
behaviour. The difference between Cc and Tt pups was significant at 
p<o.05. 
Crawling - There was a significant difference between experimental 
groups in the frequency (H(3)=9.58 p<0.03) and duration (H(3)=7.96 
p<0.05) of bouts of crawling on Pd6. In both cases the difference 
between Ct and Tt pups was significant at p<0.05, Ct pups being 
more involved in this behaviour. 
Square crossing - ANOVA revealed a significant main effect of 
foster mother treatment on pup activity between Pd9-18 as shown in 
Fig. 6.4a (F(1,38)=4.67 p<0.04); pups fostered to treated mothers 
crossed more squares than pups raised by control mothers. Activity 
levels in all groups increased with age. 
Headup - There was a group difference in the frequency of bouts of 
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Fig. 6.4: Effect of prenatal exposure to oral aluminium 
sulphate (750mg/L, GdlO-16) on C57BL16J pup (a) activity 
and (b) headup behaviour. 
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reached significance on Pd6 (H(3)=8.92 p=0.03) and on Pd18 
(H(3)=7.78 p=0.05), as shown in Fig. 6.4b. 
Edgeon - There was a significant group difference in the duration 
(H(3)=8.51 p<z0.04) and frequency (H(3)=9.24 p<0.03) of edgeon 
behaviour on Pd 15. In the latter case the difference between Cc and 
Tc scores was significant at pcz0.05. 
6.3.10 Activity at weaning 
The number of squares crossed by CBA pups was 
unaffected by treatment with 750mg/L oral Al. Conversely, when the 
dose was increased to 1000mg/L there was a significant effect of 
foster mother treatment on CBA activity (F(1,28)=5.58 p<0.03), 
pups fostered to Al-treated females exhibited lower activity levels 
(see Fig. 6.5). At the 1250mg/L dose there was a significant 
interaction between prenatal treatment and sex (F(1,67)=4.21 
p<0.05) on CBA pup activity and between minute of test and sex 
(F(4,268)=2.45 p=0.05). 
The activity of C57 pups was unaffected by exposure to Al 
at a dose of 750mg/L. Although C57 Cc pups in the 1000mgfL 
group exhibited lower activity scores during minutes 1 and 2 than 
pups in the other groups, this difference was not significant. There 
was a significant interactive effect of all variables on C57 1250mg/L 
pup activity at weaning (F(4,132)=2.92 p<0.04), no other 
interactions were significant. There were no differences in activity 
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Fig. 6.5: Effect of prenatal exposure to oral aluminium 
sulphate (1000mg/L, Gdl-20) on the number of squares 
crossed by CBA pups in a five minute openfleld test. 
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CBA 750mgfL Tt pups took the least (median=26.0s) and 
Tc pups the longest time (median=62.5s) to contact the novel object 
placed in the centre of the openfield at the end of the activity test. 
Conversely, control C57 pups took longer to make contact than 
treated pups (median=47.0, 53.0, 26.0 and 29.Os for Cc, Ct, Tt and 
Tc pups respectively). These differences were not significant. 
There were no differences in latencies between 
experimental groups at the 1 000mg/L dose of Al in either strain. 
At the 1250mgfL dose, CBA Cc pups required less time 
than the other groups to make contact whilst there was no difference 
in the time taken by C57 pups. There is a clear strain difference in 
approach time at this dose, C57 pups took less time to make contact 
than CBAs. 
6.3.11 Maze test 
There were problems with these learning experiments 
because within both CBA 750mgfL control (5 out of 10) and treated 
groups (4 out of 8) only half of the subjects reached the criterion of 
two errorless trials. Treated subjects required more days to reach 
criterion than controls (control median=12.0, treated median= 16.5 
days). Control and treated subjects did not differ in any other 
measure recorded. Even fewer animals reached criterion during 14 
days of testing when the dose was increased to 1000mg/L (control 1 
out of 7, treated 5 out of 9). As few CBA animals completed the task 
the scopolamine challenge was not undertaken. 
54% (7 out of 13) of C57 750mgfL control and 71% (10 out 
of 14) treated subjects reached criterion of two consecutive errorless 
Ft1SJ 
trials in the maze. In addition, treated males needed less days 
(=7.9(±0.89)days) to acquire the maze than controls 
(=8.86(±1.3)days); chi-square tests showed that neither of these 
measures were significant. ANOVA did not reveal any group 
differences in choice accuracy between the experimental groups. As 
there were not enough Ct pups to challenge with scopolamine, 
analysis did not take foster mother treatment into consideration. 
There was a highly significant effect of scopolamine on the number 
of trials needed to enter all 8 arms (F(1,11)=7.95 p<Z0.02) ; 
scopolamine produced the expected decrease in choice accuracy, 
both control and treated animals required more trials. There was also 
a significant interaction between day and prenatal treatment 
(F(2,22)=7.14 p<0.009), treated animals took fewer trials to enter all 
8 arms, and between these variables and the challenge (F(2,22)=5.66 
p<0.02), by the third day of treatment with scopolamine treated 
animals no longer showed any impairment (see Fig. 6.6a). Treatment 
with scopolamine also produced a significant reduction in the 
number of correct responses made by both groups (F(1,11)=14.45 
p<z0.003). Al-treated subjects made slightly more correct responses 
than controls (see Fig. 6.6b). 
The number of arms in the radial maze was reduced to six 
for C57 1000mg/L males in an attempt to improve performance. 
62.5% of control and 57.1% treated animals completed the maze test, 
treated subjects requiring slightly longer to do so (control 
median=8.0, treated median=8.5 days). Although there were slight 
differences in the number of trials taken by control animals to enter 
all 6 arms, they did not reach significant levels. 
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Fig. 6.6: Effect of a scopolamine challenge on 
C57BL16J maze performance. 
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6.3.12 Adult activity tests 
CBA adult female activity at 22 weeks of age was 
unaffected by oral Al at 750 or 1000mgfL. This was also the case for 
C57 females exposed to Al at the lowest dose. However, at the 
1000mg/L dose of Al, there was a significant interactive effect of 
minute of test, prenatal treatment and foster mother treatment on C57 
adult female activity (F(4,68)=4.23 p<0.009); Ct females were more 
active than Tcs during minutes 3-5. On day 4 of the test there was a 
significant main effect of prenatal treatment on activity 
(F(1,17)=6.19 p<0.03), control animals were more active than 
treated subjects. This was reflected in the mean total squares crossed 
which was 222.5, 234.4, 174.2 and 182.3 for Cc, Ct, Tt and Tc 
animals respectively. 
6.3.13 ChAT Activity 
Tables 6.4 to 6.7 summarise the levels of ChAT activity in 
the different brain regions at 23 weeks of age, for male and female 
animals of both strains whose mothers were exposed to oral Al at a 
dose of 1000mgIL or saline during gestation. ChAT activity was 
assayed at one age only due to the moderate sample sizes. Each 
measure is the mean (±S.E) and represents pooled brains of 3-4 
animals in each group. 
The level of ChAT activity differed between male and 
female CBA animals in all brain regions considered, and tended to 
be increased in female brains. This was also the case for females 
within the C57 strain although not all brain regions e.g. the cerebral 
cortex, showed a sex-dependent difference in enzyme activity. 
The strain dependent differences in ChAT levels were not 
as pronounced as those arising from gender. However, CBA females 
exhibited consistently higher levelsL of ChAT than C57 females 
except in the hypothalamus. This tended to be true for CBA male 
subjects except in the case of the hippocampus and brainstem where 
ChAT levels were greater in C57 males. 
Table 6.4 shows the levels of ChAT activity within 7 brain 
regions for CBA male subjects, no data is available for the 
hypothalamus. Ct animals had similar or lower levels of ChAT than 
Ccs except in the cerebellum where there was a 36% increase. This 
decrease in activity can also be seen within the Tt group except in 
the striatum, although the increase in Tt levels was only slight 
compared to Cc males (8%) in this region. This trend of exposure to 
oral Al reducing ChAT levels followed for Tc males. However, as 
with the Tt group, this was not the case within the striatum where 
there was a marked increase (41%) in ChAT levels compared to Cc 
males. Thus, the overall effect of exposure to Al, either pre- or 
postnatally, on CBA males was a reduction in ChAT activity. 
The levels of ChAT activity in each of the 8 brain regions 
for CBA females are shown in table 6.5. Ct females exhibited a 
lower ChAT level compared to Cc females except in the 
hypothalamus, striatum and brainstem. The greatest difference 
occurred in the hypothalamus (65%), although the value for activity 
in the Cc group seems remarkably low. With the exception of the 
brainstem, Tt females tended towards an increase in ChAT activity 
compared to Ccs. Tc females exhibited consistently lower levels 
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Cerebral cortex 490.5 ± 11.9 501.9 ± 7.5 402.7 ± 5.6 357•5 ± 2.7 P<0.000 ' P<0 • 002 P<0 • 04 
Cerebellum 65.5 ± 1.5 101.6 ± 2.2 49.5 ± 1.2 48.6±1.0 p<0.000I p<0.0001 p<0.000I 
Hippocampus 617.4 ±7.8 503.9 ±9.2 581.4 ± 10.5 678.1 ± 15.7 p<0.000I p<0.000I N. S. 
Midbrain 791.0 ± 14.9 499.8 ± 8.2 565.6 ± 17.6 573.6 ± 17.9 p=0.000I p<0.000I p<0.000I 
Hypothalamus N.D. N.D. N.D. N.D. - - - 
Nucleus 1683.4 ± 37.6 945.6 ± 26.4 
magnocellularis  
1372.6 ± 18.4 1399.1± 535 N. S. p<0.0001 p<0.000I 
Straitum 1213.6±4.7 1029.2 ± 17.5 1320.2 ± 18,5 2044.1 ± 46.2 p<O.0001 p<0.000I p<z0.000I 
Brainstem 739.8 ± 11.2 719.9 ± 11.7 555.9 .± 10.0 411.1 ± 53 p<0.0001 p<0.0001 p<0.000I 
Table 6.4: Effect of oral exposure to aluminium sulphate (l000ing/L) throughout gestation on the level of ChA T 
activity in different brain regions in 23-week old CBA/T6 male subjects. 	N.D.= Not Determined 





Cerebral cortex 560.2 ±32.6 452.1 ± 14.0 884.1 ± 13.6. 383.7 ± 5.7 p<0.0001 p<0.0001 p<z0.0001 
Cerebellum 102.2 ±2.9 79.4 ± 12.8 42.0 ± 2.3 77.4 ± 2.8 p=0.0002 p=0.0004 N. S. 
Hippocampus 994.5 ± 69.6 699.4 ± 25.0 1061.9 ± 193 759.8 ± 11.8 N. S. N. S. p<0.0001 
Midbrain 737.2±13.3 644.6± 32.8 911.6 ±23.5 591.0±15.9 p<0.02 p0.000I p<0.0001 
Hypothalamus 245.5 ±7.6 702.1± 17.4 570.7 ± 13.3 768.9 ± 19.2 P<0.0001 P<0.0001 P< 0.000 I 
Nucleus 
magnocellularis 
1703.7± 37.2 1718.4 ± 26.3 2007.6 ± 60.7 793.8 ± 17.5 p<0.0001 p<0.000I p<0.0001 
Straitum 1536.8 ± 19.2 1987.9 ± 67.8 1487.7 ± 18.4 802.3 ± 26.6 p<0.000I p<0.0001 p<0.007 
Brainstem 788.9 ± 16.7 969.5 ± 10.7 690.8 ± 24.1 276.6 ±5.1 p<0.0001 p<0.000I p<0.0001 
Table 65: Effect of oral exposure to aluminium sulphate (](00tng/L) throughout gestation on the level of ChAT 
activity in different brain regions in 23-week old CBA/T6 fenale subjects. 
than Cc females but again this was not the case in the hypothalamus. 
Thus, within CBA females, postnatal exposure to Al (Ct and Tt 
subjects) seemed to cause an increase in ChAT activity. 
C57 males in the Ct group (see Table 6.6) exhibited both 
increases (within the midbrain, hypothalamus, nucleus and striatum) 
and decreases (cerebral cortex, hippocampus and brainstem) in 
ChAT levels compared to Cc males. The largest increase occurred in 
the hypothalamus (46%) and the greatest decrease in activity within 
the brainstem (43%). With the exception of the brainstem, Tt males 
showed consistent increases in ChAT activity compared to Cc males. 
This increase was particularly marked in the nucleus (40%). Again, 
within the Tc group the effect of Al varied with brain region. 
Increases in ChAT were recorded in the cerebellum, hypothalamus 
and striatum, whilst decreases were found in the cerebral cortex and 
brainstem. 
As with C57 males, C57 females in the Ct group showed 
both increases and decreases in ChAT activity depending on brain 
region (see Table 6.7). There was a marked increase in ChAT 
activity in the nucleus magnocellularis of Tt females, a difference of 
25%, but the other brain regions tended towards a decrease in 
activity. Tc females also exhibited this trend of a decrease in activity 
compared to Cc females except for a slight increase in activity 
within the brainstem (6%). Again, apart from inconsistencies within 
the Ct group, C57 females showed a general trend towards a 
decrease in ChAT levels following exposure to Al, which is in direct 
contrast to CBA females. 
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Cerebral cortex 433.8 ±25.3 402.5 ±4.8 426.4 ±7•5 416.8± 	8.6 N. S. N. S. N. S. 
Cerebellum 58.9 ± 1.9 63.7 ± 1.8 77.9 ± 2.2 129.4 ± 	2.5 P<0.0001 P< 0 .000 I P<0.0001 
Hippocampus 641.0 ± 8.8 567.1 ±8.5 950.4 ± 15.6 650.0± 6.1 p<0.0001 p<0.000I p<0.0001 
Midbrain 714.1 ± 29.2 885.3 ± 15.7 829.6 ± 133 695.2 ± 12.6 N. S. p<0.0001 N. S. 
Hypothalamus 467.9 ± 59.3 871.7 ± 7.0 627.2 ± 9.5 623.6 ± 15.8 N. S. p<0.0001 p<0.0001 
Nucleus 	. 1276.2 ± 11.7 1866.6 ± 17.9 
magnocellulans  
2133.3 ± 72.1 1215.4 ± 	9.6 p<0.02 p<0.0001 p0.0003 
Straitum 918.0± 11.3 1547.4 ±33.9 1312.8 ± 24.9 1891.3±18.0 p<0.0001 N. S. p<0.000I 
Brainstem 857.3 ± 12.8 489.8 ± 5.5 427.3 ± 	5.4 564.8 ± 9.1 p<0.000I p<0.000I p<0.0001 
Table 6.6: Effect of oral exposure to aluminium sulphate (l000mg/L) throughout gestation on the level of ChA T 
activity in different brain regions in 23-week old C57BL16J male subjects. 
1 0 
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Cerebral cortex 383.6 ±.7.6 485.9 ±10.2 354.3 ±-3.1 264.8:L6.0 p<0.0001 p<0.0001 N. S. 
Cerebellum 95.5±.2.5 85.2±1.5 62.7±.1.5 91.3±3.4 p<0.0001 p<0.0001 p< O. 00 l 
Hippocampus 7744 ±.44 778.8 ±9.5 657.2 ±16.9 646.7 ±18.2 p<0.0001 N. S. N. S. 
Midbrain 605.1 ±10.3 705.5 ±19.7 544.3 ±39.5 469.2±. 7.8 P<00001 p<0.002 N. S. 
Hypothalamus 661.9 ±43.5 522.6 ±8.2 503.1 ±- 9.3 554.1 ±10.7 p<0.02 p<O.00I N. S. 
Nucleus 
magnocellulans 
1511.7±23.6 1083.4±9.2 2008.8±29.5 1049.2 ±18.8 P<00001  P<00001  P<0 • 0001  
Straitum 1023.9±34.6 823.0±7.9 947.6±14.5 780.3 ±16.9 p<0.05 N.S p<0.0001 
Brainstem 528.0± 5.1 642.3 ±3.6 607.8 ±17.9 561.9 ±12.0 N. S. p<0.0001 p<0.007 
Table 6.7: Effect of oral exposure to aluminium sulphate (JiXYJImg/L) throughout gestation on the level of ChA T 
activity in different brain regions in 23-week old C57BL16J female subjects. 
6.4 DISCUSSION 
The experiments described in this chapter investigated the 
effects of oral exposure, via the dam's drinking water, of pregnant 
CBA and C57 females to Al2(SO4)3 at three different doses (750, 
1000 and 1250mgfL). There are many complexities and 
inconsistencies with the results, but the following trends have 
emerged. I 
Adding Al to the drinking water at a dose of 750 and 
1000mgfL reduced the amount consumed compared to controls As 
control water was acidified to the same pH as the Al solution, this 
can not be explained in terms of increased acidity. Interestingly, the 
reduction in water intake was not as pronounced at the highest dose. 
Exposure to oral Al, at any of the doses employed, did not 
result in maternal weight loss or a reduction in weight gain during 
the treatment period. This is in agreement with previous studies in 
mice (Golub, et al., 1987) and in rats (Bernuzzi, et al., 1986, 1989; 
Muller, et al., 1990). On the other hand, Paternain, et al., (1988) 
have reported a decrease in maternal weight gain following exposure 
of Sprague-Dawley rats to Al(NO3)3 at a dose of 180, 360 or 
720mg/L during days 6-14 of gestation. The lack of effect of oral Al 
on maternal weight during gestation is in contrast to the maternal 
weight data following exposure by the i.p. route (see section 3.4.3); 
Al-treated females gained less weight during days 10 to 18 of 
gestation compared to controls. This suggests that the reduction in 
weight gain may have resulted from the combination of the stress of 
injection with being exposed to Al. 
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Similarly, oral Al did not alter breeding performance or pup 
mortality within either mouse strain. However, a number of studies 
have found a significant increase in postnatal pup mortality 
(Bernuzzi, et al., 1986, 1989; Domingo, et al., 1987a; Domingo, et 
al., 1987b) following oral exposure to A1C13 or Al(NO3)3. 
Slight differences in maternal behaviour resulted from 
expto_AL at the 750mg/L dose. CBA females exhibited 
increased frequencies of pup-directed maternal activities and a 
decreased duration of active behaviour. Conversely, C57 control 
females spent more time nest-building and in non pup-directed 
activities. At the higher dose (1250mgfL) only moderate differences 
between control and treated mothers were observed. In both strains 
control females exhibited more nursing behaviour compared to 
treated mothers, which declined with age in the CBA strain, but 
increased as a function of age for C57 treated mothers. Thus, within 
the C57 strain exposure to Al prolonged the expression of nursing 
behaviour. With respect to self-grooming and eating and drinking, 
CBA treated mothers showed an increased involvement in these 
behaviours during the first postnatal week, but by PdlO this trend 
was reversed. 
The effect of oral Al on pup body weight was both strain 
and dose dependent. CBA pups treated at the 750mg/L dose had a 
lower weight at birth than controls, but this may have resulted from 
the slight increase in litter size in this group rather than from a direct 
effect of exposure to Al. CBA pup body weight during the 
preweaning period was unaffected by exposure to Al at the 750mgfL 
dose. In fact, there were no significant differences in any of the 
physical landmarks or behavioural measures investigated at the 
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750m&LL dose withineCB&trp. These results suggest that, at 
atS 
the 750mgfL dose and for the CBA strain, the stomach mucosa of 
the adult is effective in protecting against the absorption of Al or 
that any Al which is absorbed is cleared, by the kjdneys. For this 
reason the dose of Al was increased to 1000 and 1250mgfL, and the 
treatment period extended to include all of gestation. Increasing the 
dose to 1000mgfL caused a reduction in birth weight but this effect 
on body weight did not persist for any experimental group. However, 
at the 125 Omg/L dose, CBA pups fostered to treated mothers 
weighed more during the preweaning period than those reared by 
control females. 
Within the C57 strain, pup weights at birth were influenced 
by oral exposure to Al at a dose of 1000mg/L only; treated pups 
weighing less than controls. Following exposure at the lowest dose 
(750mg/L), the body weight of C57 pups fostered to treated mothers 
up to weaning was greater than those reared by controls. This obesity 
continued into adulthood for male subjects and was only apparent in 
females after 13 weeks of age. Schroeder and Mitchener (1975) 
found a slight elevation in the body weight of male Long-Evans rats 
after exposure to Sppm aluminium phosphate for one year. Similarly, 
Golub, Han, Keen and Gerschwin (1992) reported a transient 
increase in growth of female outbred Swiss-Webster mice between 
8-12 weeks following 90 days of exposure to a diet containing 1000 
.ug of AlLact from 4 weeks of age. These findings emphasise the 
importance of testing subjects over their lifespan to reveal any latent 
effects. 
At the highest dose (1250mg/L) the opposite effect on C57 
pup body weight was true; pups fostered to treated mothers weighed 
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less than controls. This paradoxical effect of dosage on body weight 
is in agreement with that previously reported by Yokel (1984, 1985), 
following exposure of New Zealand white rabbits to AlLact during 
gestation (Yokel, 1985) and lactation (Yokel, 1984). Exposure of 
rabbit offspring to low levels of Al facilitated weight gain, whilst 
exposure at higher levels resulted in a decrease in body weight of 
treated subjects compared to controls. From the maternal behaviour 
observations at the 1250mgfL dose, C57 pups reared by treated 
mothers received less maternal care during the first postnatal week 
compared to pups suckling control mothers. This finding may 
explain the differences in body weight of pups reared by treated 
mothers. Al may also have affected the quality and quantity of milk 
output. 
In conjunction with the weight data at the 1250rng/L dose, 
the maternal treatment effect influenced CBA pup performance in 
forelimb grasping, by Pd12 a greater proportion of pups reared by 
treated inothers acquired an adult response. As there was some 
correlation of body weight with Fox test score, these differences may 
have resulted from the increased weight of CBA pups reared by 
treated mothers rather than a direct effect of exposure to Al. This 
effect was also true for C57 pups treated with Al at a dose of 
750mg/L. However, at the 125 Omg/L dose the trend was towards 
C57 pups reared by treated mothers exhibiting deficits in 
performance. Again, this difference may be related to the lower body 
weight of these pups. Deficits in performance in neuromotor tests 
following oral exposure to Al have been more commonly reported 
(Tsujii and Hoshishima 1979; Bernuzzi, et al., 1986, 1989; Donald, 
et al., 1989; Muller, et al., 1990). However, at the 1250mg/L dose 
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the trend was towards C57 pups reared by treated mothers exhibiting 
deficits in performance. Again, this difference may be related to the 
lower body weight of these pups. 
Exposure to Al via the oral route did not produce as 
dramatic an effect on CBA ultrasonic. calling as was found following 
i.p. exposure. There was nevertheless a trend towards treated CBA 
pups calling less than Cc pups at both doses tested (1000 and 
125 OmgfL). Further, at the higher dose the calling output of treated 
pups peaked later than controls. 
The strain differences in ultrasonic calling are clearly 
evident from graphs 6.2 and 6.3, CBA pups exhibited at least a 10-
fold increase in calling compared to C57 pups. Thus, the C57 strain 
may not be as useful a strain for the recording of ultrasonic calling as 
part of a test battery because of its innate low level of calling. This 
produces a floor effect: that is as the baseline rate of calling is so 
low, any differences induced by exposure to a toxicant are less likely 
to be clearly seen. 
The results from the maze test are inconclusive. In the case 
of CBA mice it suggests that exposure to the doses employed (750 
and 1000mg/L) resulted in only slight alterations to cognitive 
function; treated males required more days to reach criterion. Within 
the C57 strain, there was a trend towards treated males actually 
performing better than controls. The challenge with scopolamine 
produced the predicted detrimental effects on performance in the 
maze in control and treated subjects. However, the effect of 
scopolamine on treated C57 mice seemed to wane by the third 
exposure. This suggests that these animals were less sensitive to its 
effects or became tolerant to them, and implies that neurotransmitter 
systems other than the cholinergic may be more important in 
mediating performance in the maze after exposure to Al in this 
strain. For example, as suggested in chapter 3, exposure to Al early 
in development may have initiated compensatory mechanisms which 
were already activated by 10 weeks of age. 
Improvements in maze performance following drug 
exposure have been reported previously. Benton, Dalrymple-Alford, 
Brain and Grimm (1985) found that prenatal exposure of TO mice to 
diazepam (2.5mg/kg body weight) increased the number of correct 
responses compared to controls. These authors accounted for this 
difference in terms of diazepam altering some other aspect of 
behaviour which facilitated maze performance, rather than a direct 
effect on learning and memory. 
From a methodological point of view, reducing the number 
of arms in the maze to six did not improve overall performance. 
Reinstein, DeBoissiere, Robinson and Wurtman (1983) found that 
C57BL/6J mice did not perform better than chance levels in an 8-
arm radial maze. This is in contrast to a study reported by 
Ammassari-Teule and Caprioli (1985), which showed that DBA/2 
and C57BL/6J inbred strains of mice learnt a 6-arm radial maze and 
furthermore, C57BL/6J mice performed better than DBA/2. 
Although the latter study also used food as the reinforcer, in future 
experiments with mice, it may be more profitable to use a liquid 
reinforcer as the motivator than food deprivation, as has been 
successfully employed by other workers (Pick and Yanai, 1983, 
1985; Laviola, Pick, Yanai and Alleva, in press). In addition, a pilot 
study has shown that C57 males exposed to Al by i.p. injection 
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performed less well in an 8-arm radial maze when the width and 
height of the arms were reduced. 
Differences in neurochemical measures depending on the 
sex (Yanai, 1979; Luine and McEwen, 1983; Luine, Renner, Heady 
and Jones, 1986) and strain (Gilad and Gilad, 1981; Gilad, Rabey, 
Tizabi and Gilad, 1987; Wailer, Ingram, Reynolds and London, 
1983) of a subject have been reported previously and for other 
neurotransmitter systems (Tunnicliff, Wimer and Wimer, 1973). 
Following exposure to oral Al at a dose of 1000mgfL, females 
tended towards an increase in ChAT activity compared to males at 
23 weeks of age, especially within the CBA strain. Strain-dependent 
differences were not as obvious as the differences between the sexes. 
The many inconsistencies and anomalous results make only general 
observations possible. These inconsistencies may have resulted from 
individual variation in ChAT levels. Other workers have found 
considerable differences in ChAT levels between, individuals of the 
same sex and strain (Sedowofia, pers. comm.). 
The trend within CBA males was towards a decrease in 
ChAT levels following Al exposure whether the exposure occurred 
in utero or during the postnatal period following fostering to a 
treated mother. This trend was also present for CBA females in the 
Ct and Tc groups, but in contrast Tt females tended towards an 
increase in ChAT levels. 
The seemingly consistent trend found in the CBA strain, of 
exposure to Al reducing the levels of ChAT activity, is not as 
obviously apparent within the C57 strain. C57 males seem to be the 
most variable group, with the effect of Al highly dependent on brain 
region. In contrast, the trend for C57 females is similar to that found 
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for the CBA strain apart from some inconsistent results within the Ct 
group. Thus, the ChAT data demonstrates that oral Al can penetrate 
the immature blood-brain barrier and reach the central nervous 
system of the developing foetus. Indeed, even at the 750mg/L dose 
regionally specific effects on ChAT activity were found (Sedowofia, 
pers. comm.). In one of the few studies which has considered Al's 
effects on neurochemistry, Marquis (1982) reported a reduction in 
AChE activity in Sprague-Dawley rats who were nursed by mothers 
exposed to a diet containing 0.12% Al chiorohydrate. 
Interestingly, at 23 weeks of age, CBA females and C57 
males within the Tt group exhibited increased levels of ChAT 
activity. One might speculate that Al's mechanism of action may be 
similar to that of excitotoxins: that is Al may have an excitatory 
effect causing overstimulation of neurons which initially results in an 
increase in, for example, neurotransmitter release, until a critical 
point is reached after which the neurons die. This stimulation may be 
a direct effect of Al on neurons or indirectly via the production of 
excitatory amino acids. If ChAT activity had been assessed at a later 
age, levels within these susceptible regions may have been lower 
compared to controls as neuronal excitation will have given way to 
neuronal death. 
Presumably the penetrance of Al and the susceptibility to it, 
may vary between brain regions which explains the lack of uniform 
response and why certain brain regions are more susceptible than 
others. The biphasic response to Al e.g. in the body weight of C57 
pups, may have resulted from a stimulatory effect of exposure to low 
levels whilst exposure to higher levels had a depressant effect. There 
is some evidence to support this (Atterwill, 1989). In vitro treatment 
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of whole-brain reaggregate cultures with A1C13 at a concentration of 
0.01mM and 0.1mM, resulted in increased ChAT activity up to 48 
hours of exposure but thereafter activity was reduced compared to 
control values (Atterwil, 1989). To lend further support to this 
hypothesis it would be necessary to measure the Al levels in 
different brain regions and to correlate these with ChAT activity. 
In some instances e.g. within the midbrain of CBA males, 
postnatal exposure via the dam's milk seems to have had a greater 
effect on ChAT activity levels than prenatal exposure. Many systems 
are still developing during the postnatal period and this may enhance 
their susceptibility to Al's action. 
In general, it would seem that less risk is attached to 
exposure to Al via the oral route than from injection. The reduced 
effect of oral Al, especially within the CBA strain, was somewhat 
surprising considering the larger dose of Al consumed over, a longer • 
treatment period compared to i.p. exposure. However, this reduced 
effect reinforces the argument that the increased detrimental effects 
of injected Al resulted from the continued leakage of Al from tissue 
surrounding the injection site. Al administered by this route would 
pass directly into the bloodstream, thus increasing its bioavailability. 
On the other hand, oral Al passes into the stomach where its 
absorption may be prevented or slowed down, so that the foetus is 
exposed to much lower doses. 
Cranmer, Wilkins, Cannon and Smith (1986) have reported 
the Al content of the placenta and the foetus of BALB/c mice, 
exposed to oral A1C13 at a dose of 200mg/kg/day during days 7-16 
of gestation, to be twice that of controls. Thus, although the 
absorption of Al may be restricted by the gastrointestinal tract, a 
204 
proportion of the oral Al must be adsorbed, contrary to previous 
assumptions outlined in chapter 1, to produce the effects described 
here. The placenta may be effective in eliminating low levels of 
absorbed Al but its ability to prevent Al from entering the foetus is 
reduced when levels of Al are higher. 
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CHAFFER 7 
7.1 GENERAL DISCUSSION 
The vulnerability of the developing foetus to exposure of 
the mother during pregnancy to certain drugs and chemicals present 
within the environment, has led to the recognition of a wide variety 
of behavioural teratogens which can affect intrauterine and postnatal 
development. The results of the experiments presented in this thesis 
suggest that Al could be added to this list. This is of particular 
concern with respect to the increasing levels of Al which are entering 
the environment from industrial sources (Wide, 1984). 
The main limitation to this study has been the lack of 
measurements of levels of Al within various maternal and foetal 
body tissues, which would have provided definitive evidence that Al 
was absorbed and accumulated within these tissues. Data relating to 
the Al content of milk, foetal tissues and within different brain 
regions, would have enabled correlations to be made between 
alterations in behaviour and neurochemistry with the effective levels 
of Al present. Attempts were made over the course of this work to 
take such measurements, but they resulted in anomalous results 
probably due to the contamination of control material, either from 
airborne Al or from the presence of Al in the dissecting instruments. 
The underlying diminution of maternal weight gain during 
gestation following the treatment of CBA females with injected Al, 
is an undesirable confounding variable. It could be argued that this 
effect of Al on the mothers may have contributed to the changes in 
physical and behavioural development of their offspring as a result 
of undernutrition rather than a direct effect of exposure to Al. 
Certainly, the differences in maternal weight gain may account for 
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the body weight differences between control and treated pups at 
birth. However, as dams were not found to differ in their food and 
water intake or in body weight during lactation, the contribution of 
differences in maternal weight to the physical and behavioural 
differences between the experimental groups up to weaning, seems 
an inadequate and unlikely explanation. 
The most obvious effect of prenatal exposure to Al has been 
the influence of the treatment received by the foster mother on 
aspects of offspring development This suggests that postnatal 
exposure to Al is of more consequence than prenatal. The extent to 
which Al accumulates and persists in body tissues is not known, but 
it seems certain that some Al is available to distribute into the dam's 
mi1kièsuifting in continued exposure of the neonate over time. In the 
human and rodent, the maturation of many neurochemical systems 
continues postnatally. For example, granule cells within the 
cerebellum and hippocampus proliferate during the postnatal period 
(Ruppert, 1987). This may explain why postnatal exposure to Al, via 
the dam, continues to have effects on offspring development. 
Further, as gestational exposure to Al caused only slight changes in 
certain components of maternal behaviour, the contribution of 
alterations in the ability of the mother to care for her fostered young 
to the maternal effect is ruled out. 
Whatever the mechanism of action, the presence of a 
maternal effect highlights further how essential it is to incorporate a 
cross-fostering procedure in behavioural teratology studies if any 
safe deductions about mechanisms are to be made. 
In utero exposure to Al via i.p. injections reduced the 
number of ultrasonic calls produced and delayed the timing of peak 
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calling in CBA treated pups compared to controls (see chapter 4). A 
similar trend towards a diminished calling output was found 
following oral exposure but the results were not as striking. Pups 
who received Al in utero but were reared by control mothers (Tc), 
were one of the heaviest groups but called at a rate lower than 
controls. This suggests that the effect of Al was specific to disruption 
of the vocalisation system. The exact neural mechanisms underlying 
ultrasonic calling are not known and the involvement of several 
systems has been implicated. The demonstration of a reduction in 
ChAT activity following prenatal exposure to Al, leads to the 
tentative suggestion that the cholinergic system may play a role in 
the production of these calls (Rankin and Manning, 1993). 
Obviously further work is required to investigate the consequences 
of a lowered calling rate on the mother-infant interaction and to 
understand Al's mechanism of action. However, as suggested in 
chapter 4, recording of ultrasonic calling should certainly be 
included in any test battery aimed at assessing effects of possible 
behavioural teratogens on the developing animal. 
CBA pups exposed to injected Al exhibited transient delays 
in several tests of neuromotor development, specifically in forelimb, 
pole grasping and screen climbing. Following exposure via the oral 
- 
route, Al-treated CBA pups performed better in some of the Fox 
tests than controls. Information concerning the effects of injected Al 
on the neurobehavioural development of C57 pups is lacking. 
As has been reported by other workers, there was a 
paradoxical effect of dosage on body weight following exposure by 
the oral route within the C57 strain. C57 pups exposed to the lowest 
dose of oral Al (750mg/L) weighed more than controls and also 
OZ 
acquired a mature response earlier than controls in some of the Fox 
tests. Conversely, when exposed toadose of 1250ng/L oral Al, 
treated C57 pups had the lowest body-- weight which was 
accompamed by delays in the maturation of some of the 
neurobehavioural tests. Thus, performance in the Fox tests -is related 
to body weight. 
Although the results from the maze experiments were 
inconclusive, they do suggest that prenatal exposure to Al disrupts 
some aspects of maze learning. Mice certainly seem to be less 
efficient in acquiring this type of learning task compared to rats. 
Mice may be more sensitive to the physical characteristics of the 
maze such as the dimension of the alleys or the light intensity. In a 
pilot experiment which involved an 8-arm radial maze with reduced 
dimensions, i.p. Al-treated C57 males required significantly more 
trials to complete the task compared to controls. Further, the task 
may have proved to be too difficult for all the mice so that treatment 
effects were not obvious. The results of the maze experiments, the 
adult activity tests and adult body weights, suggest that in utero 
exposure to Al does not only affect aspects of neonatal development 
but that certain effects persist into adult life. 
Measurement of the levels of ChAT activity showed that 
changes induced by exposure to Al depended upon brain region age, 
strain and sex. Exposure via i.p. injection resulted in consistent 
reductions in activity within the cerebral cortex and hippocampus in 
treated CBA brains compared to controls at all ages tested. It is of 
interest to note that the brain areas which undergo the most 
consistent changes in Alzheimer's disease are the cerebral cortex, 
hippocampus and nucleus basalis of Meynert (Mann, 1988). There 
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is no information regarding the effect of injected Al on ChAT levels 
within different regions of C57 brains. This resulted from the 
insufficient number of plugged C57 females, a problem which has 
been encountered by other workers using this inbred strain. When 
exposure occurred via the oral route, there was a tendency towards a 
decrease in ChAT activity within the two strains, although deviations 
from this general trend were clearly apparent. Similar reductions in 
cholinergic system enzymes have been reported following exposure 
to other heavy metals. Sobotka, Brodie and Cook (1975) reported 
decreases in AChE and butyrylcholinesterase enzyme activities in 
the telencephalon and brainstem following neonatal exposure of rats 
to lead acetate (9, 27, 81mg/kg). Exposure of Sprague-Dawley rats to 
methylmercury at a dose of 2 or 6mg/kg during gestation days 6-9, 
caused a reduction in AChE activity in the cerebral cortex, brainstem 
and cerebellum when assayed at Pd12 (Wootten, Brown, Callahan, 
Vetrano, Wadman, Melia, Mulligan and Schatz, 1985). 
The marked differences in the levels of ChAT within 
control and treated brains implies the involvement of the cholinergic 
system in the effects described. However, it is unlikely that the 
cholinergic system is the only system affected by Al and it is more 
plausible that a number of neurochemical syrns were altered. 
However, with the association of Al and alterations to the 
cholinergic system within the Alzheimer's diseased brain, a marker 
for this system was the most obvious one to include in initial studies. 
The degree of loss of ChAT activity and the extent of 
physical and behaviouralchange are incongruous. In chapter 3 this 
inconsistent level of change was explained in terms of neuronal 
plasticity and compensatory mechanisms. It certainly seems from 
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previous studies (Yates, Gordon and Wilson, 1976; Bayer, 1989), 
that a high degree of neuronal loss can be overcome before 
behaviour is disrupted. This may be especially true in the case of 
immature animals, the nervous system of which is undergoing 
continuous change. 
Here, as in almost every study which has explored strain 
differences, susceptibility to a number of drugs has been shown to 
depend on the subject's genotype. There have been some clear 
genotypic differences in the response to exposure to Al by mice from 
the CBA/T6 and C57BL/6J inbred strains For example, the body 
weight of CBA pups was unaffected by oral exposure to Al at a dose 
of 750mgfL. On the other hand, similar exposure of C57 pups 
resulted in pups fostered to treated mothers weighing more than pups 
reared by control females. 
The exact means by which Al exerts its developmental 
toxicity is not known but several possible mechanisms may be put 
forward. For example, the mode of action may be similar otc -- 
cadmium, which interferes with the -placental, transport- of certain  
vitamins, particularly vitamin B12 (Ullberg, Dencker and 
Danielsson, 1982), although there may be other more general effects 
on nutrient transport at the placental level which may be affected by 
Al. This would result in difficulties for the exchange mechanisms 
between the mother and the foetus. Such deficits in the transport of 
essential elements to the developing foetus, would certainly explain 
the reduced body weight of treated pups at birth. If these prenatal 
deficits are transient, then pups given adequate maternal care during 
lactation may overcome such deficits. This would account for pups 
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in the Tc group having comparable body weights to that of control 
pups reared by control mothers (Cc). 
The retarding effect of Al on the growth of Ct and Tt pups 
may have resulted from differences in the quality and quantity of 
milk produced by treated mothers. This effect would be enhanced if 
difficulties in intestinal absorption and metabolism continued beyond 
birth. Indeed, Al is known to inhibit gastrointestinal tract mobility 
(Hava and Hurwitz, 1973) which may cause undernutrition. 
The question still remains of how Al gains entry to the CNS 
to exert its toxicity. The absorption of Al is dependent on the ligand 
to which it is bound and its penetration of the body's bathers is 
- ---------- - --- -- 
facilitated by its complexing with citrate (Slanina, Frech, Ekstrm, 
L&f, Slorach, and Cedergren, 1986; Martin, 1986) and nitolte 
(Kruck and McLachlan, 1989). Further, Al binds to albumin (Martin, 
1986) and transferrin (Trapp, 1983; Martin, Savory, Brown, Bertholf 
and Wills, 1987) and can be transported within the body in this way. 
Banks and Kastin (1983) have demonstrated that Al alters - the 
permeability of the rat blood-brain barrier, which allows the entry of 
substances whose access is normally restricted. More specifically, 
Banks, Kastin and Fasold (1988) have shown that Al inhibits 
saturable transport systems in the blood-brain barrier. Thus, neurons 
may be affected directly by exposure to Al and killed by a process of 
overstimulation, as suggested in chapter 6, or degeneration may be 
incurred by exposure to other substances present in the blood, the 
entry of which is facilitated by Al. 
In summary, the involvement of Al in the aetiology of a 
number of human pathological conditions in more recent years, has 
changed opinions on its previously established status as a nontoxic, 
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nonabsorbable, harmless element. To date, little attention has been 
given to Al's potential as a behavioural teratogen. It is clear that we 
still lack information on a number of behavioural systems following 
gestational exposure to Al, which severely limits a more 
comprehensive evaluation of Al's behavioural teratogenicity. 
However, the results presented herein, and those of other 
investigators, imply that prenatal exposure to Al causes alterations to 
growth, ultrasonic calling, to the development of certain sensory-
motor skills, and suggests changes to maternal behaviour and 
learning and in the levels of ChAT activity in certain brain regions. 
Moreover, such exposure may result in behavioural and 
neurochemical deficits which persist into adulthood. 
Finally, Al may be poorly absorbed from the 
gastrointestinal tract under normal conditions and at low levels, but 
in the developing animal such protective biological barriers are 
immature which may render them particularly susceptible to any 
toxic effects. Further work is certainly necessary for a better 
understanding of the influence of Al on foetal development. 
7.2 DIRECTION OF FUTURE WORK 
As is often the case with scientific research, the work 
presented here has raised as many questions as it has answered. Al is 
present in the environment in a number of different chemical forms. 
The extent of the solubility of Al in the body is dependent on the Al 
salt to which exposure results (LeBlondel and Allain, 1980; Martin, 
1986), thus the need for evaluation of inter- and intraspecies 
differences in the bioavailabiity of Al and its salts is great. 
The response to a drug is highly dependent on the species 
tested. It may be informative to expose animals from a different 
species, to Al to assess the generality of Al's effects. For example, 
Chapman and Cutler (1988) found that, for certain measures, the 
gerbil (Meriones unguiculatus) was affected to a relatively greater 
extent by prenatal exposure to phenobarbitone (60mg/kg) in their 
mother's drinking water, than the mouse. 
Further investigations are needed to examine the effects of 
gestational exposure to Al on the mother-infant interaction. For 
example, does in utero exposure to Al make a treated pup 
intrinsically different from a control pup as a stimulus object, 
making it less effective in eliciting maternal behaviour? To do this, 
one could present unfamiliar control and Al-treated pups to control 
and treated mothers, and measure the ultrasonic output of these pups 
and simultaneously record maternal behaviour and retrieval time, in 
a similar way to that employed by Ness and Franchina (1990) and 
Laviola, Rankin, Petruzzi and Alleva (subm.). Further, pups could be 
exposed to a different sensory stimulus e.g. olfaction, and the 
number of ultrasounds recorded. This would provide information on 
the specific effect of Al on the pup vocalisation system and eliminate 
any contribution from effects on the nrocesses underlvinLy  
thermoregulation. 
This study has not included any effect of prenatal exposure 
to Al on social interactions. The main reasons for this concerns 
ethical considerations and practical problems involved in such 
experiments. A further study could include a similar procedure to 
that used by Chapman and Cutler (1984, 1988) involving the 
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recording of a range of social behaviours during single sex 
encounters between unfamiliar animals. 
Thus there are fundamental problems concerned with the 
understanding of behavioural development, for example 
genotype/environmental interactions, which the ethopharmacological 
approach may help to illuminate. But also, from a practical point of 
view, we must continue to test possible teratogens to identify 
behavioural anomalies early, enough to prevent further human 
tragedies from occurring. 
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LONG-TERM EFFECTS OF .\LLMINIUM ON THE FETAL MOUSE BRAIN 
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Summary 
Potentially noxious substances may act as fetal teratogens 
at levels far lower than those required to produce detectable 
effects in adults, and behavioural teratogenicity may occur at 
levels lower than those which produce morphological 
teratogenesis. Aluminium (Al) is a potential neurotoxin in 
adults. Since pregnant women may be exposed to untoward levels 
of Al compounds under certain conditions, we have examined the 
Long-term effects of treating the pregnant mouse with 
inr.raperitoneal or oral aluminium sulphate on brain biochemistry 
and behaviour of the offspring. The cholinergic system, as 
evaluated by the activity of choline acetyl transferase (ChAT), 
..as affected differentially in different regions of the brain, 
and still showed significant effects in the adult. Differences 
between the intraperitoneal and oral series in the magnitude of 
effect seen in the regions of the brain probably reflect 
differences in the effective level of exposure. Growth rate and 
psychomotor maturation in the pre-weaning mouse were affected in 
the intraperitoneal series only, showing a marked post-natal 
maternal effect. 
The presence of aluminium (Al) compounds in the brains of sufferers 
of senile dementia of the Alzheimer type (SDAT) has led to the suggestion 
that Al accumulation in the brain leads to degenerative processes(l). 
Although Al is the third most abundant element, most of it exists in 
insoluble forms. The limited passage of Al salts across the gut, the 
efficient excretion by the kidneys, and the blood-brain barrier diminish the 
access of soluble Al compounds to the brain(2). However acute or chronic 
administration of Al compounds to experimental animals by various routes, 
including the oral(3-5), has established the neurotoxicity of soluble 
aluminium compounds, as do human conditions such as dialysis 
encephalopathy(6,7). Many of the neurological diseases in which Al has been 
implicated are those in which there is damage to the cholinergic system(S), 
and there is evidence of cholinergic damage in conditions where aluminium has 
been introduced experimentally into the brain(5,9,10). Al compounds are more 
readily taken up at acid pH or in organified form. For example Al uptake is 
increased by citrate(11,12) or by coinpiexing with sugars(13,14). Such 
organifjcation may permit solubility in cell membranes, thus affecting 
permeability and the blood-brain barrier(15). Aluminium may bind to receptor 
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tue Itniuwn effect.., of Al on thi s nem,rot.rannm tier nynt.em(9. 10). 
Mnt.rirlata and mt.hotIn 
	
Act i . 0 A.L rot  tinu,.o.Lajcmmi!iIum 	Aluminium wan 	milmintnt.ereil to pregnant. 
I mire 1w t.wii tuitIon. 	One group of mice was Injected Intraperltoneally 
1w) with '  200mg/kg uil,,mlniumm nt,lplunte (A)2(904)t.I8H20, pit 2.5-2.7) or 
l ine tic I 'I If led to thin name till ma the ml umu,, I ni tiiiu, 	from ilnyit 10-1:1 of 
it 'it inn I,,mIt,q I ye. 	The qnuu,uuul groi,p wan gIves, alumni nina a,mlpt,,tt.e ( ?!i0mg/t. 
4.1-4.1) me lbeir.qole drinking waler from dnya 10-17 of geatal.ion 
I,tqlve. ('n,tt.roi mire in thin group were given water acidified to the name 
mm f lip I,,mIntiun nimlil)nt.e. 
U" term InAt.i ofl_Q5__chpj. I ,ie - acetyl 	nf 	e__._ecjJyj.iy. Control and 
,mtnlum enpoecul nice 	were kilteit at. aqen rntmgirig from 3-41 we eks. The 
I ,un were di aqecleui In In if  f fere,it. reg lotte inn) mutt tog nerebrn I cortex, 
-u'I,u -1 lisa, 	ldfuluuiciiu?uluuun , 	mi,tttrah,, 	hyprit.tinl nmi,q, 	n,,rleuun 	mmg,iorei ltd itrin, 
tuil,,m u,,iul I t,,- Ii, mliii,t cm, 	t'iiuiloit .inmtul.'w 	nun 2-4 mice (,,u.t. neiimrnt.u.iI liy- 
nI 	74th' ,,,I I I 	,,.u'ut 	fiii- 	I Sum. ulu.t ,'rmt ,,umt.iuim, mit' ttiAf mint lv It y 
11,i pieS lionS or tIl,uvu'r rum,,! (h.'i',i (In). Ittief t y 	onmtt en were huimogeutlned nit 
in teal I,ie rout aistitig it tiltS au-I -iii, nutut ancenynul wIlt, no nanny mixture 
il aiui I lug I 'r mmcl y  ti,uA ml 17'C fur 21) ml nn. 1 4 C ncnet.y Irlu,it Inc formed war, 
.ru't.e,l into quct.a,u-2-one conta ining pot man hum nerc,url c iodide, mimi! ml lutumot.n - 
,u,tuoI in a mc tat. i hahn, counter. Each grotup of sign-matched control anti 
umtnut hi-ama was tiiaaecl.ed nail analynnul together. Ilowevr, the oral periem 
-e begun It year after the int.raprrltonenl morton, nnci tilamectlona were done 
dif ferent iipert rim'. Ilium wlil to cain), control anti treated gm-nun In wholly . 
ua'ml,1e, the controls for t.t,p intraperltoncal and oral series are not 
eia i-attic. 
tiehiny IQyrtI I miii! iIc've I r.pmt'tllM I_ atutmi I pq 	On the tiny of hit rt.ti ( uuunt.--nmt.n I 
• I'it'l ) 	lit! i'r n Iron were r,'ruurtleut. 	The f o ll ow i ng ulmy In ips were 
lithe,!, 	un'aem!, marked fly I tie cl ippi ng mittS crna a - ton t.erut tint iug a tot-Al 
It - titles - crone- foal or mIen I gut, anti we I glint! off every third tiny from l'ti 
II weunming (flee ref. 20). Thereafter, body weighta were recorded weekly. 
Ic anul remato weights were analyned aeparately from weaning onwards. lenIn 
aennori-motor coordination and development were also performed 	every 
ni day timing a modified version of the Fox battery of testa (21). Subjects 
tented for slow righting, cliff avernion, grasping with forelimiuha, pole 
tnpi,ug, climbing on a wire mesh and eye opening. 	All other behavioural  
tc'atn were performed no prevlouialy minarrlhed 
(20), except for Che lent of 
tenrni,,g mhilit.y. 
in t,huene experiments. 10 week old male mice were lenInd in 
nit P-arm radial mare for 12 days am dencrihed by Pick and Yanmi (22). Adult 
actIvity tents on three mm,ccenslve days were carried out at 22 weeks (ace 
2(1). 
TI... fu,I Ituwluig fnusr experiment-al grouepn of mice were ent.mht ished and 
I.ent..'mI - 
(I) pi,pn fi-,um t'not.u'uul It tiers ftunt.ermiml In control mothers (rmn) • (2) 101Pm 
frtum 
u'cui,t ru I Iii .tern foml.ervol to At treated mothers (CO, (3) pupa from Al treat 
cii 
IiI.Lern fostered to control mothers (Ic), and (4) pupa from Al treated 
litlern fostered to Al treated mothers (It.). All the behavioural studies were 
carried out. by tile same observer who was blind to the allocation of treatment 
grolulma. The sample else for each group. Including males and females, in the
1.1w earlea wan mm follown:- Cc nn13, Ct n14, It n12, Ic nll; and for the 
rml series Cc amP, Ct nw9, It. nm10 and Ic amP. 
$tmhistLtitYsL 	Pump weights 
at bIrth were analysed timing 
SI.,iutemut.'R I-tent.. Analynim of 
Variance (ANOVA) was employed for the weigtmtn 
n,id activity scores I.hernaft.er (23). Adult activity data wits analysed timing 
t.t,e Krmmnkal -Wall is one-way ANOVA. The categorical data generated from 
the 
Fox tents was nasessed by CM-square Cents On each day of observation.ANOVA 
followed by I-test was t,aeti 
 CO analyse ChAT activity data. Differences At 
p(0.05 were taken no significant. 
RJ 
Aimed Q_r~n_k_cted 
with an average weight of 259, pregnant mice injected 
IntrapenitofleallY with aluminium sulphate received a daily dome of O.4I.g of 
elemental aluminium. The scan amount, of fluid consumed daily by control mice 
III the orally exposed group was 6.0ml. This compares with a mean of 
4.4 ml 
,'onnuised by the trent.e,i mice, anti Is equIvalent to a daily Intake of 0.27mg 
of el.'memil ml aluminIum. Over 
a four-slay I.rpmtmrnt. period. I.p mice ree,eivemi a 
l.ot.ml of I.filmg of nitimInhtim compared with 1.89mg consumed by orally 
pxptisrd 
mice In seven days. 
Our data indicate that pre-natal exposure to aluminium sulphate 
affects the cholinerglc system, as judged by effects on choline 
,icet,yltranmferaae *ctivlty. Table I shows ChAT activity in different brain 
regions from mice whose motherswere administered aluminium MUlPhAtP by 
isutraperitoneal Injectionu The data in table 2 show the activity In mice 
whose mothers were exposed orally to aluminium. Path tables show significant 
efferl.m on the r.holinergic symt.em, and also that the effects are differential 
I,etwerm, brain regiona. It. In also clear from 
the data that., with the 
e x ception of the hypothialamun and striatum, the effects peralah. Into 
miii,) thood. 
There were no effects on the length of gestation, litter 
mire or sex 
ratio of either Al treatment. The birth weights of exposed 
pups in the 
intraperitoneal series were about 5 per cent below controls (df:1
i 47 tr2.63 
prO.011) but this difference persisted only In the mice reared by treated 
mothers. Fig. 1 shown thin clear maternal effect, and the increasing 
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divergence of pup weights reared by control or treated mothers from Pd3 up to 
weaning (df:l,42 FIR.43 p0.0002). The maternal effect on body weight. 
persisted into nrtiplttir,nd for frolon I e mire only (,lfrI , 18 F=R. 42 p(O.Ol). There 
were no a gn I firant. rffrrts on l,o,ty wright, or purprr wt,nrre mothers were exposed 
to o0iiminiiin srIlptIatM orally during gestation. 
Pupa exposed to sInai nina via the I . p ront.c' were slower to Attain adult 
srorep or, torvor-Pt 	of I he Foor arnie m,naur,M of reflex rlevelopmc'r,t.(2l 
lnrIr,rtlI'll .sI.rw rl ill ,t hg, 	I,,. I tat, q'nr'i'lflit 	(11g. 	2) 	,,,I little grneplrrg 	(Fig. 
l 	(IS. lii nrtrt t Ion, we (rave frrr,rrrt It mat err,al effect, or, n,narrr I"moh or 
performance. 	Figs. 2 and 3 show first t.reni.erl pups rr'nrr'rl by trrnt.ed mothers 
(It) are more severely affected than treated pupa reared by control mothers 
(Ic) or control pups reared by treated mothers (Ct), but all these groups are 
affected as compared to controls reared by control mothers (Cc). The 
divergence between the two extreme groups, control pups reared by control 
mothers, and treated pups reared by treated mothers is the widest. The 
significance for pole graping, for example, is p<O.00I. The other tests were 
rot rotind to he algnificnrrt. Open field activity levels were largely 
up to weaning- TAB 
LE I 
CHOLINE ACETYI,TRANSFERASF. ACTIVITY 	114 CIIA MICE. 
EXPOSED PRE-NATALLY TO Al.IJMINII1M SULPHATE 
3 weekm 17 weeks 
CONTROl. TREATED CONTROl. TREATED 
CERERRAI. CORTEX 213.44, 9.3 	210.9+ 	4.8 440.34 	2.6 328.9± 8.3* 
CF.RE.REI,TIIM 43.3+ 0.7 	50.7+ 	3.1 98.5+ 	2.7 64.9+ 	1.9' 
I!IPI(CAM PI IS 744.4+ 7.6 	580.2+ 	8.2' 1015.6+31.0 917.9 	3.6 
Mt muRAl N N. it. N. P. 793:1*13.1 856. f 
	3.9' 
tIVtS*I'IIAI,AMIIS N. 11. N. 1 1 . 665.7*19.9 
573.9*26.7 
STUlA'I'tIil 459.6+ 9.7 	251. 	5.2' 2141.7*.52.7 
11471.4+4:1.9' 
34 weeks 	 44 weeks 
CONTROl. 	TREATED 	CONTROl, 	TREATED 
CERF.RRAI. CORTEX 309.4+22.0 180.6± 1.4* 247.0± 5.3 215.4± 2.5* 
cERUFLIJIM 	 50.9± 1.1 	46.5± 0.9' 	73.2+ 1.1 	
45.6± 1.0* 
IIIPIN7CAMPI!S 381.1+18.1 	306.7± 1.4* 	567.2± 6.0 545.5410.0 
MII1RI1AIN 	 649.4+ 7.8 	552.1+ 6.:l' 	505.7415.0 	439.8+ 3.8* 
hIVt'llTtlAIlMIlS 	5:111.9* 2.1 	433.84 G. 3* 	247.54 2.4 	342.2+ 
9.0' 
¶iI'tltVI'I'tt 	 11117.7124.3 	¶195.1)4 7.1) 	431.1' ((.4 	7211.24 16.0' 
(:hnline srot.yli.rnnsfernso activity in 501150 brain. (trains were 
dissected from offspring whose mothers were injected 
i,rtrr*perit.rrnonlIY with 200mg/kg al*imirririm sulphate or saline on 
gestation nays 10-13. Enzyme activity expressed as picomolos/ag 
protoin/minflt.e. Each result represents the Mean ± SE of 4 
rl..terminiat.ions. Values p<O.OS; N.D. 	Not Determined.  
Measurements of activity at weaning and in adult life show persistent trends 
towards it maternal treatment, effect. 	
At 22 weeks, a five minute activity 
teat, was performed. 	There was no significant difference between groups on 
tIny 1 when they were Int.rodrrred to the field- However, there were marginally 
significant differences between treatment. groups In the total n,rmher of 
s9rrares crossed on days 2 and 1, pups reared by treated mothers hart lower 
activity levels. 
lAthE II 
ChAT ACTIVITY IN CI1A MICE EXI)SFl) TO ALUMINIUM SUlPhATE 
PRE-NATALLY (ORALLY ADMINISTERED TO MOThERS FROM DAY 10-17 OF PREGNANCY) 
3.5 Weeks 	 16 Weeks 
CONTROL 	TREATED 	CONTROL 	TREATED 
CERFRRAI CORTEX 197.3± 3.8 	322.9± 2.5' 	516.5±12.1 	
358.2k 5.0* 
CFRERF.l,lUM 	105.5± 1.2 61.4± 4.1' 
97.6! 2.3 87.3! 0.8* 
IIIPPOCAMP(IS 568.9+ 8.5 	661.5±26.6' 	
678.7± 5.8 	725.9±13.0* 
MIl)l)RAIN 	 733.9±18.6 	498.1± 9.1' 	
512.7± 6.1 	562.8! 6.7' 
IIYPUTIIAI,AMIIS 	338.4± 9.0 	442.7 2.7* 	
564.4± 8.7 	478.8! 3.6' 
NUCLEUS 	 1289.1± 5.3 1173.9±14.6' 1695.2±13.5 1415.1± 4.5' 
STRIATUM 831.6+ 7.7 	751.2± 9.9' 1426.4± 5.4 
	868.3±10.5' 
1IRAINSTEM 	 870.7±12.8 	890.9± 6.2 	841.1± 7.1 
	977.6±45.9' 
Choline ricetyltransferase activity In mouse brain. 	
Drain 
dissect.ions and measurement of ChAT activity were as in table I. 
Values p(O.05 were significantly different from controls. 
Tests at 10 weeks of age for learning ability and retention in an 8- 
arm radial maze could he made with small numbers only. 10 out of 13 control 
animals (77%) reached criterion [two consecutive errorless trials (22)1 and 6 
out, of 11 (55%) or the Al-exposed group. The exposed mice which did reach 
criterion were slower 1  do so (a menlian of 7.5 days, compared to 6 days for 
r:rrrut mIs) , truth. tins difference (lid not ranch statistical Rignifica"ce- 
Di scussi  
In both series the effects on ChAT levels following prenatal exposure 
to Al are differential between brain regions: 	
a finding also reported for 
the neurot.oxIc effects in Al encephalopat.hY in adult rats (24). 	Table 2 
shows that significant effects are found in ChAT activity following 
Administration by the oral. route, implying sufficient access of aluminium to 
the fetal brain for neuro toxic effects to be obtained. 
It Is civ'nr from the nhat.n on ChAT that the effects of m1nminium on the 
developing brain are not t.ransint., l,,rt. persist Into adult life, al thought 
thorn' are deviations from this trend in the striatum and hypothIamuR in the 
oldest animals. The differences in the extent to which ChAT activity was 
affected in the different regions of the brain may be due to the levels of 
aluminium reaching each region, or to differences In the dlnt.rlhutiofl of 
cirolinergic neurons in the brain. 
There were also differences in the effects on ChAT when the same 
regions of the brain are compared In the intraperitoneal and oral series. 
CPA f)lip body wtlit. 
- ii 	••'•• to 
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Thin mey ri'flu'rt a clone effect. 	it. has been shown that aluminium levels in 
tb' pharentice of pregnant, remain mice injected intraperitoneallY were 10 
I linen higher limo In ronlucile, while they were only three times higher than 
it,itt,ru,lq in orally treated 1emalem(2). Also It rise in performance In a 
c:hnnqicnlly con(hithoneci reflex tet(26) has been reported in reh,hit.s 
14,lhi,wlrig low hovels of Al ntlminiatratlnn with a fall following high leVels. 
ri r. tic •r .reiinI.n I clutch icicie ten I,nI.-nCt.a I growth, have also 
lee.',, reported 
Ivy ,ievei'u, I eel hu,u wo,'ti,'rs (21-31), asciI tether I,
1v est.lgatn'A leave. releorl ..,I 
mimi Icr requite to ours, in that. Al trat.rpiit its s,tern afferte It.' 
cieceloitment of certain bust not all senqori-motor skills (32,33). Treatmesit or 
infant. mice similarly affects motor skills (27), and regular clinical 
e,lminlmtratinfl of Al to human infants is neurotoxic (34). 
The increneing divergence between the pup weight.s of offspring reared 
Ivy 
'c-out rul or treai.c'ui mothers lip to weaning, may he due to retention of 
ehiumlutium by the mother and Its release into the milk, to effects on milk 
nuutiuttt.(2), or to errects on maternal behaviour(35), but the neurochemical 
nequeelar wnivid imply t.hmt. the pupa received Al in the milk. Alt.houugh 
ycilcel(26) Ii,uuuuul relat-ively low levels of At In the milk of treated dams. It 
mumy he in organifieci complexes and thus readily absorbed by the neonate. 
Although some behavioural me*a'lres ahoy effects, others do not, and 
overall the behavioural effects do not ace, commensurate with the degree of 
ChAT deficit.. Such, dleparltiem can also occur in SPAT brains (36,37). It 
suet he pointed out that responses to depressed levels of ChAT may be highly 
mc.lert.ive amouiget. different, types of memory (38) so that our battery of teats 
(20) nnul the effert,a on mice do not pnrmit us to predict any particular loam 
uul 
ment.ml f,,nct.ircnn In mall. However, Adams (39) has pointed to the si.ilarity 
0ir 
huehavic"sral responses in humans and rodents after exposure to several 
different types of heel,avhousra) t.eratogenm, suggesting that mice may provide 
It 
v'ry allit.fthle model for l,ehevlousr,tt teratogenicity in humans. It may also he 
Clint reduced MAT activity increases the liability of the system to other 
firms of st.rena, a ponnlhllil.y which requliree investigation. 
Vinslly we lieve ricer evidence for genetic differences in remponne to 
ipratogenm,(17,20, 40
) anti for sensitivity to aluminium. Pregnant CS? rice, 
given the same intraperitoneal close levels an were used for the CRA genotype 
utriul reported here, railed to continue to term. 
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Main analysis of variance (ANOVA) tables and medain (+lower and upper interquartile ranges). Th e tail 
probability value for the repeated measure interactions is the Greenhouse Geisser correction. 
ANOVA table of maternal body weight of CBA females injected i.p. with aluminium sulphate (200mg/kg 
Gd 10-13). 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 23999.01788 1 23999.0 1788 3522.02 0.0000 
TREAT 34.40706 1 34.40706 5.05 0.0461 
ERROR 74.95397 11 6.81400 
DAY 273.60113 2 136.80057 50.13 0.0000 
DT 10.40009 2 5.20004 1.91 0.1926 
ERROR 60.03888 22 2.72904 
ANOVA table of CBA pup body weight following prenatal exposure to aluminium sulphate (200mg/kg, 
Gd 10-13). 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 6566.47828 1 6566.47828 4350.63 0.0000 
TREAT 0.23429 1 0.23429 0.16 0.6956 
FMAT 23.05899 1 23.05899 15.28 0.0003 
SEX 0.15242 1 0.15242 0.10 0.7522 
TF 0.60917 1 0.60917 0.40 0.5287 
TS 1.81962 1 1.81962 1.21 0.2785 
F S i..)hLlh I 1.52212 t.V1 LJ..)LIU 
TFS 0.01814 1 0.01814 0.01 0.9132 
ERROR 6339136 42 1.50932 
DAY 1797.97353 6 299.66226 3471.31 0.0000 
DT 0.11414 6 0.01902 0.22 0.7683 
DF 7.55227 6 1.25871 14.58 0.0000 
DS 0.12234 6 0.02039 0.24 0.7556 
DTF 0.10122 6 0.01687 0.20 0.7889 
DTS 0.44752 6 0.07459 0.86 0.4106 
DFS 0.36911 6 0.06152 0.71 0.4730 
DTFS 0.05028 6 0.00838 0.10 0.8794 
ERROR 21.75401 252 0.08633 
ANOVA table of CBA adult female body weights. 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 116216.53540 1 11621633540 6900.57 0.0000 
TREAT 26.34204 1 26.34204 1.56 0.2271 
FMAT 160.27994 1 160.27994 9.52 0.0064 
TF 6.19717 1 6.19717 0.37 0.5517 
ERROR 303.14869 18 16.84159 
WEEK 2524.13494 12 210.34458 348.62 0.0000 
246 
WT 11.89850 12 0.99154 1.64 0.1431 
WF 13.13340 12 1.09445 1.81 0.1040 
WTF 3.06930 12 0.25577 0.42 0.8598 
ERROR 130.32551 216 0.60336 
ANOVA table of CBA pup activity during postnatal days 9-18. 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 137954.05044 1 137954.05044 178.81 0.0000 
TREAT 68.56514 1 68.56514 0.09 0.7671 
FMAT 3080.07171 1 3080.07171 3.99 0.0522 
SEX 167.26682 1 167.26683 0.22 0.6439 
TF 350.43200 1 350.43200 0.45 0.5040 
TS 1573.69329 1 1573.69329 2.04 0.1606 
FS 119.62528 1 119.62528 0.16 0.6957 
TFS 1113.73557 1 1113.73557 1.44 0.2363 
ERROR 32403.14048 42 771.50334 
DAY 83477.87999 3 27825.96000 93.94 0.0 
DT 403.79421 3 134.59807 0.45 0.6333 
DF 601.97146 3 200.65715 0.68 0.5085 
DS 904.35513 3 301.45171 1.02 0.3649 
DTF 1249.89793 3 416.63264 1.41 0.2508 
DTS 1036.15660 3 345.38553 1.17 0.3161 
DFS 77.80410 3 25.93470 0.09 0.9137 
DTFS 4070.33841 3 1356.77947 4.58 0.0134 
ERROR 37321.01190 126 296.19851 
ANOVA table of the time spent crawling in a three minute openfield test during postnatal days 6-18. 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 735330.16158 1 735330.16158 433.45 0.0000 
TREAT 224.60527 1 224.60527 0.13 0.7178 
FMAT 4306.83 157 1 4306.83157 2.54 0.1186 
SEX 558.28490 1 558.28490 0.33 0.5693 
TF 3416.66725 1 3416.66725 2.01 0.1632 
TS 2643.54542 1 2643.54542 1.56 0.2188 
FS 1228.83491 1 1228.83491 0.72 0.3995 
TFS 93.81313 1 93.81313 0.06 0.8152 
ERROR 71250.81096 42 1696.44788 
DAY 192756.22562 4 48189.05641 75.87 0.0000 
DT 3654.58901 4 913.64725 1.44 0.2288 
DF 5 177.82837 4 1294.45709 2.04 0.1003 
DS 1917.35168 4 492.83792 0.78 0.5282 
DTF 4954.33415 4 1238.58354 1.95 0.1135 
DTS 9470.04186 4 2367.5 1047 3.73 0.0088 
DFS 253751467 4 634.37867 1.00 0.4041 
DTFS 7092.89915 4 1773.22479 2.79 0.0342 
ERROR 106704.77259 168 635.14746 
247 
REARING 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 1434.77124 1 1434.77124 67.19 0.0000 
TREAT 3.45997 1 3.45997 0.16 0.6893 FMAT 63.93616 1 63.93616 2.99 0.0909 
SEX 6.43382 1 6.43382 0.30 0.5860 
TF 8.97292 1 8.97292 0.42 0.5204 
TS 16.47059 1 16.47059 0.77 0.3848 FS 5.37815 1 5.37815 0.25 0.6184 TFS 3.28256 1 3.28256 0.15 0.6970 
ERROR 896.84127 42 21.35336 
DAY 462.04077 2 231-02038 21.29 0.0 
DT 12.65106 2 6.32553 0.58 0.5261 
DF 27.51591 2 13.75795 1.27 0.2828 DS 4.43666 2 2.21833 0.20 	. 0.7687 
DTF 7.60659 2 3.80330 0.35 0.6602 
DTS 14.56 166 2 7.28083 0.67 0.4843 
DFS 14.03995 2 7.01998 0.65 0.4953 
DTFS 106.78260 2 53.39130 4.92 0.0151 
ERROR 911.36825 84 10.84962 
STILL 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 2748.23619 1 2748.23619 506J7 0.0000 
TREAT 3.67148 1 3.67148 0.68 0.4155 
FMAT 23.92506 1 23.92506 4.41 0.0419 
SEX 0.02471 1 0.02471 0.00 0.9465 
TF 0.16035 1 0.16035 0.03 0.8644 
TS 2.98941 1 2.98941 0.55 0.4622 
FS 5.86287 1 5.86287 1.08 0.3047 
TFS 1.68640 1 1.68640 0.31 0.5803 
ERROR 228.04000 42 5.42952 
DAY 209.94970 4 52.48742 15.12 0.0 
DT 17.60019 4 4.40005 1.27 0.2879 
DF 7.30110 4 1.82527 0.53 0.6771 
DS 9.81244 4 2.45311 0.71 0.5585 
DTF 2.33296 4 0.58324 0.17 0.9273 
DTS 18.17862 4 4.54466 1.31 0.2734 
DFS 3.45642 4 0.86411 0.25 0.8738 
DTFS 31.53730 4 7.88433 2.27 0.0789 
ERROR 583.13143 168 3.47102 
Median (+ lower and upper interquartile ranges) frequency and duration of bouts of edgeon behaviour 
exhibited by CBA pups exposed to aluminium sulphate (200mg/kg, Gd10-13). 
FREQUENCY 
Day Cc ct Tt Tc 
9 1.0 
( 	 0.0, 	5.5) 1.0 
( 	










































































































( 	 0.0. 1.5) 2.0 ( 1.0. 4.0) 0.0 ( 0.0, 1.0) 0.0 ( 	 0.0, 1.0) 15 3.0( 	2.0, 10.5) 8.0 ( 3.0 1  16.0) 2.0 ( 	 0.3, 3.8) 2.0 (1.0, 7.5) 
18 10.5( 	2.0, 19.5) 11.0( 4.0, 19.0) 10.5 
( 	 5.0, 18.0) 11.5 (4.8, 19.0) 
DURATION 
Day Cc CE Tt Te 
9 5.0 
( 	 0.0, 24.2) 3.1( 0.9, 16.3) 0.0 ( 0.0, 31.9) 3.1 (0.8, 16.3) 
12 1.4 
( 	 0.0, 7.1) 0.0( 0.0, 1.9) 0.0(0.0, 1.4) 0.0(0.0, 1.9) 
15 8.4( 	1.9, 13.9) 1.7( 1.0, 9.1) 2.3 (0.3, 8.4) 1.7 (1.0, 9.1) 
18 17.8 
( 	 4.0, 25.8) 16.3 ( 8.4, 20.1) 11.3 (4.3, 25.1) 16.3 ( 8.4, 20.1) 
ANOVA table of CBA pup activity at weaning following prenatal exposure to aluminium sulphate 
(200mgfkg, GdlO-13). 
SOURCE 	SUM OF 	DEGREES 	MEAN 	 F VALUE 



















































3.7 13 19 
93 .29 848 












SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 85648.08870 1 	85648.08870 322.37 0.0000 
TREAT 1496.00419 1 1496.00419 5.63 0.0278 
FMAT 276.00419 1 276.00419 1.04 0.3203 
TF 258.22954 1 258.22954 0.97 0.3360 
ERROR 5313.65238 20 265.6 8262 
MIN 566.15748 4 141.53937 1.55 0.2046 
MT 236.46734 4 59.1 1683 0.65 0.6056 
MF 725.59410 4 181.39852 1.99 0.1165 
MTF 5 13.36875 4 128.34219 1.41 0.2458 
ERROR 7299.61905 80 
Median (+ lower and upper interquartile ranges) activity of CBA adult females at 22 weeks of age following 
prenatal exposure to aluminium sulphate (200mg/kg, GdlO-13).) 
DAY 2 
Minute Cc Ct Tt Tc 
1 35.0 (27.3, 40.3) 21.0 (16.0, 37.3) 16.0 (11.0, 30.0) 25.0 (15.0, 46.5) 
2 39.0 (34.3, 49.3) 24.0 (14.5, 47.7) 25.0 (13.0, 29.5) 29.0 (17.5, 33.0) 
3 32.5 (275, 34.8) 19.5 (18.3, 34.3) 14.0 
( 9.0, 28.5) 33.0 (17.5, 38.5) 
4 32.5 (22.3, 37.0) 18.0 (13.7, 51.2) 16.0 (12.5, 26.0) 26.0 (18.5, 30.5) 
5 26.0 (21.8, 39.0) 21.0 (15.5, 49.0) 18.0 
( 	 7.0, 29.0) 15.0 (13.5, 34.0) 
DAY  
Minute Cc Ct Tt Tc 
1 48.0 (433, 59.0) 25.5 (215, 41.5) 21.0 (14.5, 37-0) 33.0 (22.0, 41.5) 
2 34.5 (335, 44.8) 26.0 (12.8, 38.5) 19.0 (14.5, 39.5) 29.0 (24.5, 37.0) 
3 39.5 (28.5, 44.0) 16.5 (145, 33.3) 14.0 (10.5, 35.0) 20.0 (13.0, 25.5) 
4 36.0 (26.0, 44.3) 19.5 (16.5, 29.5) 17.0 
( 	 8.0, 28.0) 29.0 (20.0, 33.0) 
5 30.5 (23.3, 42.3) 21.5 (115,465) 18.0 (11.0, 26.0) 21.0 (15.5, 33.0) 
250 
Median (+ lower and upper interquartile ranges) weight gained by CBA pups following prenatal exposure to 
aluminium sulphate (200mg/kg, Gd 10-14). 
Day Cc CE Tt Ic 
6 1.58 (1.48,1.64) 0.73 (0.66,1.56) 0.99 (0.63,1.07) 1.28 (1.16,1.37) 
9 1.58 (1.52.1.70) 1.38 (135,1.42) 1.31 (1.20,1.39) 1.47 (1.36,1.50) 
12 1.42 (0.92,131) 1.44 (1.32,1.55) 1.29 (1.29,1.41) 1.40 (1.23,1.42) 
15 0.77 (0.54,0.90) 0.84 (0.73,1.50) 0.75 (0.72,1.19) 0.76 (051,1.09) 
18 0.52 (0.41,0.83) 0.45 (0.33,0.61) 0.58 (0.52,0.70) 0.74 (0.40,1.00) 
21 1.01 (0.76,1.13) 1.00 (0.87,1.12) 1.05 (0.58,1.15) 0.73 (0.56,0.94) 
ANOVA table of the crawling behaviour of CBA pups prenatally exposed to aluminium sulphate 
(200mg/kg, Gd 10-14). 
FREQUENCY 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 12740.00196 1 12740.00196 454.83 0.0000 TREAT 461.22549 1 461.22549 16.47 0.0009 FMAT 0.07059 1 0.07059 0.00 0.9606 SEX 33.64902 1 33.64902 1.20 0.2893 TF 8.54118 1 8.54118 0.30 0.5884 TS 14.16667 1 14.16667 0.51 0.4872 FS 5.71765 1 5.71765 0.20 0.6575 TFS 15.88235 1 15.88235 0.57 0.4624 ERROR 448.16667 16 28.01042 
DAY 7102.07157 4 1775.51789 78.21 0.0000 DT 275.00490 4 68.75123 3.03 0.0392 DF 168.37549 4 42.09387 1.85 01510 DS 29.16961 4 7.29240 0.32 0.8071 DTF 106.80686 4 26.70172 1.18 0.3285 DTS 21.31863 4 5.32966 0.23 0.8691 DFS 87.98333 4 21.99583 0.97 0.4143 DTFS 92.79902 4 23. 19975 1.02 0.3906 
ERROR 1453.00000 64 22.70312 
DURATION 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 279876.04406 1 	279876.04406 451.59 0.0000 TREAT 8083.77866 1 8083.77866 13.04 0.0023 
FMAT 962.84414 1 962.84414 155 0.2305 SEX 3480.69892 1 3480.69892 5.62 0.0307 TF 100.54824 1 100.54824 0.16 0.6924 TS 260.43879 1 260.43879 0.42 0.5260 FS 86.51173 1 86.51173 0.14 0.7136 TFS 613.91406 1 613.91406 0.99 0.3344 
ERROR 9916.16674 16 619.76042 
DAY 123382.54568 4 30845.63642 41.65 0.0000 DT 3432.61103 4 858.15276 1.16 0.3351 DF 1142.87824 4 285.7 1956 0.39 0.7627 DS 4265.52257 4 1066.38064 1.44 0.2429 
251 
DTF 916.67771 4 229.16943 0.31 0.8174 DTS 627.90575 4 156.97644 0.21 0.8867 DFS 1567.19515 4 391.79879 0.53 0.6636 DTFS 3498.18383 4 874.54596 1.18 0.3268 ERROR 47392.58375 64 740.509 12 
HEAD UP 
FREQUENCY 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 13895.26628 1 13895.26628 1009.81 0.0000 TREAT 4.20840 1 4.20840 0.31 0.5874 FMAT 5.84912 1 5.84912 0.43 0.5231 SEX 35.31020 1 35.31020 2.57 0.1276 TF 4.37740 1 4.37740 0.32 0.5801 TS 20.23634 1 20.23634 1.47 0.2418 FS 0.12590 1 0.12590 0.01 0.9249 TFS 5.08664 1 5.08664 0.37 0.55 12 ERROR 233.92500 17 13.76029 
DAY 3991.09270 5 798.21754 68.50 0.0000 DT 108.46196 5 21.69239 1.86 0.1457 DF 23.26435 5 4.65287 0.40 0.7605 DS 52.47394 5 10.49479 0.90 0.4499 DTF 166.48059 5 33.29612 2.86 0.0441 DTS 10.72144 5 2.14429 0.18 0.9119 DFS 78.10933 5 15.62187 1.34 0.2709 DTFS 24.33 821 5 4.86764 0.42 0.7474 ERROR 99035833 85 
DURATION 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 250735.05868 1 250735.05868 1051.77 0.0000 TREAT 2080.16431 1 2080.16431 8.73 0.0089 FMAT 14.60361 1 14.60361 0.06 0.8075 SEX 209.03236 1 209.03236 0.88 0.3622 TF 28.58817 1 2858817 0.12 0.7334 
TS 11.04833 1 11.04833 0.05 0.8321 FS 13.38338 1 13.38338 0.06 0.8155 TFS 103.04587 1 103.04587 0.43 0.5197 
ERROR 4052.69164 17 283.39363 
DAY 66735.61036 5 13347.12207 25.45 0.0000 DT 4657.18827 5 931.43765 1.78 0.1771 DF 285.31141 5 57.06228 0.11 0.9234 
DS 132936111 5 265.91222 0.51 0.6356 DTF 3123.77807 5 624.75561 1.19 0.3195 
DTS 740.50779 5 148. 10 156 0.28 0.7897 
DFS 1504.01321 5 300.80264 037 0.5951 




SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 3871.42061 1 3871.42061 206.32 0.0000 
TREAT 127.07905 1 127.07905 6.77 0.0180 
FMAT 58.40278 1 58.40278 3.11 0.0947 
SEX 6.79098 1 6.79098 0.36 0.5549 
TF 6.79098 1 6.79098 0.36 0.7243 
FS 7.73748 1 7.73748 0.41 0.5289 
TFS 0.00772 1 0.00772 0.00 0.9840 
ERROR 337.75000 18 18.76389 
DAY 1470.20460 2 735.10230 45.71 0.0 
DT 84.71448 2 42.35744 2.63 0.0896 
DF 152.59691 2 76.29846 4.74 0.0169 
DS 4.49678 2 2.24839 0.14 0.8575 
DTF 8.49266 2 4.24633 0.26 0.7556 
DTS 15.05645 2 7.52822 0.47 0.6180 
DFS 49.01529 2 24.50765 1.52 0.2328 
DTFS 0.75741 2 0.37870 0.02 0.9717 
ERROR 578.90000 36 16.08056 
STILL 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 944.79840 1 944.79840 335.31 0.0000 
TREAT 22.42715 1 22.42715 7.96 0.0118 
FMAT 0.96607 1 0.96607 0.34 0.5659 
SEX 2.30739 1 2.30739 0.82 0.3781 
TF 0.0 1 0.0 0.0 1.0000 
TS 0.03194 1 0.03194 0.01 0.9165 
FS 0.28743 1 0.28743 0.10 0.7533 
TFS 4.22355 1 4.22355 1.5 0.2375 
ERROR 47.90000 17 2.81765 
DAY 19.09242 4 4.77310 1.27 0.2940 
DT 28.11038 4 7.02759 1.87 0.1455 
DF 47.13234 4 11.78308 3.14 0.0327 
DS 5.40379 4 1.35095 0.36 0.7840 
DTF 11.10439 4 2.77610 0.74 0.5345 
DTS 11.95469 4 2.98867 0.80 0.5027 
DFS 5.35589 4 1.33897 0.36 0.7863 
DTFS 13.07246 4 3.26811 0.87 0.4633 
ERROR 255.30000 68 3.75441 
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Median (+ lower and upper interquartile ranges) number of trials required by CBA males to enter all 8 arms 
in an 8-arm radial maze, following prenatal exposure to aluminium sulphate (200mg/kg, Gd 10-14). 
NUMBER OF TRIALS 
Trial Control Treated 
1 14.0 (12.3, 16.0) 16.0 (12.0, 16.0) 
2 11.5( 8.8, 16.0) 15.0 (12.0, 16.0) 
3 8.5( 8.0, 12.0) 14.0 (10.0, 15.5) 
4 8.0( 8.0, 10.0) 15.0 (10.0, 16.0) 
5 8.5( 8.0, 16.0) 10.0( 8.0, 15.0) 
6 10.5( 8.0, 13.5) 8.0( 8.0, 15.5) 
7 9.0( 8.0, 11.0) 10.0( 8.5, 12.5) 
8 13.0( 8.0, 16.0) 8.0( 8.0, 12.5) 
9 10.0( 8.0, 12.3) 10.0( 8.0, 12.0) 
10 8.5( 8.0, 12.3) 8.0( 8.0, 	8.0) 
11 8.5 
( 8.0, 11.5) 8.0( 8.0, 11.5) 
12 9.0( 8.0, 13.0) 10.0( 8.5, 14.0) 
CORRECT RESPONSES 
Trial Control Treated 
1 5.5 (5.0, 7.0) 6.0 
( 
5.5, 7.0) 
2 7.0 (6.8, 7.3) 6.0 
( 5.0, 7.0) 
3 7.5 (7.0, 8.0) 6.0 
( 5.5, 7.0) 
4 8.0 (7.5, 8.0) 6.0 
( 
4.5, 7.5) 
5 7.5 ( 7.0, 8.0) 7.0 ( 5.5, 8.0) 
6 7.0 
( 7.0, 8.0) 8.0 ( 5.5, 8.0) 
7 7.5 (6.8, 8.0) 7.0 
( 7.0, 7.5) 
8 7.0 (6.0, 8.0) 8.0 
( 7.5, 8.0) 
9 7.0 (6.0, 8.0) 7.0(6.5, 8.0) 
10 7.5 (6.8, 8.0) 8.0 
( 8.0, 8.0) 
11 75 (6.8, 8.0) 8.0 
( 
6.5, 8.0) 





Alterations to the Pattern of Ultrasonic Calling after Prenatal Exposure to 
Aluminium Sulfate 
JUMTH RANKIN AND AUSREY MANNING' 
Institute of Cell. .-mcl and Population Biology, University of Edinburgh. Kings Buildings, West Mc Road, Edinburgh  
United Kingdom 
Pregnant CEA mice were exposed to aluminium sulfate 
at a dose of 200=g/kg body wt injected intraperitoneally 
during Days 10 to 13 of gestation. We used a variety of 
ethological measures, which have been shown to be sen-
sitive indicators of toxicants, to assess effects on the 
mother and the behavioral development of pups. P'enat.al 
aluminium resulted in a reduction in the rate of ultrasonic 
calling by pups accompanied by a shift in the timing of 
peak calling; treated pups exhibited decreased growth and 
delays in neurobehavioral development. The treatment 
received by a pup's foster mother was also found to in-
fluence development. We recommend ultrasonic calling as 
a sensitive measure in studies of behavioral teratogen- 
icity. C 1993 Academic Preaa, Inc. 
The producnon of ultrasounds by the young of 
many rodent species is now well established (e.g., 
Okon, 1972; Sales & Smith, 1978; Elwood & Mc-
Cauley, 1983) and its function as a form of com-
munication between young and mother has been 
characterized. Calls may be elicited as a result of 
gentle handling (Okon, 1970b), during isolation 
(Noirot, 1966; Robinson & D'Udine, 1982), under 
cold stress (Okon, 1970a), or from exposure to un-
usual tactile (Okon, 1970b) or olfactory stimuli (Os-
wait & Meier, 1975). 
Rodent neonates emit ultrasonic calls with a re-
liable and stable pattern from a few days after birth. 
Their calling is easily measured and thus this re-
sponse could form a marker against which the re-
sults of environmental or physiological changes can 
be measured. As pointed out by Minden (1981), this 
response may function as a sensitive indicator of 
subtle behavioral effects caused by prenatal or post-
natal drug treatments. As yet, few studies have in- 
We thank the United Kingdom Health and Safety Executive 
for support, Dr. S. K. A. Sedowofla for injecting the mice, and 
R. Clayton for helpful comments. Reprint requests should be 
addressed to Judith Rankin.  
corporated this technique: their test battery aimed 
at assessing the behavioral teratogenicity of an 
agent despite the recommendation by Cuomo, 
DeSaliva, Maselli, Santo, and Cagiano (1987). In 
those studies which have measured ultrasounds 
both increases and decreases in calling have been 
described. Rat pups were treated chronically with 
haloperidol, a dopamine antagonist, during the 
early postnatal period Days 2-16) which resulted 
in a reduction in the rate and frequency i their 
ultrasonic calls when isolated (Cagiano. Sales, 
Renna, Racagni, & Cuonto. 1986). Similarly, Adams 
(1982) recorded ultrasonic calls from Sprague—Daw-
ley rats treated prenatally with vitamin A 'aimi-
tate, a known behavioral teratogen. Pups xrosed 
at the highest dose levei 'EO,OOO flJ/kg) called at a 
significantly higher rate than controls. 
As part of our studies on behavioral teratoicgy 
we have reported earlier a marked effect of the 
treatment received by a pup's foster mother during 
gestation on aspects of its physical and behavioral 
development (Clayton, Sedowofia, Rankin, & Man-
ning, 1993). Since ultrasonic calling forms part of 
the complex intercommunication system between a 
mother and her litter, we have investigated the pat-
tern of ultrasonic emissions in treated and control 
mice in an attempt to elucidate some of the mech-
anisms which might be implicated. In this case we 
treated pregnant mice with aluminium. 
METHODS 
Treatment 
CBA/T6 virgin females between 10 and 12 weeks 
of age were mated with males from the same strain. 
Plugged females were individually housed in stan-
dard plastic cages (310 x 130 x 120 cm) lined with 
wood shavings. All mice were maintained in an air- 
0163.1047.93 MDO 
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cycle (lights on 2100 h) at a temperature of 22-
23°C. On Gestational Day 10 iGDIO) pregnant fe-
males were randomly assigned to one of two groups. 
The groups were coded such that the experimenter 
was blind to the allocation of treatment groups. 
Over GD10 to 13 inclusive the females of one group 
were administered aluminium sulfate intraperito-
neally Op) at a dose of 200 mg/kg body wt and the 
control group received the equivalent volume of sa-
line acidified to the same pH as the aluminium so-
lution (pH 4.1). Maternal weights were recorded on 
Days 10, 12, and 18 of gestation. 
Procedure 
Pregnant females were checked twice daily for 
pups. At birth, litter size was recorded and the sex 
of each pup determined. On Postnatal Day 1 Pdl), 
all pups born were weighed and each litter was 
culled to four pups, leaving two males and two fe-
males where possible. Each pup was toe-clipped for 
individual identification. The pups were cross-fos-
tered using a balanced, split-litter total cross-foster 
procedure (Sedowofia, Innes, Alleva, Manning, & 
Clayton, 1989) with other litters born within the 
same 12-h period. Briefly, each mother received two 
control and two treated pups from other litters. In 
this way none of the mothers reared any of their 
own pups. Thus, the pups could be classified into 
four treatment groups; control pups cross-fostered 
W- control mothers (Cc), control pups fostered to 
treated mothers (Ct), treated pups fostered to control 
mothers (Tc), and treated pups fostered to treated 
mothers (Tt). 
Ultrasonic Recording 
Ultrasonic emissions were recorded on 6 days (on 
PD3, 4, 5, 6, 9, and 12). These days were chosen on 
the basis of pilot studies and from previous work 
which typically showed that few calls are emitted 
at birth and that CBA pups have ceased calling by 
Days 12-13. 
The litter was removed from the home cage and 
placed in a crystalizing dish lined with nesting ma-
terial (dish 1), and kept at a temperature compa-
rable to that of the maternal nest (34-36°C) with 
a lamp (25 W). Each pup was then removed indi-
vidually from dish 1 and placed in a second dish 
(dish 2) which was cooler (24-26°C) and acted as a 
mild thermal stressor. Ultrasounds were recorded 
using a QMC Instruments Mini-2 Bat detector set 
at a frequency of 70-80 kHz (see Robinson & 
D'Udine, 1982) and mounted 10 cm above dish 2. 
minute was counted for 5 mm. Scoring was delayed 
for I min after placing the pup in dish 2 to allow 
any immediate response to handling to die down. 
The same type of nesting material as used for the 
maternal nest was placed in each dish to reduce 
sound emissions due to unusual tactile surnuh 
(Noirot & Pye, 1969; Okon, 1970b). 
Recording for 5 ruin was sufficient to even out 
short-term fluctuations in calling. It was not un-
common for pups to produce calls at a rate greater 
than 250/mm. In these instances our method of re-
cording may have underestimated the number of 
calls produced, although this would have been con-
stant across all treatment groups. The pup was re-
placed into dish 1 and the procedure was reeated 
for each pup in the litter. Individual pups were not 
returned to the home cage until all pups in the litter 
had been tested. The order in which litters and in-
dividual pups were recorded was randomized on 
each test day. 
Body weight was recorded every third day from 
Pd3 to weaning at Pd21. At the same time ?ups 
underwent the modified version of the Fox tests for 
sensorimotor coordination. (Fox, 1965) as renorted 
for an earlier study (Sedowofia et al., 1989). 
Maternal Retrieval 
The maternal retrieval test was similar to that 
employed by Noirot (1966). On completion of re-
cording of ultrasonic calling, the four pups were 
replaced together into the home cage at the opposite 
end from the maternal nest, waiting until the 
mother had moved into it. The time taken to return 
one of the pups to the nest was recorded to the 
nearest second. 
Data Analysis 
Maternal weight gain during gestation and pup 
birth weight were compared using Student's t test. 
Thereafter, body weights were analyzed using anal-
ysis of variance (ANOVA) with repeated measures; 
prenatal treatment, foster mother treatment, and 
pup sex were the independent factors and day was 
the repeated measure (Dixon, 1988). Because of var-
iability within the groups and the occurrence of zero 
scores, the ultrasonic data were analyzed using the 
Kruskal-Wallis one-way ANOVA which includes a 
multiple comparisons option (Dixon, 1988). The Fox 
test scores were analyzed by x2  tests (Ryan, Joiner, 
& Ryan, 1979). 
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nificantly different between the groups. 
Maternal Weights 
Prenatal exposure to ip aluminium sulfate during 
Gestation Days 10-13 had no effect on breeding 
performance. The mean gestation length for control 
mothers (n = 10) was 19.9 (±0.23) and 20 (0.37) 
days for those females exposed to aluminium (n = 
9). Pup mortality occurred in both treatment groups. 
Although control females were found to have a 
larger mean litter size (x = 6.0 0.71) compared 
to aluminium exposed females (x = 4.8 ± 0.8), this 
difference was not significant. There were no dif-
ferences in the amount of food or water consumed 
by control and treated females during pregnancy or 
the preweaning period. 
Weight gain during pregnancy was adversely af-
fected by exposure to aluminium, treated mothers 
gaining significantly less weight during Gestation 
Days 10-18 than control mothers (control: x = 8.69 
(±0.7) g; treated: z = 5.65 (±0.81) g, t(16) = 2.84, 
p < .02). However, maternal weights during lac-
tation up until weaning were largely unaffected by 
treatment. 
Pup Weights 
There was a highly significant difference between 
mean birth weights (control: n = 37, x = 1.35 ± 
0.02 g; treated- a = 25, x = 1.19 = 0.03 g, t(37) 
= 3.95, p = .0003), pups exposed to aluminium were 
12% lighter than controls. 
ANOVA revealed a highly significant effect of 
Prenatal (F(1, 33) = 32.34, p < .001) and foster 
mother treatment (F(1, 33) = 54.56, p < .001) on 
pup weight during the preweaning period. As can 
be seen from Fig. 1, Cc pups were found to be the 
heaviest group and Tt pups weighed the least, a 
difference of 20% by Pd21. The treatment groups 
ran parallel to their foster mother treatment; those 
pups fostered to control mothers weighed more than 
pups reared by mothers who had been exposed to 
aluminium. For example, by the time of weaning 
Ct pups weighed 11% less than their control coun-
terparts (CO and similarly Tt pups were 14% lighter 
than Tc pups. 
Fox Tests 
x2  analysis of the seven Fox tests used revealed 
a highly significant difference between the treat-
ment groups in forelimb grasping on Pd12 (X2  (3) = 
20.401, p < .001) with only two out of nine Tt pups 
having reached an adult response by this age and 
in screen climbing on Pd15 ()(2  (3)= 11.16, .05 > p 
Ultrasonic Calling 
Figure 2 summarizes the changes in the total 
number of ultrasounds emitted on each test day by 
the four treatment groups as a function of age. As 
expected calls were more frequent during the ear-
liest postnatal days reaching a peak which then 
steadily declined such that by Day 12 very little 
calling was evoked by the drop in temperature. It 
is not possible to say when tailing ceased completely 
as no further measurements were taken after 9d12. 
The most striking result is that, throughout the 
test period, the total number of calls emitted was 
dramatically reduced in those pups exposed to al-
uminium in utero. Kruskal—Wallis one-way AN-
OVA showed this difference to be especially pro-
nounced on Days 3 (H(3) = 12.79, p < .006) and 
4(H(3) = 20.95, p = .001). The rate of calling of Cc 
pups increased to a peak on Postnatal Day 4 (a 
median rate of 204.5 calls/mm) and then slowly 
declined to a median of less than 2 calls/min by 
Pd12. Ct and Tc pups produced their greatest num-
ber of calls on Day 5 (196.5 and 114.5 calls/mm, 
respectively) and 'Pt pups on Day 6 (128 calls/mm). 
Although control pups from both groups emitted 
more total calls than treated pups, Ct pups had a 
considerably lower initial rate of calling on Day 3. 
Their rate of output reached levels comparable to 
that of Cc pups only on Day .5. The decline in calling 
.with age was also more dramatic for this group. 
Thus, being raised by a treated mother dampened 
the rate at which these pups called. In summary, 
prenatal aluminium exposure resulted in a reduc-
tion in the rate of calling and shifted the timing of 
peak calling. 
Maternal Retrieval 
Although control mothers had a shorter latency 
to retrieve on Pd3 there was no effect of treatment 
on the time taken to first retrieval. As pups grew 
older both groups tended to reduce their latency to 
contact the pup. Maternal retrieval was not tested 
on Pd12 as pups were capable of homing to the nest 
before the mother could pick them up. 
DISCUSSION 
Some of the trends recorded in this experiment 
are in agreement with those previously reported 
(Clayton et al., 1993) where aluminium adminis-
tered to a pup's foster mother during gestation was 
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FIG. 1. CBA pup body weights of offspring whose mothers received intraperitoneal injections of either aluminum sulphate or aiine 
during gestation days 10 to 13. Weights were recorded every third day from birth to weaning. 
found to have a marked effect on pup body weights 
up to weaning. By contrast, our results show a direct 
effect on a pup's production of ultrasounds which is 
strongly reduced by exposure to aluminium in utero. 
It is not possible to determine with confidence 
whether this disparity in calls was due to effects of 
exposure to aluminium on the vocalization system 
per se or on its rate of maturation. It is unlikely to 
be a result of damaged vocal apparatus as pups from 
all groups appeared to call normally when they did 
so. However, treated pup calling did not reach a 
maximum until a day later than control pups. It 
would certainly seem possible that the mechanisms 
of sound production matured more rapidly in control 
pups. 
The results of the sensorimotor tests imply that 
pups exposed to aluminium prenatally were, in some 
respects, slower to mature than control pups. Sim-
ilar delays in neurobehavioral development follow-
ing exposure to Al have been reported previously 
(Bernu.zzi, Desor, & Lehr, 1986, 1989; Donald, Go-
lub, & Gershwin, 1989). This finding also gives some 
support to the idea that the differential profiles of 
calling for the treatment groups may have resulted  
from a delay in the maturation of the mechanisms 
responsible for ultrasonic vocalizations. 
However, other possible explanations must be 
considered. The differential calling profiles may be 
related to changes in the pups' detection of or re-
sponse to chilling. As mentioned previously several 
investigators have established a correlation be-
tween the emission of ultrasonic calls and the de-
velopment of homiothermy (Okon 1970a; Allin & 
Banks, 1971). The typical age profile for calling 
when exposed to cooling is one of few calls imme-
diately after birth during the period of poikilo-
thermy, followed by a greater intensity of calling 
during the first stages of development of thermo-
regulatory ability, and finally a decrease in the rate 
of calling as thermoregulation is achieved. This is 
the calling profile followed by our Cc pups, whereas 
treated pups did not exhibit these characteristic 
changes with age. Exposure to aluminium might 
lead to a prolongation of the early stage of poikil-
othermy. To eliminate this possibility would require 
investigations into the processes underlying tem-
perature regulation. 
Ultrasounds certainly function to elicit maternal 
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FIG. 2. The total number of CBA pup ultrasonic calls emitted in a 5-min test for each of the four reatment groups on ear-! i f 5 
test days. 
responses, particularly evoking searching by the 
mother and retrieval of lost pups back to the se-
curity of the nest. If pups exhibit weak or fewer 
calls this might have serious repercussions for sur-
vival of the litter. 
However, despite the altered level and pattern of 
calling in treated pups, our results do not reveal 
any change to the mother's responses. This is not 
surprising, for three reasons. First, although the 
procedure used to test maternal retrieval was that 
employed in many other studies, it may not be a 
good discriminator between treatment groups, as 
the distance over which the females had to travel 
was small. Second, some mothers were seen to be 
having difficulty seizing a pup as it was moving 
especially during the latter test days. This meant 
a lengthened time to retrieve, although the mother 
may have responded just as quickly. Finally, Beach 
and Jaynes (1956) have described a number of stim-
uli to which mother rats respond when retrieving 
their pups. For example, they showed that if the 
olfactory characteristics of a pup are altered (by 
covering it with perfume) the pup is still eventually 
retrieved, although control pups are retrieved pref-
erentially. Thus, even if aluminium affected one  
aspect of the pup's stimulus quality, other sen.ory 
modalities would remain to evoke a normal reaction-
In addition, as mothers were tested for retrieval 
with whole litters, the two control pups could :ro 
vide a normal ultrasound stimulus. It will be in-
teresting to investigate whether mothers retrieve 
control pups first in this situation. 
Since there was no difference in the amount of 
food or water ingested by control and treated moth-
ers, the body weight differences of their pups could 
not have resulted from undernourishment of the 
treated mothers which has been shown to result in 
less efficient retrieval of young and in a reduction 
in licking (Smart & Preece, 1973). 
Certainly alterations in maternal behavior are 
known to affect infant development and several 
drugs have been shown to disrupt elements of ma-
ternal behavior (Laviola, Sedowofla, Innes, Clayton, 
& Manning, 1990). Thus, any interruption to the 
pattern of maternal care might explain why Ct pups, 
who were found to emit a similar profile of calls 
although at a lower level compared to their Cc coun-
terparts, had body weights notably reduced from 
that of Cc pups. Similarly, Tc and 'ft pups had com-
parable profiles of calling but Tc pups were of 
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greater body weight. In the case 01 i't pups tne 
diminished number of calls may have affected the 
ability of the treated mother to provide adequate 
maternal responses even in the presence of calls 
from control pups. Tc pups had a similar reduced 
profile of calls to that of Tt pups, the difference being 
that these treated pups were raised by control moth-
ers. These mothers may have been more finely tuned 
to their pups such that even a dirmnution in the 
number of calls was not sufficient to alter maternal 
responsiveness. It will be necessary to investigate 
further the maternal behavior of mothers rearing 
control and aluminium-treated pups. 
Terkel, Damassa, and Sawyer (1979) claim that 
ultrasonic calling stimulates the release of prolactin 
from the mother's anterior pituitary (although 
Stern, Thomas, Rabii, & Barfield, 1984, do not con-
firm this). The primary stimulus for prolactin se-
cretion is probably suckling although several other 
features of the pup have been found to increase its 
release. If ultrasounds are indeed one such feature, 
then the increase in sound emissions by Cc pups 
could have the effect of augmenting the nourish-
ment available for them, which has obvious con-
sequences for growth. 
The exact mechanisms underlying the regulation 
of ultrasonic calling are not known. The develop-
ment of the vocalization system is undoubtedly com-
plex and probably involves several neurotransmit-
ter systems. However, Brudzynski and Bihari (1990) 
have suggested the involvement of the cholinergic 
system in their production. In a previous paper 
(Clayton et al., 1993) we reported a reduction in 
choline acetyltransferase activity in brains of mice 
exposed to aluminium in utero. That such treatment 
led to a reduction in calling is at least consistent 
with Brudzynski and Bihari's (1990) hypothesis. 
In summary, prenatal exposure to aluminium 
causes alterations to growth, ultrasound production, 
and sensorimotor development. Additional work is 
required to investigate the consequences of a low-
ered calling rate on the mother-infant interaction 
but the results we report here certainly suggest that 
ultrasound recording should be included in any bat-
tery of tests aimed at assessing possible behavioral 
teratogenicity. 
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APPENDIX D 
CHAPTER 4 
ANOVA table ofCBA maternal body weight following gestational exposure to aluminium sulphate 
(200mg/kg, Gd 10-13). 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 25730.25654 1 25730.25654 1181.45 0.0000 
TREAT 22.05225 1 22.05225 1.01 0.3438 
ERROR 174.22900 8 21.77863 
DAY 10.21275 3 3.40425 19.57 0.0004 
DT 5.56475 3 1.85492 10.66 0.0040 
ERROR 4.17500 24 0.17396 
ANOVA table of CBA pup body weights following prenatal exposure to aluminium sulphate (200mg/kg, 
GdlO-13). 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 5673.06940 1 5673.06940 7462.77 0.0000 
TREAT 23.36847 1 23.36847 30.74 0.0000 
FMAT 23.06733 1 23.06733 30.34 0.0000 
SEX 0.09565 1 0.09565 0.13 0.7254 
TF 0.83946 1 0.83946 1.10 0.3020 
IS 0.07811 1 0.07811 0.10 0.7508 
FS 2.04557 1 2.04557 2.69 0.1117 
TFS 2.15447 1 2.15447 2.83 0.1030 
ERROR 22.04530 29 076018 
DAY 1172.61478 6 195.43580 3076.22 0.0000 
DT 1.75672 6 0.29279 4.61 0.0032 
DF 3.38538 6 0.56423 8.88 0.0000 
DS 0.10724 6 0.01787 0.28 0.8623 
DTF 0.29221 6 0.04870 0.77 0.5305 
DTS 0.04774 6 0.00796 0.13 0.9590 
DFS 0.22432 6 0.03739 0.59 0.6451 
DTFS 0.22199 6 0.03700 0.58 0.6493 
ERROR 11.05443 174 0.06353 
C57BLI6J 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 15824.29810 1 15824.29810 9018.72 0.0000 
TREAT 4.23017 1 4.23017 2.41 0.1272 
FMAT 21.80863 1 21.80863 12.43 0.0010 
SEX 10.23070 1 10.23070 5.83 0.0197 
TF 0.42728 1 0.42728 0.24 0.6240 
TS 1.49818 1 1.49818 0.85 0.3602 
FS 0.41257 1 0.41257 0.24 0.6300 
TFS 0.32710 1 0.32710 0.19 0.6679 
ERROR 82.46647 47 1.75461 
262 
DAY 2384.07038 6 397.34506 3699.91 0.0000 DT 1.33152 6 0.22192 2.07 0.1308 DF 4.85441 6 0.80907 7.53 0.0008 DS 2.30723 6 0.38454 3.58 0.0304 DTF 0.29096 6 0.04849 0.45 0.6435 DTS 0.55542 6 0.09257 0.86 0.4282 DFS 0.88719 6 0.14786 1.38 0.2573 DTFS 0.07437 6 0.01239 0.12 0.8961 ERROR 30.28491 282 0.10739 
MALES 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 9251.42251 1 9251.42251 4953.35 0.0000 TREAT 0.38556 1 0.38556 0.21 0.6533 FMAT 9.01943 1 9.01943 4.83 0.0371 IF 0.83516 1 0.83516 0.45 0.5096 ERROR 48.56048 26 1.86771 
DAY 1403.71388 6 233.95231 2407.51 0.0000 DI 0.17700 6 0.02950 0.30 0.7502 DF 1.75381 6 0.29230 3.01 0.0551 DTF 0.12235 6 0.02039 0.21 0.9733 ERROR 15.15945 156 0.09718 
FEMALES 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 6827.26595 1 6827.26595 4228.53 0.0000 
TREAT 4.88919 1 4.88919 3.03 0.0965 FMAT 12.81907 1 12.81907 7.94 0.0103 
TF 0.00303 1 0.00303 0.00 0.965 8 
ERROR 33.90600 21 1.61457 
DAY 1021.19119 6 170.19853 1417.81 0.0000 DT 1.56967 6 0.26161 2.18 0.1279 
DF 3.78337 6 0.63056 5.25 0.0101 
DTF 0.23194 6 0.03866 0.32 0.7184 
ERROR 15.12546 126 0.12004 
Median (+ lower and upper mterquartile ranges) number of ultrasonic calls produced by CBA pups prenatally 
exposed to aluminium sulphate (200mg/kg, Gd 10-13). 
Day Cc Ct Tt Ic 
3 119.5 
( 	 41.7, 215.2) 553 ( 31.7, 	86.2) 11.0( 4.5, 	22.5) 40.0 
( 	 8.5, 	80.2) 4 204.5 (157.5, 276.5) 79.0 
( 47.2,153.5) 28.0( 12.0, 	48.5) 35.0 (26.5, 	92.0) 
5 194.0 (141.0, 325.5) 196.5 (134.0, 220.7) 116.0( 53.5, 221.5) 114.5 (17.2,247.2) 
6 205.0 (163.5, 273.5) 179.5 
( 665, 382.2) 128.0( 39.0 204.5) 78.0 ( 12.0, 195.7) 
9 169.0 
( 	 14.5, 248.7) 96.5 ( 55.0, 151.5) 64.0( 243, 288.0) 80.0 (19.7, 102.7) 
12 7.5 
( 	 0.0, 	40.2) 10.5 ( 	 0.8, 	23.8) 3.0 	( 1.5, 	10.5) 3.5 ( 	 2.0, 	7.3) 
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CS 7BLJ6J 
Day Cc 	 Ct Tt 	 Ic 
3 41.0( 	15.5, 	82.5) 	23.0 ( 	9.5, 	60.5) 36.0 ( 	 10.8, 64.3) 	78.0 (12.0, 188.0) 
4 16.0 ( 	8.3, 27.8) 30.0( 10.0, 93.7) 21.0 ( 	14.5. 	48.5) 11.0 ( 	 6.0. 	39.0) 6 22.5 ( 	9.5, 	71.0) 	17.5 ( 	 8.0, 	29.0) 53.0( 	143, 90.7) 	54.0 (10.0, 	77.0) 
8 76.5 ( 25.0, 109.8) 29.5 (20.0, 76.7) 30.5 
( 	 20.0, 	68.0) 75.0 ( 51.0, 124.0) 
Median (+ lower and upper interquartile ranges) latency (s) to first retrieval of a pup back to the nest by 
CBA mothers exposed to aluminium sulphate (200mg/kg, GdlO-13) or saline by i.p. injection. 
Day Control Treated 
3 24.0(18.5, 36.5) 54.0(29.0,1110) 
4 21.0 (18.0, 50.0) 32.0 
( 25.5, 42.5) 
5 19.0 (15.5, 	32.0) 29.0 
( 26.0, 34.5) 
6 40.0 (25.5, 42.0) 25.0 
( 21.5, 41.0) 
9 26.0 (17.0, 32.2) 17.0 (16.0, 	56.0) 
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Pregnant CBA and C57B1I6J females were exposed to aluminium sulphate at a dose of 
200mg/kg by intraperitoneal injection during gestation days 10-13 inclusive. The 
offspring were cross-fostered at birth, and maternal behavior was observed during the 
first 3 postpartum weeks. Aluminium caused a slight reduction in maternal weight gain 
during gestation. Only moderate changes in maternal behavior were observed. Al-
exposed CBA females spent less time nursing and were more involved in non pup-
directed behaviors. Conversely, C57 females showed enhanced nursing. Previously 
reported alterations to pup development are likely to have resulted from a direct effect of 
Al rather than any disruption to maternal behavior. 
GESTATIONAL ALUMINIUM AND MATERNAL BEHAVIOR 
ALUMINIUM GESTATION MATERNAL BEHAVIOR INBRED MICE 
267 
INTRODUCTION 
The maintenance of maternal care in rodents depends not only on hormonal 
influences (Rosenblatt and Siegel, 1983) but also on the efficiency of the bidirectional 
exchange of a number of sensory cues between the mother and her offspring, both 
playing an important active role (Smith and Sales, 1980). For example, ultrasonic 
vocalizations emitted by pups play an important communicative role in this relationship, 
specifically as directional cues (Noirot, 1972). Further, olfactory stimuli are important in 
pup recognition as evidenced from lesions of the noradrenergic projection to the 
olfactory bulbs in nulliparous BALB/c females before parturition which resulted in 
cannibalistic behavior (Dickinson and Keveme, 1988). 
More specifically, maternal behavior is sensitive to subtle stimulus changes 
which can alter this behavior and in turn may have longterm effects on the development 
of the offspring. It has been suggested that the enhancing effects of early handling 
procedures on pup development may be explained in terms of changes in MB. For 
example, several studies have described increased licking behavior by mothers 
following handling of young (Lee and Williams, 1974; Priestnall 1983). Certain 
characteristics of the litter have also been shown to modify maternal behavior (Alleva, et 
al., 1989). 
Recently, studies involving the investigation of the effects of administration 
of drugs or toxicants during pregnancy on offspring development, have examined the 
effect of such treatments on the expression and pattern of maternal behavior. Alcohol-
exposed CFW females were found to exhibit an increase in the frequency of exploratory 
behavior 1-day after birth (Ewart and Cutler, 1979). Interestingly, Hard and colleagues 
(1985) found that female Wistar rats, exposed in utero to ethanol (16% ethanol 
solution), took longer to retrieve their pups and built nests of a lower depth than 
controls. 
By contrast, enhancements of maternal behavior have also been reported. 
Outbred female mice exhibited an increased duration of time involved in nursing and an 
increased frequency and duration of social investigation of their young on Pdl following 
exposure to phenobarbitone (PhB) in their drinking water (120-190mg/kg daily) 
throughout gestation and lactation (Chapman and Cutler, 1983). At Pd21 PhB-treated 
females were still actively engaged in nursing behavior (a mean duration of 61s for 
treated females compared to a mean of 0.4s for the control group). Futhermore, Laviola 
and colleagues (1990) have demonstrated strain-specific differences in the influence of 
prenatal exposure to PhB (60mg/kg by i.p. injections during days 10-16 of gestation) on 
maternal behaviour. CBA treated females continued to nurse their offspring for longer 
than controls whilst C57 PhB-exposed dam's exhibited less nursing behavior. 
These studies imply that disturbance to maternal care or to the delicate 
mother-pup relationship may explain differential patterns of behavior in the offspring 
rather than direct effects of prenatal exposure to a toxicant. 
Aluminium (Al) is a ubiquitous element used extensively in our modern 
environment. In recent years, it has been demonstrated that Al is involved in a number 
of human pathological conditions. Unlike other heavy metals e.g lead and 
methylmercury, the development toxicity of Al has been little considered. In previous 
studies (Clayton, et al., 1992; Rankin and Manning, 1993), we have reported several 
developmental effects of prenatal exposure to Al including body weight changes, 
transient delays in several tests for sensory-motor development and alterations to 
ultrasonic calling. Moreover, the treatment received by a pup's foster mother was found 
to influence several of these measures. Alterations to the quantity or quality of maternal 
behavior following exposure to Al during pregnancy was suggested as a possible 
explanation for the maternal treatment effect on pup weight. For this reason, we have 
undertaken to characterise in two inbred strains of mice (CBA and C57BL/61), which 
are known to differ in several behavioral and neurochemical parameters (Sedowofla, et 
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al., 1989), any changes to the pattern of maternal behavior of control and Al-treated 
mothers. A comprehensive array of behaviors was considered to enable assessment of 
the effects of Al exposure not only on the overall pattern of maternal behavior but also 
on individual components of it. 
Only one previous study in rats has included simultaneous recording of 
maternal behavior after prenatal exposure to Al (Bernuzzi, et al., 1986). These authors 
reported no significant differences between treatment groups in nest-building, retrieval 
of pups to the nest or time spent with the young following exposure to A1C13 (160 or 
200mg Al/kg body weight/day) in the dam's diet from day 8 to 20 of gestation. 
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METHODS 
Animals and Treatment 
All mice were maintained in an air-conditioned room at 21±1 0 C and 
60±10% relative humidity, with a 12 hour light cycle. Pellet food (enriched standard diet 
purchased from Picciom 1-2500 Brescia, Italy) and tap water were freely available. 
Females were mated with males from the same strain. 
Pregnant females were randomly divided into control and treated groups. 
Treated females were exposed to Al2(SO4)3 at a dose of 200mg/kg body weight during 
gestation days 10 to 13. The dose range and the schedule of exposure were selected on 
the basis of previous literature and experiments (Ondreika, et al., 1966; Clayton, et al., 
1992). Maternal weights were recored during gestation and the amount of food and 
water ingested were determined during this period. 
Maternal Behavior 
On the day of birth (postnatal day 0, PdO), all pups were weighed and each 
Utter was culled to four. Pups were intrastrain cross-fostered using a balanced split-litter 
total cross-foster procedure (Chariotti, et al., 1987; Sedowofia, et al., 1989), with other 
litters born within the same 12 hour period. Each mother received two control and two 
treated pups from other litters and none of which were her own. Following cross-
fostering on Pdl, each mother was housed in a clear plastic cage, to facilitate maternal 
behavior observation. The cage contained shavings and ig of nesting material consisting 
of strips of paper. The cages were not cleaned until maternal behavior observations were 
completed. The procedure employed for maternal behavior observation was based on 
that described by Laviola and colleagues (1990). 10 minute recording sessions occurred 
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twice daily (during the initial and final hours of the dark phase) under red light and were 
randomised so that the treatment groups were equally represented at different times. 
Dams were placed in the experimental room 30 minutes prior to commencement of 
recording and remained there until the end of the day. The cage lids were not replaced 
by a perspex one for two reasons. Firstly, pilot studies showed that the changeover 
disturbed the mother and increased exploration of the new cage lid. Secondly, leaving 
the standard lid, made it possible to include the recording of eating and drinking 
behaviour. Although these behaviors are clearly not part of the maternal behavior 
repertoire, their recording may be important in assessing any influence of Al exposure 
on milk production. Also recording was continued to include a later age, day 18 
postpartum, to investigate whether exposure to Al during gestation prolonged the 
expression of any behaviors. 
Observations were made on postnatal days 2, 3, 5, 7, 10, 14 and 18 but not 
on Pdl due to possible neophobic reactions to the new cage and cross-fostering. These 
time periods are thought to correspond with major developmental and neurochemical 
changes within the infant mouse (Sedowofia, et al., 1989). Behavior was recorded on a 
keyboard linked to a computer which recorded the frequency and duration of each key 
press as mutually exclusive and independent events (Deag, 1983a). The information was 
stored on computer discs for subsequent analysis (Deag, 1983b). The following elements 
of maternal behavior were recorded: 
Pup-directed behaviors 
Nursing - The mother adopts the classic lactation position, arching her body over the 
pups. Nursing was recorded even when the mother was seen in the nest grooming 
herself but having at least one pup attached to a nipple, a condition which was common 
during the later ages. 
272 
Licking - Scored when the mother is solely actively engaged in licking any part of a 
pup's body. 
Nest-building - This is recorded when the mother is in the nest and pulling shavings into 
it, is carrying material to the nest or is using her forepaws to push material towards it. 
Retrieving - The mother returns a pup which had wandered from the nest site. In a 
laboratory situation such as this, retrieval of a pup is rarely seen. 
If the mother was nursing but also engaged in one of the other pup-directed activities, 
the former was scored to record any actual nourishment received by the pups in 
preference to other maternal activities occuring at the same time, in order to estimate if 
the pups were being affected by postnatal events. 
Non pup-directed activities 
Active - The mother is out of the nest and is moving around the cage. 
Rearing - The mother is on her hind legs leaning against the cage walls. 
Grooming - The mother is licking any part of her own body. 
Still - The mother is lying still with no pups attached either beside the nest or at the other 
end of the cage. 
273 
Eating and Drinking - The mother is eating from the food hopper or drinking from the 
water bottle. 
At the end of the 10 minutes recording period the quality of the nest was scored on a 
scale of 0 to 4; a score of 0 was given when there was no discernible nest and the pups 
were scattered, and a nest was judged to have a score of 4 when it was well constructed 
and the pups were not obviously visible. 
STATISTICAL ANALYSIS 
Each of the control and treated maternal behaviors were compared using 
Mann-Whitney U-tests on each test day. Maternal weight, and food and water intake 
were analysed by Student's r-tests. The nest scores were analysed using analysis of 
variance (Dixon, 1988). 
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RESULTS 
Level of aluminium exposure 
Pregnant females, with an average weight of 25g, injected i.p with 
A.12(SO4)3 received a total of 1.64mg over the four days of treatment. 
Maternal weight 
Within the CBA strain there were 14 control and 15 treated pregnant females 
and 9 control and 12 treated females in the C57 strain. The greater number of CBA 
females resulted from the experiment being set up twice. For both strains weight gain 
during the treatment period (GdlO to 13) was slight but increased greatly after its 
termination. Control and treated females gained weight at a comparable rate in both 
strains, although CBA control females weighed about 5% more than treated females by 
day 18 of gestation. 
As with prenatal weights, the weights recorded for control and treated dams 
from day 3 postpartum to weaning were not significantly different either between 
treatment groups or strains. 
Food and water intake 
There were no differences in the amount of food and water ingested by 
control and treated CBA females during gestation days 10-18. Food intake was similar 
for control and treated C57 females, however water consumption was slighity reduced 




For the purposes of analysis, maternal behavior scores for the two daily 
sessions were combined in the absence of any reliable differences between the two test 
sessions. Figures 5.1 and 5.3 summarize the most important differences in maternal 
activities for control and treated mothers over the 7 test days for CBA (7 control and 6 
treated) and C57 (6 control and 8 treated) females. The graphs represent the mean 
duration and frequency of bouts of the pup-directed maternal behaviors (nursing, 
licking) and the non pup-directed activities (combined eating and drinking). Although 
individual comparisons of each behavior between treatment groups were analysed using 
nonparametric tests, the means are presented rather than the medians due to the frequent 
occurrence of zero scores. Pup retrieval was not observed on any test day. 
In accordance with the Laviola et al., (1990) study and others (Ewart and 
Cutler, .1979; Chapman and Cutler, 1983) maternal care was, in general, more 
pronounced during the first few days after birth in both treatment groups and for both 
strains, and subsequently declined as the pups matured, being replaced by non pup-
directed activities. Although there were few significant differences between control and 
treated mothers for any of the behaviors measured, the graphs reveal clear and consistent 
trends which are described below. 
Nursing - The frequency of bouts of nursing was similar for control and treated CBA 
females during the test period. However, control CBA dam's spent an increased amount 
of time involved in nursing their offspring especially during the latter test days. The 
duration of this behavior during these days was less than during the initial postpartum 
days. 
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From days 3 to 10 postpartum Al-exposed C57 mothers showed an increased 
number of bouts of nursing which were of longer duration than control mothers but only 
reached marginal significance on Pd5. 
FIGURE 1 HERE 
Licking - Low levels of licking behavior were recorded for both control and treated 
mothers in both strains throughout the test period. On PdlO and 14 CBA treated dam's 
exhibited an increased number of bouts of licking of longer duration than control CBA 
females which were significantly different on Pd14 (frequency U=56.0 p<0.03; duration 
U=56.0 p<0.03). 
The frequency and duration of licking behavior on all test days except Pd18 
were slightly greater for treated C57 mothers than controls. For both control and treated 
mothers licking behavior increased as a function of age and peaked on Pd 10, although 
this difference was not significant. 
FIGURE 2 HERE 
Nest-building - Very low levels of this behavior were exhibited by either control or 
treated females from either strain. 
As described earlier, non pup-directed behaviors were rare during the first postnatal 
week but became more predominant thereafter. 
Active - The frequency and duration of bouts of active behavior increased from Pd7 
onwards for both control and Al-exposed CBA females. On Pd14 treated CBA females 
showed an increased number of these bouts which were of longer duration but did not 
reach significance. 
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C57 mothers did not show such a clear pattern of active behavior, although 
the frequency and duration of this behavior was greater from PdlO onwards. As with 
CBA Al-exposed females, treated C57 females showed a trend towards an increase in 
the number and duration of bouts of active behavior compared to controls, although this 
was not significant. 
Still - Mothers of both strains and both groups showed an increased frequency and 
duration of bouts of still behavior during the second postnatal week. Control CBA 
females tended towards a greater amount of this behavior during Pd7, 10 and 14 
although this difference was not significant. 
The frequency of still behavior was similar for C57 control and treated 
mothers, although control C57 females tended towards spending more time involved in 
this behavior. 
Groom - The frequency and duration of bouts of grooming behavior increased as a 
function of age for CBA control mothers. However, Al-exposed CBA females showed a 
significant increase in the frequency (U=42.0 p<0.03) and duration (U=39.5 p<0.02) of 
grooming behavior during Pd5. 
The frequency and duration of grooming behavior was similar throughout the 
test period for control and treated C57 females except on Pd5 when control C57 mothers 
spent more time involved in grooming (U=133.0 p< 0.04). 
Rear - The frequency and duration of rearing behavior increased from Pd3 onwards for 
CBA mothers and both control and treated groups showed similar levels of this 
behavior. However, on Pd14 Al-exposed CBA mothers showed a significantly greater 
number of bouts of rearing (U=43.0 p<0.03) and of longer duration (U=41.0 p<0.02) 
than controls. 
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The frequency of rearing for both C57 control and treated groups declined 
between Pd2 to 7 and then increased. Treated C57 females showed a greater number of 
bouts of rearing which were of longer duration than control mothers but did not reach 
significance. 
Eating + Drinking - Control and treated CBA mothers showed similar frequency and 
duration of bouts of eating and drinking which increased slightly from Pd3 to 18. 
However, on PdlO treated CBA females exhibited an increased frequency of bouts of 
eating and drinking which were of longer duration, but this difference was only 
marginally significant. 
The frequency of food and water ingestion increased from Pd2 to 7 and then 
declined for C57 control females but steadily increased from Pd5 for Al-treated C57 
mothers. Control C57 females ingested more food and water during Pd5-10 than treated 
females, although this difference did not reach significance. 
FIGURE 3 HERE 
Nest quality score 
The total score of nest quality over the 7 test days showed that both control 
and treated CBA and C57 mothers built nests to a similar standard (CBA control 
x=39.7(±1.3), treated x=40.5(±1.4); C57 control x=41.8(±1.0), treated x=40.3(j1.1)). 
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DISCUSSION 
The results of these observations, which examined the effects of exposure to 
Al during a limited period of gestation on a number of maternal activities, revealed only 
slight differences between control and Al-treated mothers and then only on certain days. 
The pattern of some components of maternal behavior depended both on prior treatment 
and on the strain of the mother whilst others were only treatment dependent. Al-exposed 
CBA mothers spent less time involved in nursing their offspring whilst C57 treated 
dams showed enhanced nursing behavior compared to controls. However in the case of 
licking, the Al-treated mothers from both strains spent more time involved in this 
behavior. The low level of licking behavior may have resulted from the preferential 
recording of nursing behavior if both behaviors occurred simultaneously. CBA treated 
mothers tended towards increased involvement in non pup-directed activities. 
Hence, only slight differences in certain elements of maternal behavior were 
found which are unlikely to reflect alterations in the ability of the mother to respond 
maternally towards her young. Exposure to Al did not affect the mechanisms responsible 
for the expression and organisation of maternal behavior, which is in accordance with 
Bernuzzi, et al., (1986). Presumably the level of pup stimulation was equal for control 
and treated dams, as each litter consisted of two control and two Al-treated pups. There 
is no evidence to suggest a decrease in the ability of the pups to elicit adequate maternal 
responses. 
The impairment in weight gain by CBA pups fostered to treated mothers 
described in Clayton, et al., (1992), can not be explained by deficits in availability of 
nourishment, as treated CBA mothers showed similar levels of nursing, eating and 
drinking behavior as controls. However, although mothers were seen in the nursing 
position, lying with an arched back over the pups, the possiblity exists that the pups 
were not always actively involved in suckling, or that the milk is not of the same quality. 
There was only a slight difference in the amount of food and water ingested 
by control and treated CBA and C57 mothers during gestation. Thus the body weight 
differences did not result from undernourishment of the treated mothers which has been 
shown to result in less efficient retrieval of young and in a reduction in licking (Smart 
and Preece, 1973). 
Despite the lack of significant effects of exposure to Al during gestation on 
maternal behavior, Al had toxic effects on other maternal characteristics. In both this 
experiment and the one described in Clayton et al., (1992), pregnant CBA females 
exposed to Al via i.p. injection gained less weight during gestation than that of control 
females, although this difference was not significant here. However, maternal weights 
during lactation did not differ between control and treated mothers, suggesting that the 
influence of any decrease in body weight which occurred prenatally was overcome. 
The unlikely contribution of differences in maternal care points to a direct 
effect of Al on the physiology of the mother. Exposure to Al during pregnancy has been 
shown to reduce milk consumption of rabbit offspring in a dose-dependent manner 
(Yokel, 1984; Yokel, 1985). This is the case for both treated and control pups suckling 
from Al-exposed lactating does. Thus, the maternal treatment effect is not likely to be 
mediated via changes in the ability of the Al-exposed mothers to care for their young but 
effects of Al on milk production may be of greater relevance. Moreover, the nutritional 
value of the milk produced by Al-exposed mothers may be inferior to that produced by 
control mothers. 
Finally, Al may exert its effects directly on the pup. A decrease in milk yield 
may be accompanied by a decline in attempts made by the offspring to suckle from 
treated mothers. As milk output and Al content were not assessed during this 
experiment these possibilities remain speculative. 
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Fig. 3: Effect of gestational exposure to aluminium sulphate (200mg/kg, 
GdlO-13) on the frequency and duration of bouts of eating and drinking 
for (a) CBA and (b) C57BL/6J dams, 
APPENDIX F 
CHAPTER 5 
ANOVA table of CBA pup activity on Id 15 and 18 following exposure to aluminium sulphate (200mg/kg, GdlO-13). 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 163358.23171 1 163358.23171 442.65 0.0000 TREAT 1170.73171 1 1170.73171 3.17 0.0909 FMAT 52.24573 1 52.24573 0.14 0.7109 SEX 
TF 
545.33415 1 545.33415 1.48 0.2390 
TS 
8.70915 1 8.70915 0.02 0.8795 
FS 
49.20000 1 49.20000 0.13 0.7190 
TFS 






159.19207 0.43 0.5 192 
369.04211 
DAY 418.54167 1 418.54167 2.42 0.1364 DT 22.80996 1 22.80996 0.13 0.7206 DF 
DS 
123.02520 1 123.02520 0.71 0.4096 
DTF 
8.37581 1 8.37581 0.05 0.8282 
DTS 
1120.54959 1 1120.54959 6.47 0.0198 
DFS 
180.74167 1 180.74167 1.04 0.3196 
DTFS 






9.83740 0.06 0.8141 
173.05965 
C57BL16J FEMALES 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 196692.09069 1 196692.09069 418.88 0.0000 TREAT 46.69563 1 46.69563 0.10 0.7539 FMAT 42.27304 1 42.27304 0.09 0.7655 SEX 177.23680 1 177.23680 0.38 0.5419 TF 10.56909 1 10.56909 0.02 0.8814 TS 2645.21237 1 2645.21237 5.63 0.0218 FS 315.97749 1 315.97749 0.67 0.4162 TFS 149.63409 1 149.63409 0.32 0.5751 ERROR 22069.40813 47 469.56188 
DAY 16419.61321 1 16419.61321 50.58 0.0000 DT 31.26372 1 31.26372 0.10 0.7577 DF 278.26372 1 278.66254 0.86 0.3589 DS 193.32081 1 193.32081 0.60 0.4442 DTF 167.43348 1 167.43348 0.52 0.4762 DTS 2170.23695 1 2170.23695 6.69 0.0129 DFS 535.23289 1 535.23289 1.65 0.2054 DTFS 51.89452 1 51.89452 0.16 0.6911 ERROR 15257.16131 47 324.62045 
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ANOVA table showing the effects of a scopolamine challenge on CBA pup activity at weaning. The sex 
variable was not included in this analysis as some of the sample sizes would have been one. 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 419469.08741 1 419469.08741 507.19 0.0000 
TREAT 0.15306 1 0.15306 0.44 0.5112 
FMAT 2174.45984 1 2174.45984 2.63 0.1154 
CHALL 53684.51265 1 53684.51265 64.91 0.0000 
TF 325.82294 1 325.82294 0.39 0.5350 
TC 4289.61712 1 4289.61712 5.19 0.0301 
FC 1311.10761 1 1311.10761 1.59 0.2177 
TFC 394.85595 1 394.85595 0.48 0.4949 
ERROR 24811.43667 1 827.04789 
BK 33170.16097 4 8292.54024 23.33 0.0000 
BT 1316.31825 4 329.07956 0.93 0.4443 
BF 932.22155 4 233.05539 0.66 0.6083 
BC 4689.25223 4 1172.31306 3.30 0.0168 
BTF 2367.55165 4 591.88791 1.67 0.1694 
BTC 821.69534 4 205.42383 0.58 0.6614 
BFC 1466.23010 4 366.55752 1.03 0.3901 
BTFC 1454.24291 4 363.56073 1.02 0.3942 
ERROR 42651.18000 120 355.42650 
C5 7B1J6J 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 94515957818 1 945159.57818 727.99 0.0000 
TREAT 3.34586 1 3.34586 0.00 0.9598 
FMAT 879.83520 1 879.83520 0.68 0.4154 
SEX 234.80893 1 234.80893 0.18 0.6730 
CHALL 22149.17818 1 22149.17818 17.06 0.0002 
TF 1617.23924 1 1617.23924 1.25 0.2712 
TS 11610.80691 1 11610.80691 8.94 0.0048 
FS 1257.25091 1 1257.25091 0.97 0.3312 
TC 17.98828 1 17.98828 0.01 0.9069 
FC 1079.21028 1 1079.21028 0.83 0.3675 
Sc 262.26213 1 262.26213 0.20 0.6556 
TFS 808.21769 1 808.21769 0.62 0.4349 
TFC 407.69109 1 470.69109 0.36 0.5506 
TSC 2113.89648 1 2113.89648 1.63 0.2095 
FSC 19.43722 1 19.43722 0.01 0.9032 
TFSC 4510.01253 1 4510.01253 3.47 0.0699 
ERROR 50634.57333 39 1298.32239 
BK 44971.67962 4 11242.91990 39.23 0.0000 
BT 732.69309 4 183.17327 0.64 0.5954 
BF 1800.28456 4 450.07114 1.57 0.1990 
BS 11 16.40061 4 279.10015 0.97 0.4092 
BC 7298.55773 4 1824.63943 6.37 0.0004 
BTF 129.01744 4 32.25436 0.11 0.9556 
BTS 3231.69780 4 807.92445 2.82 0.0405 
BFS 1107.77232 4 276.94308 0.97 0.4128 
BTC 460.90813 4 115.22703 0.40 0.7571 
99 
BFC 3044.43585 4 761.10896 2.66 0.0500 
BSC 1494.48725 4 373.62181 1.30 0.2762 
BTFS 713.65403 4 178.41351 0.62 0.6060 
BTFC 1060.68568 4 265.17142 0.93 0.4329 
BTSC 1287.20756 4 321.80189 1.12 0.3434 
BFSC 1652.46817 4 413.11704 1.44 0.2334 
BTFSC 384.923 16 4 96.23079 0.34 0.8048 
ERROR 44706.06000 156 286.57731 
MALES 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 515024.79093 1 515024.79093 394.10 0.0000 
TREAT 6311.22427 1 6311.22427 4.83 0.0388 
FMAT 2385.32730 1 2385.32730 1.83 0.1904 
CHALL 15317.86972 1 15317.86972 11.72 0.0024 
TF 78.13336 1 78.13336 0.06 0.8091 
TC 979.80912 1 979.80912 0.75 0.3959 
FC 780.92730 1 780.92730 0.60 0.4477 
TFC 4440.76063 22 4440.76063 3.40 0.0788 
ERROR 
BK 31502.03470 4 7875.50867 27.50 0.0000 
ff1' 3359.30591 4 839.82648 2.93 0.0396 
BF 1978.87712 4 494.71928 1.73 0.1697 
BC 6894.72359 4 1723.68090 6.02 0.0011 
BTF 522.69985 4 130.67496 0.46 0.7146 
BTC 1341.28672 4 335.32168 1.17 0.3277 
BFC 4096.28722 4 1024.07181 3.58 0.0183 
BTFC 54233520 4 135.58380 0.47 0.7027 
ERROR 25205.26000 88 286.42341 
FEMALES 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 438835.11566 1 438835.11566 340.90 0.0000 
TREAT 5403.75808 1 5403.75808 4.20 0.0562 
FMAT 15.11566 1 15.11566 0.01 0.9150 
CHALL 7916.00051 1 7916.00051 6.15 0.0239 
TF 2120.40455 1 2120.40455 1.65 0.2166 
TC 1134.84899 1 1134.84899 0.88 0.3609 
FC 364.04091 1 364.04091 0.28 0.6018 
TFC 930.02475 1 930.02475 0.72 0.4071 
ERROR 21883.95000 17 1287.29118 
BK 16277.64444 4 4069.41111 14.19 0.0000 
BT 88050707 4 220.12677 0.77 0.5116 
BF 1034.14949 4 258.53737 0.90 0.4430 
BC 2397.96162 4 599.49040 2.09 0.1167 
BTF 340.24444 4 85.06111 0.30 0.8175 
BTC 500.27474 4 125.06869 0.44 0.7181 
BFC 950.18384 4 237.54596 0.83 0.4794 
BTFC 867.17980 4 216.79495 0.76 0.5180 
ERROR 19500.80000 68 286.77647 
APPENDIX 0 
CHAPTER 6 
ANOVA table ofC57B!J6J pup body weights following prenatal exposure to oral aluminium sulphate 
(750mgfL, GdlO-16). 
SOURCE 	SUM OF 	DEGREES 	MEAN 	 F VALUE 	TAIL SQUARES OF 	- SQUARES PROB. 
FREEDOM 
MEAN 12169.18231 1 12169.18231 4903.24 0.0000 TREAT 0.55307 1 0.55307 0.22 0.6397 FMAT 14.10039 1 14.10039 5.68 0.0225 SEX 
TF 
0.83423 1 0.83423 0.34 0.5657 
TS 
0.19022 1 0.19022 0.08 0.7835 
FS 
0.50868 1 0.50868 0.20 0.6535 
TFS 






0.02248 0.01 0.9247 
2.48186 
DAY 2036.30605 6 339.38434 2410.53 0.0000 DT 0.09402 6 0.01567 0.11 0.8609 DF 1.51312 6 0.25219 1.79 0.1805 DS 1.18039 6 0.19673 1.40 0.2539 DTF 0.32886 6 0.05481 0.39 0.6423 DTS 0.72906 6 0.12151 0.86 0.4096 DFS 0.74254 6 0.12376 0.88 0.4037 DTFS 0.25897 6 0.04316 0.31 0.6981 ERROR 30.41115 216 0.14079 
C57BL16J I 250mg IL 
SOURCE SUM OF DEGREES MEAN F VALUE TAIL 
SQUARES OF SQUARES PROB. 
FREEDOM 
MEAN 9649.87736 1 9649.87736 4353.66 0.0000 TREAT 0.00257 1 0.00257 0.00 0.9730 FMAT 21.51843 1 21.51843 9.71 0.0038 SEX 0.00990 1 0.00990 0.00 0.9471 TF 0.00704 1 0.00704 0.00 0.9554 TS 2.56079 1 2.56079 1.16 0.2902 FS 0.25568 1 0.25568 0.12 0.7363 TFS 1.41025 1 1.41025 0.64 0.4308 ERROR 73.14448 33 2.21650 
DAY 1799.44635 6 299.90773 1752.76 0.0000 DT 0.49208 6 0.08201 0.48 0.6717 DF 1.05527 6 0.17588 1.03 0.3773 DS 0.28553 6 0.04759 0.28. 0.8142 DTF 0.72122 6 0.12020 0.70 0.5344 DTS 0.73541 6 0.12257 0.72 0.5268 DFS 0.13918 6 0.02320 0.14 0.9194 DTFS 0.37749 6 0.06292 0.37 0.7490 ERROR 33.87892 198 0.17111 
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ANOVA table of C57BLJ6J adult female body weights following prenatal exposure to oral aluminium 
sulphate (750mgIL, GdlO-16). 




1 99826.39858 8705.07 	0.0000 
















12 13 1.47950 469.37 	0.0000 2.56395 
WF 	 8.62631 
12 
12 
0.21366 0.76 0.5738 




1.08 0.3810 ERROR 	43.69869 156 0.28012 
Median (+ lower and upper mterquartile ranges) number of ultrasonic calls produced following 
oral aluminium sulphate. exposure to 
CBA 1000mg/L 
Day 	 Cc Ct Tt Tc 
3 	61.0 (41.5, 203.5) 59.0 	15.0,217.0) 24.0(17.0, 103.0) 47.5(12.2, 100.2) 4 110.0(35.7, 198.7) 143.0(22.0,239.0) 70.0(17.0, 151.0) 91.0(31.0, 134.0) 5 	250.5 (123.2,277.2) 55.0 (215, 219.0) 66.0(23.0, 166.0) 54.5 (31.2, 151.0) 6 114.5 (66.0, 159.2) 62.0 (27.0, 180.0) 67.0( 	14.0, 97.0) 69.0 (50.0, 166.2) 9 	49.0 
( 9.2, 129.7) 46.0(22.5, 132.0) 27.0( 	4.0, 64.0) 25.5 (11.5, 	49.5) 12 8.5 
( 6.2, 116.7) 23.0 
( 	 8.5, 111.5) 11.0( 	4.0, 	74.0) 33.0(11.7, 	76.5) 
Cs 7R1i61 
Day 	 Cc Ct Tt Ic 
3 	34.5 (10.5, 91.7) 7.0( 	3.5, 35.0) 21.0( 	6.0, 	33.0) 14.0( 	3.0, 23.0) 4 21.5 (10.8, 35.0) 13.0( 	5.0, 	18.5) 8.0( 	3.5, 53.5) 11-0( 	5.0, 	16.5) 5 	9.0( 	5.3, 22.0) 5.0 ( 	3.5, 	13.0) 10.0( 	5.5, 215) 9.0( 4.0, 	115) 6 5.5( 	3.0,30.0) 
9 
14.0( 	7.5, 21.0) 6.0( 	3.5, 	19.0) 11.0( 	3.5, 	15.0) 
1.5( 	1.0, 	4.8) 15.0( 6.0, 33.0) 4.0( 	3.0, 	13.5) 3.0 ( 	 2.0, 	3.5) 12 	1.0( 	0.8, 	4.0) 1.0( 	0.5, 21.0) 2.0( 	1.0, 	4.0) 1.0( 	0.5, 	3.0) 
CBA I250mg/L 
Day 	 Cc Ct Tt Tc 
3 	235 
( 	
6.0, 	88.8) 43.0 (11.0, 69.0) 26.0 (14.5, 	61.0) 12.0( 	0.0, 55.3) 4 125.0 
( 67.3, 163.3) 119.0 
( 89.0, 254.0) 96.5 (62.3, 181.3) 72.0 ( 19.0,131.2) 5 	117.0 
( 25.5, 250.8) 117.0 ( 32.0, 223.0) 97.0 ( 48.5, 1975) 46.0 (11.5, 116.7) 6 120.0 
( 
63.3, 255.7) 101.0 
( 32.0, 223.0) 755 (54.5, 139.5) 92.0 (56.7, 174.3) 9 	74.0 
( 54.0, 157.8) 46.0 (17.0, 126.0) 50.0 
( 31.8, 	96.2) 665 (475, 	99.2) 12 50.5 (24.2, 	75.8) 31.0 
( 	 6.0, 119.0) 17.0 ( 	 0.0, 	58.5) 48.5 (21.5, 123.5) 
CS 7BLI6J 
Day 	 Cc Ct Tt Tc 
3 	6.0 
( 	 2.0, 	15.5) 8.0 ( 0.0, 	25.3) 5.0 ( 	 2.3, 	13.8) 75 










8.5( 	5.5, 17.8) 12.0( 	6.3, 20.8) 14.5 (10.5, 	27.5) 
9 0.0( 0.0, 1.0) 
8.0( 4.5, 
0.0( 	0.0, 
22.3) 	5.5(. 	0.8, 
0.0) 0.5( 	0.0, 
1.3) 	14.5 ( 7.0, 	37.0) 






ANOVA of pup activity at weaning following prenatal exposure to oral aluminium sulphate. 
CBA l000mg/L 










336.80048 1.25 0.2728 
SEX 31.32964 1 
1501.98857 5.58 0.0253 






















144.93 137 4 36.23284 0.67 0.5979 
MF 






44.68284 0.83 0.4991 
















91.14519 1.70 0.1624 















0.01259 0.00 0.9937 












836.79316 1 836.79316 4.21 0.0441 
TFS 

















36.08067 0.49 0.7327 





















0.5660 ERROR 19718.35485 268 73.57595 
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EDGEON DURATJO!V 
Day 	 Cc Ct Tt Ic 
15 	0-0( 	0.0, 	1.7) 
18 14.8( 	8.9. 17.7) 
	
5.2 (0.5, 	21.7) 
22.8 




( 	 0.8, 12.6) 
( 9.0, 28.6) 20.3 (15.8, 27.6) 
FREQUENCY 
Day 	 Cc Ct Tt Ic 
15 	0.0 	
( 	 0.0, 	1.3) 
18 14.0( 	9.0. 	16.0) 




4.0 	(1.0, 8.5) 4.5 
( 	 0.8, 	10.5) 
15.5 (8.3, 19.3) 16.0 (11.0, 	20.5) 
RIGHTING DURATION 
Day 	 Cc Ct It Tc 
3 	41.1 (19.4, 	62.2) 
6 2.4 
( 0.0, 	41.3) 
16.7 (0.0, 	41.6) 
0.0 (0.0, 	0.0) 
4.3 (0.0, 23.9) 0.0 (0.0. 	43.2) 
0-0(0-0, 10.7) 0.0 (0.0. 	8.3) 
ACTIVITY 
SOURCE 	SUM OF DEGREES MEAN F VALUE 	TAIL SQUARES OF SQUARES PROB. FREEDOM 
MEAN 	215631.39358 
TREAT 
















3 63619.72392 125.99 0.0000 















ANOVA table of the effects of a scopolamine challenge on the number of trials required by 
males to enter all 8 	in C57BLJ6J arms 	a radial maze. 
Foster mother treatment was not taken into consideration. 
NUMBER OF TRAILS 





3957.02703 384.52 0.0000 










0.9243 113.20000 11 10.29091 




4.11171 1.09 0.3429 







ERROR 	 82.93333 
2 21.32252 5.66 
0.4334 
0.0179 22 3.76970 
OW 
2.0( 0.8, 4.3) 
9.0 ( 5.8, 10.5) 
8.5 ( 4.5, 9.3) 
6.5( 3.0, 14.0) 
28.5( 22.3, 32.0) 
Cc 
C'57BL16J l000mgJL 
SOURCE 	SUM OF 
SQUARES 
DEGREES 	MEAN 	 F VALUE 	TAIL OF 	 SQUARES 	 PROB. FREEDOM 
MEAN 
TREAT 








20.51396 0.04 0.8371 
















117.22047 0.25 0.6237 






4795.82305 4 1198.96084 10.03 0.0000 
MF 
488.82305 4 122.20576 1.02 0.3909 
MS 






41.46639 0.35 0.8117 












4 348.73574 2.92 0.0325 
132 11957877 
Median (+ lower and upper intraquartile ranges) values of bouts of crawling behaviour by C57BU6J pups following prenatal exposure to oral aluminium sulphate (750mgfL, GdlO-16). 
DURATION 
Day Cc Ct Tt Ic 
6 19.8 
( 4.2, 	29.8) 
9 74.3( 44.6, 109.7) 
12 41.7( 285, 53.7) 
15 32.6( 10.4, 47.7) 
18 118.1( 87.6, 143.5) 
FREQUENCY 
Day Cc 
3 2.0( 1.0, 	3.5) 
6 7.0( 5.8, 	9.3) 
9 9.5( 7.0, 12.5) 
12 11.0( 9.5, 13.5) 
15 11.5( 9.8, 19.0) 
18 22.0( 19.3, 	26.0) 
16.4 
( 0.0, 43.5) 
45.8( 23.1, 60.4) 
48.9( 33.7, 63.7) 
56.6 ( 17.4, 97.7) 
129.7 (111.8,148.8) 
Ct 
0.0( 	0.0, 3.5) 
6.0( 	4.0, 8.0) 
8.0( 	5.5, 13.0) 
15.0 (19.5, 29.0) 
26.0(20.0, 30.0) 
Ct 
4.0( 3.0, 	5.0) 
5.0( 3.5, 	5.5) 
9.0( 6.0, 10.0) 
12.0( 10.0, 13.0) 
16.0 ( 11.0,26.5) 





65.8 (42.2, 88.5) 
35.1 (15.4, 55.7) 
49.7(28.6, 68.7) 
117.7 
( 97.8, 150.2) 
Tt 
3.0 ( 1.0, 7.0) 
7.5 ( 4.8, 13.0) 
7.0 (115, 17.5) 
19.0( 19.0, 27.0) 
23.0( 19.8, 31.0) 
It 
4.0( 3.0, 	9.0) 
7.0( 5.8, 	9.0) 
8.5( 7.0, 13.0) 
11.5( 8.0, 17.3) 
17.0( 8.0, 23.0) 
15.0( 12.8, 19.3) 
33.0 
( 7.8, 	62.4) 
60.4( 40.1, 	81.1) 
54.8( 38.6, 	77.9) 
52.5 ( 14.2 9 	83.2) 
123.1 (107.7, 144.2) 
Tc 
3.0 ( 1.0, 6.0) 
11.0 ( 5.0, 13.0) 
11.0( 6.0, 13.0) 
18.0( 7.0, 29.0) 
25.0 ( 21.0, 26.5) 
4.0( 2.0, 4.0) 
7.0( 4.0, 9.0) 
9.0( 7.0, 13.0) 
14.0 ( 8.0, 17.0) 





















3.56787 3.93 0.0730 
TC 0.50480 1 
13.11742 14.45 0.0029 
ERROR 9.98889 11 










1.18228 1.61 0.2264 
DTC 3.39520 2 
058048 0.79 0.4465 
ERROR 16.11111 22 




BEHAVIOURAL EFFECTS OF GESTATIONAL EXPOSURE TO 
ALUMINIUM. 
Judith RANKIN, Kofi SEDOWOFIA, Ruth CLAYTON and Aubrey MANNING. 
Institute of Cell, Animal and Population Biology, Edinburgh, U.K. 
Summary. - The involvement of aluminium in the aetiology of a number of human 
pathological diseases has altered its status from being a nontoxic, nonabsorbable, 
harmless element. This maybe of particular concern to the developing foetus which is 
more susceptible to agents and at lower levels than the adult. Little attention has been 
given to aluminium's potential reproductive toxicity until recently and further research 
is required for a full evaluation of its toxicity. Our preliminary results demonstrate 
behavioural and neurochemical alterations in the offspring of mice exposed to 
aluminium during gestation. Further, the effects of such exposure are also present in 
the adult animal suggesting persistent changes in behaviour following prenatal 
exposure. 
KEY WORDS: Aluminium Prenatal exposure Mouse 
Riassuto Q. - 
Introduction 
Human exposure to aluminium (Al) arises from several sources; it is 
present in food and used in the food processing industry, in cookware, in 
pharmaceutical preparations and as a flocculant in water treatment. In addition, there 
are growing amounts of Al entering the environment, particularly in the area of Al 
smelters, and as a result of leaching from soils by acid rain [1].  From these diverse 
routes of contact there is an increased likelihood of unknowingly being exposed to Al 
at levels higher than is recommended. 
For a long time it had been presumed that exposure to Al was without toxic 
effect. However, in contrast to this assumed harmlessness, Al has been implicated as a 
causative factor in several human pathological diseases in recent years; dialysis 
encephalopathy and osteomalacia [2], senile dementia of the Alzheimer's type (SDAT) 
[3], ainyotrophic lateral sclerosis and Parkinson's disease of Guam [4].  Although its 
exact role in these diseases is still a subject of discussion, this implication has led to an 
abundant literature concerning possible mechanisms by which Al exerts its 
neurotoxicity in adult animals and to tentative animal models for its effects on human 
beings. 
The lack of concern over the effects of Al ingestion resulted from the 
assumption that absorption from the gastrointestinal tract was minimal. It is now 
known that this is not the case and that Al may be absorbed e.g. from Al containing 
antacids [5]. Moreover, the absorption of Al is increased by the presence of 
parathyroid hormone [6] and by certain dietary factors, particularly citrate [7]. 
Of greater relevance to behavioural teratology is the accumulating clinical 
evidence which points to Al loading in infants with renal dysfunction not receiving 
dialysis but exposed to Al from the oral ingestion of Al-containing antacids. The 
levels of Al in plasma, serum and bone were elevated compared to controls [8,9]. 
Moreover, Sedman et al. [10] have shown that the intravenous feeding of premature 
infants resulted in a 10 fold increase of Al in bone. Further, urinary Al concentration 
did not reach the control level until several weeks after parenteral feeding was 
stopped, suggesting an accumulation of Al within body tissues. In addition, cases have 
been reported of infants with Al intoxication when the only possible source of 
exposure was from infant formula [11]. 
In the only documented study of accidental exposure of pregnant women to 
high levels of oral Al, Golding and coworkers [12] found no effects on the occurrence 
296 
of perinatal death, on body weight at birth, before term delivery or congenital 
malformations. However, there was an increased incidence of talipes among exposed 
infants (4.4% of cases). 
In contrast to the extensive literature on the neurotoxic effects of Al, few 
studies have considered the consequences of exposure to Al compounds during 
pregnancy and the early postnatal period. In recent years some attention has been 
given to such effects on the developing foetus but a full evaluation of risk effects has 
not been undertaken. This is of particular concern as exposure of the developing 
nervous system to insults may have very different consequences than those resulting 
from exposure of the adult nervous system. Furthermore, the developing foetus is 
more susceptible to and affected at doses far lower than those required to produce 
changes in the adult central nervous system [13]. 
The paucity of studies aimed at assessing this aspect of Al's biology may 
have resulted from the lack of detailed information on the distribution of Al following 
exposure and from the lack of adverse effects revealed by initial studies [14]. Within 
the studies which have addressed this question, it is difficult to generalise the effects 
resulting from exposure to Al. This is because studies have used different Al salts, the 
solubility of which vary greatly [15],  different doses and experimental animals. 
In the present paper we briefly report some preliminary findings from our 
studies on gestational exposure to aluminium sulphate (Al2(SO4)3) in mice and 
compare these with results in other studies. In the frame ol' our studies aimed at 
investigating the role of the genotype in individual sensitivity to drugs or toxicants, we 
have chosen the mouse as our experimental model. This altrical rodent has a similar 
placentation to that of humans and has been reported to show similarities in 
behavioural responses following exposure to known human behavioural teratogens 
[16]. Moreover, the development of inbred strains of mice has led to the introduction 
of almost isogenic individuals within a strain. 
Pregnant CBA mice were exposed to Al2(SO4)3 at a dose of 200mg/kg 
body weight and injected intraperitoneally during days 10 to 13 of gestation. The dose 
range and gestational period of exposure have been selected on the basis of previous 
experiments [17,18]. We have used a variety of ethological measures, which have 
been shown to be sensitive indicators of toxicants, with the aim of assessing subtle 
behavioural effects on the mother and the behavioural development of pups [19]. The 
use of a fostering procedure in behavioural teratology studies, to differentiate between 
direct effects of prenatal exposure and those arising from alterations in maternal 
behaviour or physiology, has been recommended by a number of authors (e.g. [20]). 
For this reason, all litters were cross-fostered on the day after birth (postnatal day 1) so 
that each mother reared two control and two treated pups. This gave 4 treatment 
groups; control pups fostered to control mothers (Cc), control pups fostered to treated 
mothers (Ct), treated pups fostered to treated mothers (Tt) and treated pups reared by 
control mothers (Tc). 
Effects of prenatal exposure 
Maternal weight 
In our experiments gestational weight gain of CBA females was reduced 
during the treatment period (gestational days 10-13). This decrease in maternal body 
weight was transient as all mothers increased their weight following the termination of 
treatment. Further, there was no difference in body weight between the treatment 
groups during the preweaning period. A decrease in maternal body weight following 
exposure to oral and injected Al has been observed by several authors [21,22]. 
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Maternal behaviour 
Alterations in the behaviour of the mother are known to affect infant 
development and several drugs have been shown to disrupt elements of maternal 
behaviour [23]. Thus, any disturbance to maternal care or the delicate mother-pup 
relationship may explain differential patterns of behaviour in the offspring rather than 
direct effects of prenatal exposure to a toxicant. The results of a pilot study suggested 
that differences exist in the pattern of maternal behaviour displayed by control and Al-
exposed mothers. Control mothers spent more time involved in the pup-directed 
behaviours of nursing and licking and less time in nest-building during the first two 
postnatal weeks than dams treated with Al during gestation. 
To further characterise any differences between Al-treated and control 
mothers we employed a pup retrieval test. Treated mothers had a longer latency to 
retrieve on postnatal day 3 (PO), although this difference did not reach significance. 
Only one previous study has included simultaneous recording of maternal 
behaviour after prenatal exposure to Al, showing no significant differences between 
treatment groups in nest-building, retrieval of pups to the nest or time spent with the 
young following exposure to A1C13 in the dam's diet from day 8 of gestation [24]. 
Thus it will be necessary to quantify further the maternal behaviour of mothers 
rearing control and Al-treated pups, an investigation currently being undertaken in our 
laboratory. 
Pup weight 
Prenatal exposure of pregnant female CBA mice to Al2(SO4)3 had no 
significant effect upon breeding performance; the length of gestation, litter size and 
sex ratio were unaffected by prenatal Al. Pup mortality, as a result of infanticide or 
neglect by the mother, occurred in both treatment groups at birth, thus this cannot be 
attributed to Al. The mean birth weight was significantly lower (by 6%) among Al-
exposed offspring. 
Similarly, the offspring of BALE/c mice had a reduced birth weight after 
i.p. exposure to A1C13 during gestation days 7 to 16, and an increased incidence of 
foetal resorptions was also reported [25]. Such effects on Al-treated offspring were 
also found following oral exposure of pregnant Sprague-Dawley rats to Al by gavage 
[26]. The lower birth weight of CBA treated pups persisted for those pups reared by 
treated mothers only, reflecting the significant effect foster mother treatment had on 
body weight. Thus, when treated pups are given adequate maternal care it is possible 
to overcome the weight impairment. As maternal food and water intake did not differ 
during the preweaning period, the diminished body weights cannot be accounted for in 
terms of nutritional deficiency. 
This postnatal maternal influence may have resulted from retention of Al 
within the mother's body allowing continued exposure via the dam's milk after 
termination of treatment. Yokel and McNamara [27] injected lactating rabbits with 
aluminium lactate (AlLact) and found 12% of the total injected Al still present in the 
area of the injection site seven days after the last injection. This postnatal effect seems 
likely as in our experiment control pups, which had no prenatal contact with Al, 
fostered to treated mothers (Ct) had reduced body weights compared to control pups 
reared by control mothers (Cc). Yokel [21] also found this to be the case; offspring of 
mothers exposed to 400 umol/AI/kg in utero and control offspring fostered to these 
does, gained less weight. 
Impairment in offspring body weight gain during the preweaning period is 
the most consistent observation following prenatal exposure to Al, irrespective of the 
route of administration or the chemical form of Al used [2 1,22,24,26]. However, the 
extent of present research with gestational Al does not permit the exclusion of a 
maternal factor accounting for this weight impairment. 
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Neurobehavioural development 
We have employed a modified version of the Fox battery of tests to 
measure sensory-motor development in control and Al-exposed offspring [28]. We 
found that treated offspring differed in their attainment of a mature response for 
forelimb grasping and pole grasping on Pd15. A maternal effect appeared also in the 
results for pole grasping as few Ct or Tt pups had reached a mature response by Pd15. 
Similarly, a significant difference between treated and controls was found for slow 
righting on Pd6, cliff aversion on Pd12 and screen climbing on Pd18. The 
impairments in attainment of these reflexes were transitory as all pups eventually 
achieved the adult response. 
It could be argued that the delays in neurobehavioural development are 
secondary to the reduction in physical maturation. However, we did not find a 
correlation between the performance in the particular Fox measure and body weight 
on the same day. Bemuzzi et al. [24] found that by Pd9, when delays in the response 
to negative geotaxis were present, no further treatment group differences in body 
weight existed. In accordance with our observations, Golub et al. [22], using a 
combined score to estimate performance in a battery of neurobehavioural tests, 
observed a delay in prenatally Al-treated offspring on Pd14 and 16. 
Thus, Al treatment in utero affects maturation of certain sensory-motor 
skills but not all. 
Pup behaviours 
In our study with CBA pups, the overall expression of the behavioural 
repertoire was unaffected by exposure to Al. However, the appearance of certain 
behaviours were delayed in Al-exposed offspring. Pup locomotor activity during 
postpartum days 9-18 showed a trend towards diminished activity levels in pups 
reared by treated mothers. Control pups spent more of their time involved in crawling 
compared to treated pups, as was the case for pups fostered to control mothers. In line 
with this, pups fostered to treated mothers exhibited a greater frequency of bouts of 
being still. On Pd18 treated pups exhibited a greater number of bouts of rearing which 
were of longer duration than that of controls. 
Ultrasonic vocalisations 
Rodent neonates emit ultrasonic vocalisations with a reliable and stable 
pattern from a few days after birth. The developmental and physical characteristics of 
such calls depend not only on the species under investigation but also the strain. As 
pointed out by Zbinden [29], this response may function as a sensitive indicator of 
subtle behavioural effects caused by prenatal or postnatal drug treatments. Several 
authors have shown consistent alterations in the production of these calls following 
drug exposure which have led them to recommend their incorporation in any battery 
of tests aimed at assessing behavioural teratogenicity [30]. 
In a very recent study we found that prenatal treatment with Al produced a 
striking reduction in the total number of ultrasonic vocalisations emitted by exposed 
CBA pups compared to controls on removal from the nest [31]. This difference was 
especially pronounced on days 3 and 4 after birth. In addition, treated pup calling did 
not reach a maximum until a day later than control offspring. In combination with the 
results of the sensory-motor tests, in which pups exposed to Al prenatally were slower 
to mature in certain tests than controls, this suggests that the mechanisms responsible 
for sound production matured later in Al-treated offspring. An alternative explanation 
is that in utero exposure to Al alters the ability of the neonate to detect or respond to a 
reduced temperature. 
It is not known if the ultrasonic calls of Al-exposed pups differed in other 
acoustic properties e.g. sound pressure, duration etc. as such measures were not 
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undertaken. However analysis of such characteristics, to further reveal any treatment 
effects, are currently under investigation. 
Activity at weaning 
The effect of in utero exposure to Al on CBA activity scores in an 
openfield at weaning (Pd21) was sex dependent. Treated females had lower activity 
scores during the 5 minute test than control females. Conversely, Al-exposed male 
pups crossed more squares than controls. Although treated pups took less time to 
approach a novel object placed in the centre of the openfield at the end of the activity 
test, this difference was only marginally significant. 
In a test of locomotor coordination, in which the subject was placed in 
water and could reach a platform by climbing a metal rod, Wistar rat pups from 
mothers treated orally with AlLact during gestation required more time to complete 
the task [32]. 
Long-term effects of early exposure 
Since subtle behavioural changes are not always immediately apparent, the 
attribution of such an effect to a substance taken by the mother during pregnancy is 
difficult. Thus, in experimental models of behavioural teratology it is vital to test 
subjects at different ages throughout life to assess whether effects from exposure are 
transient and may be recovered from, persist into adulthood or are present as delayed 
effects which only arise late in development. To date, few studies have considered 
long-term effects of early Al exposure on the adult animal. In our experiments, 12-
week old male subjects were tested in an 8-arm radial maze to assess learning ability. 
Results suggested an effect of Al on performance in the maze. More control animals 
reached the criterion of eight correct arm choices in the first  8 entries on 2 consecutive 
days (77%) than subjects previously exposed to Al in utero (55%). Also, the number 
of days required to reach this criterion was greater for treated mice. Tsujii and 
Hoshishima [33] observed deficits in learning ability of 5- to 7-week old mice exposed 
prenatally to repeated injections of Al and raised in standard laboratory cages. Young 
rabbits exposed during gestation to Al and tested for a classically conditioned 
response task at 11 weeks of age, showed a dependent effect of dose; animals in the 
low dose group performed better whilst the high dose group showed impaired 
acquisition and retention [21]. Muller et al. [32] found that the performance of rats 
treated prenatally with AlLact in an operant conditioning test, carried out 65 days after 
birth, was behind that of controls. In an activity test performed at 22 weeks of age, 
CBA female mice reared by treated mothers (Ct and Tt subjects) tended towards lower 
activity scores. 
In our experiments, the impairment in growth of offspring reared by treated 
mothers persisted into adulthood. As with performance in a classical conditioning 
learning task, Yokel [21] found a biphasic effect of gestational exposure to 
subcutaneously injected AlLact on the offspring's weight gain after weaning. 
Although the results were not significant, exposure to low levels of Al increased 
weight gain whereas weight loss was recorded at high exposure levels. 
Neurochemical changes 
The most consistent neurochemical finding in postmortem brains of 
patients with, for example, SDAT, has been alterations to the cholinergic system, the 
extent of which varies with brain region [34]. Because of the suggested association 
between the incidence of these diseases and exposure to Al, we have measured the 
levels of choline acetyltransferase (ChAT), the enzyme responsible for the synthesis 
of acetylcholine, in a number of brain regions and at different ages. 
Although some inconsistencies existed in the levels of ChAT activity at 
each age and between each brain region, the direction of change in the cerebral cortex, 
cerebellum and hippocainpus (the areas affected in SDAT) between control and 
treated subjects was the same at each time point; treated brains exhibited a reduced 
level of enzyme activity compared to controls. For example, the amount of ChAT 
activity measured at 34 weeks of age in the cerebral cortex of treated animals was 
44% less than that in controls. 
Discussion 
It is clear that there is a lack of information on a number of behavioural 
measures following gestational exposure to Al, which limits a more comprehensive 
evaluation of aluminium's behavioural teratogenicity. The results presented in this 
brief report suggest that prenatal exposure to Al causes alterations to body growth, 
ultrasound production and sensory-motor development. Moreover, exposure to Al 
during gestation may result in behavioural deficits during early postnatal development 
which may persist into adulthood. 
The foetus may be directly exposed to Al in utero via placental transfer. 
The extent of any persistence of Al in the body is not fully known. However, the data 
presented herein suggests that Al is available to distribute into the dam's milk resulting 
in continued exposure of the neonate over time. 
Further work is required to investigate the consequences of Al exposure on 
the mother-infant interaction. For example, as ultrasonic calls function to elicit 
maternal care [35], exposure to Al during gestation may have affected the ability of 
treated mothers to respond adequately to the ultrasonic calls of their fostered pups. 
Although the exact neural mechanisms responsible for eliciting ultrasonic 
vocalizations are unknown, the involvement of a number of different neurotransmitter 
systems has been proposed. These include the dopaminergic [36], GABAergic [37], 
cholinergic [38] and the opioid system [39]. We have shown that prenatal exposure to 
Al resulted in decreased levels of ChAT during adulthood which leads to the tentative 
suggestion that the cholinergic system may play a role in the production of these calls. 
From a methodological point of view the results we report herein certainly 
suggest that ultrasound recording should be included in any battery of tests aimed at 
assessing possible behavioural teratogenicity. 
In particular, the presence of a maternal influence in our results emphasis 
the importance of including a fostering design in teratology studies to ensure adequate 
interpretation of results. To date only one study has done so [21]. 
Al is present in the environment in a number of different chemical forms. 
The extent of the solubility of Al in the body is dependent on the Al salt to which 
exposure results, thus the need to evaluate inter- and intraspecies differences in the 
bioavailability of Al and its different salts is great. As susceptibility to a number of 
drugs depends on the genotype, further studies of gestational exposure to Al with a 
second inbred strain of mouse are being carried out. 
Aluminium may be poorly absorbed from the gastrointestinal tract under 
normal conditions. However in the developing organism such protective barriers are 
immature which may render it more susceptible to any toxic effects. 
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